In Brief: The @uk_biobank adds a detailed immune dataset to its repository to enable a better understanding of how immune variation affects health, aging and disease www.nature.com/articles/s41587-026-03388-7
rdcu.be/dV9WEME5S6Ya
Nature Biotechnology
Nature Biotechnology is a monthly peer-reviewed scientific journal published by Nature Portfolio. The editor-in-chief is Barbara Cheifet who heads an in-house team of editors. The focus of the journal is biotechnology including research results and the commercial business sector of this field. Coverage includes the related biological, biomedical, agricultural and environmental sciences. Also of interest are the commercial, political, legal, and societal influences that affect this field. More on Wikipedia
-
Nature Biotechnology
@NatureBiotech
-
Nature Biotechnology
@NatureBiotech
A comprehensive analysis of CBER experience with AAV gene therapy IND submissions www.nature.com/articles/s41587-026-03378-9
-
Nature Biotechnology
@NatureBiotech
A CD7-targeted AAV variant enables efficient T and NK cell engineering in vivo www.nature.com/articles/s41587-026-03344-5
-
Nature Biotechnology reposted
nature
@Nature
Agricultural biotechnology once found itself in opposition to environmental science. Now it could reduce the impact of food systems on global warming and biodiversity loss
go.nature.com/4zHvvUf -
Nature Biotechnology reposted
Alberto Ciccia
@CicciaAlberto
Excited to share that our map of the genetic interaction network of the DNA Damage Response is out in @NatureBiotech! Led by Sam Hayward, @vaitsiankova and @tlmdz_.
rdcu.be/VM8XuctGW5Ra -
Nature Biotechnology
@NatureBiotech
The AI titans are placing their bets on drug discovery, and investors are coming along for the ride www.nature.com/articles/s41587-026-03382-z
[šread free with login] -
Nature Biotechnology
@NatureBiotech
Deployability of biotechnologies for environmentally resilient agriculture www.nature.com/articles/s41587-026-03373-0
-
Nature Biotechnology
@NatureBiotech
The relentless expansion of agriculture is ravaging biodiversity and the climate. Biotech can help redesign food systems for sustainability www.nature.com/articles/s41587-026-03394-9
#cop31 -
Nature Biotechnology
@NatureBiotech
A systematic screen identifies RNA elements that enhance the stability and translation of base-modified mRNA go.nature.com/4opTAsV
rdcu.be/VN5MMEkURbia -
Nature Biotechnology
@NatureBiotech
Thank you @Nature for highlighting our Focus Issue on climate biotechnology in this editorial
#cop31
nature
@Nature
Agricultural biotechnology once found itself in opposition to environmental science. Now it could reduce the impact of food systems on global warming and biodiversity loss
go.nature.com/4zHvvUf -
Nature Biotechnology
@NatureBiotech
How biotechnology can mitigate climate change by curbing the global land squeeze www.nature.com/articles/s41587-026-03371-2
#cop31 -
Nature Biotechnology
@NatureBiotech
In Brief: Chinaās government proposes to block the sale of certain technology platforms to foreign entities, including five technologies related to pathogen gain-of-function platforms, cell and gene therapy and small interfering RNA www.nature.com/articles/s41587-026-03397-6
rdcu.be/wK7ys99uoUEa -
Nature Biotechnology
@NatureBiotech
The seeds of resilience: Plant biotechnologists are fine-tuning genetic pathways to develop a new generation of crops equipped to cope with the myriad pressures of climate change www.nature.com/articles/s41587-026-03372-1
#cop31 [šread free with login] -
Nature Biotechnology reposted
nature
@Nature
Two years ago, countries at a UN biodiversity summit agreed that companies profiting from Earthās genetic data should pay to help preserve nature. So far theyāve contributed just US$10,588.
go.nature.com/4zq2yMr -
Nature Biotechnology
@NatureBiotech
Cas12a-based combinatorial knockout screens define the genetic architecture of the DNA damage response www.nature.com/articles/s41587-026-03339-2
Nature Biotechnology
@NatureBiotech
Wayne State faculty contributes to new study mapping the genetic architecture of the DNA damage response #nbtinthenews today.wayne.edu/medicine/news/2026/11/11/wayne-state-facuā¦
-
Nature Biotechnology
@NatureBiotech
Research Highlight: De novo design of proteases www.nature.com/articles/s41587-026-03389-6
nature
@Nature
Nature research paper: De novo design of cysteine proteases
go.nature.com/4zUMtOP -
Nature Biotechnology
@NatureBiotech
Are AI tech giants hijacking drug discovery? www.nature.com/articles/s41587-026-03382-z
[šread free with login] -
Nature Biotechnology
@NatureBiotech
The next frontier in nitrogen fixation www.nature.com/articles/s41587-026-03336-5
-
Nature Biotechnology
@NatureBiotech
Biotechnologies for climate resilience www.nature.com/articles/s41587-026-03394-9
-
Nature Biotechnology
@NatureBiotech
The November issue is live. This month's special issue focuses on biotech research for climate mitigation and adaptation, with a selection of Perspectives and Comments on how biotechnologies could help tackle the acute challenge facing agriculture and beyond in the coming decades
-
Nature Biotechnology
@NatureBiotech
Democratizing synthetic biology requires reducing costs, improving logistics and distribution, developing local expertise, and motivating educators and students www.nature.com/articles/s41587-026-03338-3
rdcu.be/xo9QXiQMBp7a -
Nature Biotechnology reposted
Darko Barisic
@LabBarisic
Excited to share our other recent paper in @NatureBiotech from Christina Leslie and our lab. We developed and in vivo validated DynaVelo, a deep learning tool that predicts rescue of genetic loss-of-function mutations. Brilliantly led by @karbalayghareh www.nature.com/articles/s41587-026-03348-1
-
Nature Biotechnology
@NatureBiotech
Each year, we highlight companies that received sizeable early-stage funding in the previous year. Wild Bioscience is pursuing crop gene editing for higher yields and climate resilience www.nature.com/articles/s41587-026-03377-w
-
Nature Biotechnology
@NatureBiotech
Join pioneering researchers at RNA at the Bench and Bedside V on December 8-10, 2026. The conference will discuss the development of nucleic acid medicines including recent clinical successes, and current and upcoming challenges. Registration is available until November 10:
-
Nature Biotechnology
@NatureBiotech
Scientists mining the ādark proteomeā are uncovering thousands of previously missed proteins, including promising new targets for cancer immunotherapies www.nature.com/articles/s41587-026-03306-x
rdcu.be/YxZrAghhPmsa -
Nature Biotechnology
@NatureBiotech
Engineered human Argonaute 2 for targeted C-to-U RNA base editing www.nature.com/articles/s41587-026-03359-y
Nature Biotechnology
@NatureBiotech
Stanford repurposes a human protein into an RNA editor that beats Cas13 tools #nbtinthenews allsci.com/news/biotech/rna-base-editor-stanford-repurposā¦
Nature Biotechnology
@NatureBiotech
Research Briefing: Human Argonaute 2 is a programmable targeting domain for RNA editing www.nature.com/articles/s41587-026-03358-z
-
Nature Biotechnology
@NatureBiotech
Happy anniversary! Our October editorial celebrates 10 years of accomplishments and looks ahead to the future www.nature.com/articles/s41587-026-03365-0
Human Cell Atlas
@humancellatlas
To mark our tenth Anniversary month, watch HCA Co-Founder Aviv Regev reveal her hopes for the Human Cell Atlas initiative, and how it is already helping to improve medicine.
#humancellatlas #healthcare -
Nature Biotechnology reposted
Rong
@_RongL
Looking forward to #sitc26 next week! If youād like to discuss your recent work or upcoming submissions to Nature Biotechnology, please get in touch. See you in Phoenix!
@NatureBiotech @sitcancer -
Nature Biotechnology reposted
Jean-Philippe Vert @jeanphi_vert
Excited to see @bioptimus_ai featured as Editor's pick this month in @NatureBiotech !
From tissue pathology (H-Optimus) to molecular scales (M-Optimus) and global data generation via STELA, weāre building a foundational world model of human biology.
rdcu.be/71DqJQmxNLea -
Nature Biotechnology reposted
Sudarshan GC, M.Sc. @Sudarsh07847591
Biology should not be limited within a boundary. It needs more people, more diversity, more inclusivity, to explore it or exploit it.
@NatureBiotech
Nature Biotechnology
@NatureBiotech
Expanding global access to synthetic biology www.nature.com/articles/s41587-026-03338-3
-
Nature Biotechnology reposted
Konstantinos Drosatos @Kdrosatos
Giving AI a seat at the peer review table OR AI as Reviewer 4?
Nature Biotechnology
(www.nature.com/articles/s41587-026-03369-w)
Together with Aristotelis Tsirigos @artsinyc, we aim to open a dialogue on the responsible use of large language models and AI/SI in peer review. Rather than pretending reviewers do not use these tools, it is time to establish how to use them appropriately while safeguarding the confidentiality of manuscripts and grant applications.
Drosatos, K., Tsirigos, A. Giving AI a seat at the peer review table. Nat Biotechnol (2026). doi.org/10.1038/s41587-026-03369-w -
Nature Biotechnology reposted
Springer Nature
@SpringerNature
Springer Nature and @GoogleDeepMind are partnering to co-design an AI peer review assistant, exploring how AI can help reviewers navigate manuscripts more effectively and focus their time on specialist scientific judgement.
Learn more: spklr.io/6017EVgrh -
Nature Biotechnology
@NatureBiotech
A true multidisciplinary scientist, Bowen Li finds that some of the most interesting questions are located precisely at the boundaries between fields www.nature.com/articles/s41587-026-03340-9
rdcu.be/BiMQqoAu6WLa -
Nature Biotechnology
@NatureBiotech
Research Highlight: Tracing the origins of CRISPRāCas www.nature.com/articles/s41587-026-03353-4
Kenneth Loi
@kenjmloi
VIPR is now out in @ScienceMagazine!
What started with a mysterious RNA led us to an unexpected way of recognizing DNA, as well as some clues to CRISPRās origins.
So happy to share these two papers with an incredible team. Links below; original discovery thread here āThis post is unavailable. See it on X. -
Nature Biotechnology
@NatureBiotech
Recent moves of note in and around the biotech and pharma industries www.nature.com/articles/s41587-026-03341-8
rdcu.be/aF3kuHx5yhsa -
Nature Biotechnology
@NatureBiotech
CellWhisperer uses multimodal learning of transcriptomes and text to answer questions about single-cell RNA-sequencing data go.nature.com/3WPGJnW
rdcu.be/TamrmUPBYm6a -
Nature Biotechnology
@NatureBiotech
Giving AI a seat at the peer review table www.nature.com/articles/s41587-026-03369-w
Nature Biotechnology
@NatureBiotech
Nature authors propose AI as a non-voting āReviewer 4ā to ease peer review workload #nbtinthenews www.thecatalystbrief.com/article/nature-authors-propose-aā¦
-
Nature Biotechnology
@NatureBiotech
In vivo engineering of CAR natural killer cells for immunotherapy using ligand-directed lipid nanoparticles www.nature.com/articles/s41587-026-03310-1
Nature Biotechnology
@NatureBiotech
Reprogrammed NK immune cells target cancer and autoimmune disorders #nbtinthenews via @MIT news.mit.edu/2026/reprogrammed-nk-immune-cells-target-canā¦
Nature Biotechnology
@NatureBiotech
MIT scientists reprogram immune cells inside the body to destroy cancer #nbtinthenews scitechdaily.com/mit-scientists-reprogram-immune-cells-inā¦
-
Nature Biotechnology
@NatureBiotech
Biotech news from around the world: Turkey, South Korea, Denmark, Lithuania www.nature.com/articles/s41587-026-03347-2
rdcu.be/k8r28fA5sLPa -
Nature Biotechnology
@NatureBiotech
Research Highlight: Live-cell imaging goes WHOLISTIC www.nature.com/articles/s41587-026-03354-3
nature
@Nature
Nature research paper: Imaging cellular activity across all organs reveals body-wide circuits
go.nature.com/4xSOOsS -
Nature Biotechnology
@NatureBiotech
Regeneron approval brings relief for āsecond skeletonā bone disorder www.nature.com/articles/s41587-026-03346-3
-
Nature Biotechnology
@NatureBiotech
Engineering an immune receptor improves resistance to bacterial and fungal pathogens in a variety of plants go.nature.com/474nnA9
rdcu.be/HhLtVgah1mHa -
Nature Biotechnology
@NatureBiotech
As the @humancellatlas project enters its second decade, the question is no longer whether we can map human cells, it is what we will do with the map www.nature.com/articles/s41587-026-03365-0
-
Nature Biotechnology
@NatureBiotech
An engineered, compact Cas12m variant for multiplexed gene activation in vivo www.nature.com/articles/s41587-026-03352-5
-
Nature Biotechnology
@NatureBiotech
An mRNAālipid nanoparticle vaccine against H5N1 influenza virus protects lactating dairy cows from infection www.nature.com/articles/s41587-026-03343-6
-
Nature Biotechnology
@NatureBiotech
A metagenomic screen identifies retron reverse transcriptases for precise genome-editing applications go.nature.com/4nkr7DE
rdcu.be/uETQjocfSgna -
Nature Biotechnology
@NatureBiotech
Deep dynamical models of single-cell multiomic velocities predict loss-of-function and rescue perturbations in B cells www.nature.com/articles/s41587-026-03348-1
Nature Biotechnology
@NatureBiotech
Researchers develop AI tool that can predict a cellās fate ā and help change it #nbtinthenews www.eurekalert.org/news-releases/1148934
-
Nature Biotechnology
@NatureBiotech
An analysis of the CRISPRāCas patent landscape is essential for understanding applications in depth and overcoming challenges strategically, thereby supporting a safer integration of CRISPRāCas into clinical practice www.nature.com/articles/s41587-026-03337-4
rdcu.be/QhJVkdcUu7Ja -
Nature Biotechnology
@NatureBiotech
Recent patents relating to systems, methods and compositions for use in genome editing www.nature.com/articles/s41587-026-03324-9
rdcu.be/qoVixcVcNrAa -
Nature Biotechnology
@NatureBiotech
Expanding global access to synthetic biology www.nature.com/articles/s41587-026-03338-3
-
Nature Biotechnology
@NatureBiotech
Stem cell repair of injured monkey spinal cords restores hand function in 53% of trials go.nature.com/3LKx0ge
rdcu.be/AYFYsSnnpwZa
Nature Biotechnology
@NatureBiotech
In a major step toward clinical translation, transplanting stem cells into the injured spinal cords of rhesus monkeys improves hand function #nbtnv go.nature.com/3JIjfOG
rdcu.be/eQCUr -
Nature Biotechnology
@NatureBiotech
Recordanelles for transcriptome-wide single-cell RNA recording in human cells www.nature.com/articles/s41587-026-03327-6
Nature Biotechnology
@NatureBiotech
Research Briefing: Recordanelles capture transient gene expression in single human cells www.nature.com/articles/s41587-026-03350-7
Nature Biotechnology
@NatureBiotech
New method reveals what a cell did days ago #nbtinthenews ethz.ch/en/news-and-events/eth-news/news/2026/10/new-methā¦
-
Nature Biotechnology
@NatureBiotech
.@Regeneron's newly approved antibody stops abnormal bone growth in patients with the devastating disease fibrodysplasia ossificans www.nature.com/articles/s41587-026-03346-3
-
Nature Biotechnology reposted
Alireza Karbalayghareh @karbalayghareh
I am excited to share that DynaVelo is now published in @NatureBiotech!
Paper: www.nature.com/articles/s41587-026-03348-1
Code: github.com/karbalayghareh/DynaVelo -
Nature Biotechnology reposted
Christopher Reinkemeier
@ReinkemeierCD
Ever wondered what a cell has experienced in the past? This is in general hard to measure. Here we introduce the recordanelle, to equip cells with a tool that lets them record their own history.
www.nature.com/articles/s41587-026-03327-6
@NatureBiotech @ETH @randall_platt @ETH_BSSE -
Nature Biotechnology reposted
Steven Banik
@StevenMBanik
Our final version of human AGO2 led editing of RNA is out today in @NatureBiotech! Led by @noScandineHere, we got excited by the reduced immunogenic risk and efficacy advantages of using a human-derived protein for non-downregulatory RNA manipulation.
www.nature.com/articles/s41587-026-03359-y -
Nature Biotechnology reposted
Jennbrophy.bsky.social
@jennbrophy7
Huge congratulations to
@vivzhong97, Michaela Jones and team on the publication of their work in @NatureBiotech today!
doi.org/10.1038/s41587-026-03360-5
Aditya Kunjapur
@kunjapur
This work led by @jennbrophy7 and her student @vivzhong97 in collaboration with my lab & student Michaela Jones published online this morning at Nature Biotechnology
www.nature.com/articles/s41587-026-03360-5
Helps limit engr'd microbial functions to target plants
Exciting science, amazing collabThis post is unavailable. See it on X. -
Nature Biotechnology
@NatureBiotech
Epithelial organoids are grown without Matrigel using a single-chain antibody go.nature.com/3Le6j3i
rdcu.be/8aRvgWzbvuRa -
Nature Biotechnology
@NatureBiotech
Deep learning perturbation models can outperform baselines on calibrated metrics - @ShiftBioscience www.nature.com/articles/s41587-026-03307-w
Nature Biotechnology
@NatureBiotech
Shift Bioscience publication increases confidence in AI virtual cells for novel target discovery #nbtinthenews www.businesswire.com/news/home/20261005043215/en/Shift-Biā¦
Nature Biotechnology
@NatureBiotech
New calibration framework improves confidence in AI virtual cell models #nbtinthenews www.genengnews.com/topics/artificial-intelligence/new-calā¦
Nature Biotechnology
@NatureBiotech
Flawed benchmarks hid AI success in gene perturbation prediction #nbtinthenews bioengineer.org/flawed-benchmarks-hid-ai-success-in-gene-ā¦
Nature Biotechnology
@NatureBiotech
New research from Shift Bioscience increases confidence in AI virtual cells for novel target discovery #nbtinthenews www.scientistlive.com/new-research-from-shift-bioscience-ā¦
-
Nature Biotechnology
@NatureBiotech
An effective CRISPR RNA occlusion strategy enhances mismatch detection when using Cas13 go.nature.com/4oglebG
rdcu.be/ZaS8Y5zE3WVa -
Nature Biotechnology
@NatureBiotech
Regeneron approval brings relief for āsecond skeletonā bone disorder www.nature.com/articles/s41587-026-03346-3
-
Nature Biotechnology
@NatureBiotech
Cancer immunotherapy benefits from antibody-lectin chimeras that block glyco-immune checkpoints go.nature.com/4aRDpk8
rdcu.be/ZqESYB6vavSa -
Nature Biotechnology
@NatureBiotech
Decoding systemic vascular health and hypertensive disorders in pregnancy through retinal imaging and Visionary AI www.nature.com/articles/s41587-026-03303-0
Nature Biotechnology
@NatureBiotech
The eye as a biomarker: why retinal AI could reshape how trials screen and stratify pregnant patients #nbtinthenews www.clinicaltrialvanguard.com/article/article-deep-dive/tā¦
-
Nature Biotechnology
@NatureBiotech
Genetic code expansion enables plant-directed control of bacterial activity www.nature.com/articles/s41587-026-03360-5
-
Nature Biotechnology
@NatureBiotech
Discovery and protein language model-guided design of hyperactive transposases go.nature.com/4gXLGEw
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
AI-designed proteins surpass nature in genome editing #nbtinthenews via @digwatchworld dig.watch/updates/ai-designed-proteins-surpass-nature-in-ā¦
Nature Biotechnology
@NatureBiotech
Scientists use generative AI to build better proteins for editing DNA #nbtinthenews www.thebrighterside.news/post/scientists-use-generative-aā¦
-
Nature Biotechnology
@NatureBiotech
In Brief: @FDA greenlights @ionispharma's #zanvastro, the first disease-modifying drug for a rare, progressive and often fatal neurological condition known as Alexander disease www.nature.com/articles/s41587-026-03349-0
rdcu.be/ufenZXWBDYda -
Nature Biotechnology
@NatureBiotech
Five questions with Bowen Li www.nature.com/articles/s41587-026-03340-9
-
Nature Biotechnology
@NatureBiotech
Each year, we highlight companies that received sizeable early-stage funding in the previous year. @bioptimus_ai is developing multimodal and multiscale AI pathology models for biomarker and drug treatment prediction www.nature.com/articles/s41587-026-03345-4
-
Nature Biotechnology reposted
nature
@Nature
How much do PhD students earn?
The first comprehensive overview of PhD income shows vast imbalances across much of Europe
Read the full story: go.nature.com/4B8qAwD go.nature.com/4zwzdiR -
Nature Biotechnology reposted
Ke Cheng, Ph.D. @KeChengLab
Many thanks to @NatureBiotech for selecting our work as the front cover. Congratulations again to @ShuoL_ and the entire team.
Nature Biotechnology
@NatureBiotech
The October issue is live www.nature.com/nbt/volumes/44/issues/10
On the cover, engineered inhalable exosomes display a bispecific T cell activator targeting a cancer cell along with a T cell. PD1 and FZD on the exosomes block tumor-cell PD-L1 signaling and neutralize tumor-secreted Wnt, respectively go.nature.com/496Ins7
rdcu.be/avnjBsFZKzFa -
Nature Biotechnology reposted
Human Cell Atlas
@humancellatlas
Fabulous to see this editorial from @NatureBiotech, highlighting HCA achievements and technologies over the past 10 years, and the ambitious plans for the future. Watch this space!
#humancellatlas #genomics
Nature Biotechnology
@NatureBiotech
Ten years, tens of millions of cells www.nature.com/articles/s41587-026-03365-0
-
Nature Biotechnology reposted
Temerty Centre for AI in Medicine (T-CAIREM)
@UofT_TCAIREM
š Wonderful Q&A with @UofT researcher Bowen Li (@BowenLi_Lab)! @NatureBiotech
www.nature.com/articles/s41587-026-03340-9
#medx #medtwitter #meded #aiinhealthcare #healthai #healthtech -
Nature Biotechnology
@NatureBiotech
Highly multiplexed mammalian metabolic engineering with a shotgun approach - @sudpinglay @JefBoeke www.nature.com/articles/s41587-026-03318-7
Nature Biotechnology
@NatureBiotech
Research Briefing: High-throughput metabolic engineering in mammalian cells www.nature.com/articles/s41587-026-03317-8
rdcu.be/3vBcu8BGsmWa
Nature Biotechnology
@NatureBiotech
Shotgun engineering fires up mammalian metabolic design #nbtnv www.nature.com/articles/s41587-026-03329-4
Nature Biotechnology
@NatureBiotech
Shotgun genetic engineering lets mammalian cells stumble onto new metabolic pathways #nbtinthenews scienmag.com/shotgun-genetic-engineering-lets-mammalian-cā¦
-
Nature Biotechnology
@NatureBiotech
T cell immunity declines with thymic atrophy, but thymic cell grafts rescue T cell function go.nature.com/3Jp6B72
rdcu.be/4C6R4B1ZJaWa
Nature Biotechnology
@NatureBiotech
Cross-species analysis of thymic stroma in mice and humans reveals a subset of mesenchymal cells that are capable of restoring thymic function, which suggests new strategies for thymus regeneration #nbtnv go.nature.com/4r1A8Vp
rdcu.be/eOpTg -
Nature Biotechnology
@NatureBiotech
While mammalian delivery technologies are advancing to translation at an exceptional rate, delivery to plant tissues faces challenges, limiting their practical applications www.nature.com/articles/s41587-026-03356-1
-
Nature Biotechnology
@NatureBiotech
Structural variant detection across sequencing technologies www.nature.com/articles/s41587-026-03332-9
-
Nature Biotechnology
@NatureBiotech
Accelerated discovery of thermostable mRNAālipid nanoparticle vaccines using data-efficient AI www.nature.com/articles/s41587-026-03331-w
Nature Biotechnology
@NatureBiotech
Research Briefing: AI-guided optimization for thermostable mRNA vaccines www.nature.com/articles/s41587-026-03330-x
Nature Biotechnology
@NatureBiotech
New formulation helps RNA vaccines withstand high temperatures #nbtinthenews via @MIT news.mit.edu/2026/new-formulation-helps-rna-vaccines-withā¦
Nature Biotechnology
@NatureBiotech
The AI that eliminated cold chain from mRNA vaccines just changed how you design a phase 1 #nbtinthenews www.clinicaltrialvanguard.com/article/intel-brief/the-ai-ā¦
Nature Biotechnology
@NatureBiotech
Scientists found a way to make RNA vaccines survive higher temperatures #nbtinthenews www.yahoo.com/news/science/articles/scientists-found-way-ā¦
Nature Biotechnology
@NatureBiotech
Experimental approach uses AI to eliminate cold storage for mRNA vaccines #nbtinthenews www.reuters.com/business/healthcare-pharmaceuticals/experā¦
-
Nature Biotechnology
@NatureBiotech
In Brief: @FDA approves @RevMedicinesā #rasonque, a first-in-class RAS inhibitor targeting the most common form of pancreatic cancer. An early-stage trial shows that the drug also has promise in lung cancer www.nature.com/articles/s41587-026-03363-2
rdcu.be/hJwr1gqQSW3a -
Nature Biotechnology
@NatureBiotech
Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment www.nature.com/articles/s41587-026-03286-y
Nature Biotechnology
@NatureBiotech
Insilico Medicine
@InSilicoMeds
Nature Biotechnology | Insilicoās AI-Driven IPF Candidate Rentosertib Shows Potential for Biological Age Reversal, as Assessed by Six Proteomic Aging Clocks www.nature.com/articles/s41587-026-03286-y
First-in-Class Evaluation of an AI-Driven Candidate: This is the first de-novo drug designed with generative AI for a de-novo target discovered using AI and Aging Research (AI aging clocks, AI models and Hallmarks of Aging Assessment).
First Universal Consensus Across Six Independently-Developed Proteomic Aging Clocks: Analyzing 12-week longitudinal Olink proteomic data from 42 IPF patients, six aging clock models (including ProtAge, OrganAge, and PAC) independently developed by the leading groups from Harvard, Oxford, PKU, and Insilico, unanimously indicated that rentosertib reversed predicted biological age.
First Scalable Blueprint for Dual-Purpose Clinical Trials: The study is the first demonstration of a novel drug for a novel target discovered using aging research purposed to the age-related disease with aging biomarkers applied in a context of a clinical study. It establishes a standardized framework for embedding geroscience endpoints into standard disease trials, aligned with FDA Biomarker/BEST guidelines for dual-purpose aging and disease therapeutics.
CAMBRIDGE, Mass. ā Monday, September 7, 2026 (5AM EST) ā Insilico Medicine (āInsilicoā), a clinical-stage company focused on generative AI-driven drug discovery and development, today announced the publication of a new study conducted in collaboration with an international team of scientists from Harvard Medical School, Stanford University, The Broad Institute, RWTH Aachen University, Peking University and Westlake University.
Using longitudinal Olink proteomic data (CNCB OMIX accession: OMIX008341) collected during a Phase IIa clinical trial of rentosertib, researchers evaluated biological age using six internationally recognized, independently developed proteomic aging clocks. All six models consistently indicated a reduction in predicted biological age among patients treated with rentosertib. In addition, the Forced Vital Capacity (FVC), the essential measure of lung function declining with age, showed promising dose-dependent reversal compared to placebo aligning with the proteomic aging clock age reversal.
Recently published in Nature Biotechnology, the study represents the first clinical evaluation of a potentially first-in-class drug candidate featuring both an AI-discovered target with relevance to aging and disease biology and an AI-designed molecule, rather than a repurposed generic drug such as rapamycin or metformin. The findings also provide a proof-of-concept framework for integrating aging biomarkers into standard clinical trials to accelerate the discovery of geroprotective drugs and longevity therapeutics.
The results will be presented by first author Alex Zhavoronkov, founder and CEO of Insilico Medicine, at the Nature conference: Redefining Healthcare in the Age of AI, to be held at Sorbonne University in Paris on September 8, 2026.
From aging biology to a clinical drug
Unlike traditional geroscience studies that rely on repurposed drugs like rapamycin or metformin, Insilico pursued a different approach by incorporating aging biology into its drug discovery strategy from the outset.
Using its AI-powered target discovery platform, Insilico identified TNIK as a novel target implicated in aging and fibrosis and performed hallmarks of aging assessment where TNIK scored highly in 6 hallmarks. TNIK was subsequently prioritized as a dual-purpose target relevant to both underlying aging biology and idiopathic pulmonary fibrosis (IPF). Insilicoās generative chemistry platform, Chemistry42, was then deployed to design the small-molecule candidate rentosertib targeting TNIK. The program progressed from target identification to preclinical candidate nomination in approximately 18 months, with the preclinical findings published in Nature Biotechnology in 2024.
In June 2025, Insilico reported the results of a Phase IIa trial of Rentosertib for IPF (NCT05938920) in Nature Medicine. The trial met its primary safety endpoint and demonstrated a promising dose-dependent trend in efficacy. One of the common efficacy outcome measures is Forced Vital Capacity (FVC), the essential measure of lung function. The typical age of onset of IPF is around 65 years. Interestingly, in healthy individuals older than 65, FVC declines as well typically at the rate of 20-50 mL/year and may also serve as a potential physiological biomarker of aging. In the previous publication, it was revealed that in the 60-mg once-daily group, patients experienced a mean improvement in forced vital capacity (FVC) of +98.4 mL, compared with a mean decline of -20.3 mL in the placebo group (-62.3 excluding outlier).
Crucially, the trial protocol prospectively included longitudinal serum proteomic screening for exploratory biomarker analyses, which proved consistent with the drugās proposed anti-fibrotic and anti-inflammatory activity. All data collected from the trial were subsequently deposited with the China National Center for Bioinformation (CNCB), enabling the current investigation of biological aging biomarkers.
Six different clocks point to strong biological age reversal measured by proteomics
In the current study, researchers evaluated serum proteome profiles from 42 trial participants across 2,841 proteins. The team applied six independently developed proteomic aging clocks, including ProtAge, OrganAge (chronological and mortality variants), PAC, ipfP3GPT, and PAOPAC. Despite relying on diverse methodologies and training criteria, all six clocks consistently exhibited a trend toward reversed biological age among rentosertib-treated patients compared to placebo. The peak effect is observed at Week 4 in participants receiving 30 mg BID with approximately 3ā4 years reversal in biological age and up to 6 years in a certain aging clock.
š·
Rentosertib decreases predicted biological age across various regimens as measured by most aging clocks, most significantly in the 30 mg BID group and in week 4.
Beyond changes in biological age scores, the study showed that rentosertibās anti-aging effects operate partially independent of its respiratory benefits. Notably, the dose associated with the greatest improvement in lung function differed from that producing the strongest age-reversal signal, suggesting that the drugās geroprotective activity was not merely a downstream consequence of disease improvement.
This systemic impact was further validated through comparisons with 55,319 UK Biobank profiles, which showed that rentosertib directly reversed the typical age-related protein-expression trajectories. Mechanistically, the drug acted as a senomorphic agent, suppressing key drivers of cellular senescence, including EREG, ESM1, IGFBP4, ITGA2, MMP10, MMP13, and SPP1 while downregulating growth-factor signaling pathways associated with accelerated aging, including RTKāPI3K and RASāERK, and modulating antioxidant and cholesterol metabolisms.
A framework for the future
To support reproducibility and further research, all research data have been deposited at CNCB (accession OMIX008341), and the underlying pipeline code has been published as the open-source Python library on GitHub.
Beyond these specific findings, the study lays out a scalable blueprint for embedding geroscience endpoints into disease-focused drug development. The research proposes a stepwise framework: collecting aging and senescence biomarkers prospectively as exploratory endpoints in disease trials, and ultimately pursuing biomarker qualification or composite clinical endpoints under the FDA Biomarker Qualification Program and FDAāNIH BEST framework. Such an approach could surface geroprotective candidates years or even decades earlier than the traditional path of post-approval drug repurposing.
Insilicoās dual-purpose therapeutic strategy is also proving its viability as a sustainable commercial model. Recently, Insilico reported total revenue of approximately $106 million in the first half of 2026, a 287% year-over-year increase, and achieved its first profitable half-year since listing, with an adjusted net profit exceeding $51 million. This milestone was driven by a series of out-licensing, co-development, and R&D collaborations with global partners, including Eli Lilly, Servier, Takeda, SK Biopharmaceuticals, Qilu Pharmaceutical, Hygtia Therapeutics, CMS, and Tenacia. As of the latest practicable date, the total contract value of transactions announced by Insilico in 2026 reached approximately $7.3 billion, pushing the cumulative contract value of its major collaborations since 2021 approximately $11 billion.
On the AI-driven R&D front, Insilico nominated nine development candidates within nine months of 2026 as of late August, setting a new company record for annual pipeline productivity and achieving eight clinical milestones across its proprietary and co-developed programs. Leading this progress is rentosertib (ISM001-055), the world's first drug candidate discovered and developed using generative AI, which has advanced to a Phase III trial evaluating for idiopathic pulmonary fibrosis (IPF). In addition, Insilico Medicine launched a comprehensive set of benchmarks that allow foundation models to be evaluated in all tasks needed for drug discovery and launched state of the art (SOTA) foundation models outperforming other models and even internal tools in benchmarks. Using this new capability Insilico hopes to expand and accelerate longevity drug discovery and development both in terms of scale, therapeutic modalities, and indications.
Industry Commentary
"Six proteomic clocks from six independent groups, applied to the same 42 patients, all reported a younger biological age in the treated arms. What convinces me is not the size of the effect but the agreement, because these models share neither their features nor their training data.ā said Michael Levitt, PhD, 2013 Nobel Prize laureate in Chemistry. āThis trial cannot yet separate slower aging from a treated lung, and the authors say so plainly. The experiment in healthy volunteers is the one I want to see next."
āInsilico Medicine was built with one purpose ā to develop a credible and sustainable business model for the development of frontier deep learning technology and its application to practical aging research and drug discovery with the purpose of developing using AI and practical discovery and development of longevity therapeutics. This first program demonstrates the first proof of concept for the novel dual-purpose therapeutic targeting aging but proposed toward the age-related disease discovered in record time making exploratory development in multiple indications commercially viable.
Today, the majority of Insilicoās 40+ drug programs have dual purpose targeting aging and disease in a broad range of therapeutic areas. By pursuing a credible biotechnology business model, the company reached profitability and established the longevity board, which is rare for the publicly-traded frontier biotechnology company. I am also happy that the drug carries the name of the true hero of the AI drug discovery revolution, our co-CEO, Dr. Ren.
The social and economic opportunity for drugs reversing biological age is vast - trillions of dollars and billions of life years. If you add just 3 extra years to everyoneās lifespan, that translates into roughly 25 billion life years on the global scale - at current life expectancy, that is roughly 340 million human lifetimes. More lifetimes than humanity lost in all the wars ever fought. If you manage to add 3 years to everyoneās life, the drug should be able to significantly extend the healthy portion of life as well translating into trillions of dollars in productivity and savingsā, said Alex Zhavoronkov, PhD, founder and co-CEO of Insilico Medicine.
āIn this study, we evaluated clinical trial data to compare the blood proteomic profiles of pulmonary fibrosis patients treated with Rentosertib versus placeboā, said Ludger Goeminne, Research Fellow in Medicine at Harvard Medical School, and co-author of the paper. āUsing six proteomic aging clocks including models our team published in Cell Metabolism, we observed significant reductions in predicted biological age across multiple organ-specific clocks, and further pathway analysis confirmed that Rentosertibās biological impact extends far beyond merely reducing fibrosis.ā
āAs the developer of PAOPAC (Proteome-Aware Organ Proxy Aging Clock), I am thrilled to see our tool applied to the analysis of the Phase IIa clinical trial for rentosertib. Dr. Zhavoronkov and his colleagues are the first to systematically evaluate a novel drug candidate using multiple proteomic aging clocks within a single clinical trial cohort. The methodologies underlying these clocks range from traditional machine learning (OrganAge, PAOPAC, PAC) to deep learning (ProtAge, ipfP3GPT), with training targets encompassing both chronological age (ProtAge, OrganAgechrono, ipfP3GPT, PAOPAC) and mortality risk (PAC, OrganAgemortality). Across the board, these clocks consistently predicted a reduction in biological age within the rentosertib treatment group. This cross-model consistency demonstrates that rentosertib's effect on aging-related proteomic signals is not a model-specific artifact, but rather a highly robust biological phenomenon.ā, said Professor Jing-Dong Jackie Han, Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Center for Quantitative Biology (CQB), China. āFurthermore, this study establishes a relatively comprehensive workflow for the standardized application of aging clocks in clinical trials, covering cohort establishment, omics profiling, multi-clock parallel analysis, result cross-validation, and mechanistic interpretation. It also introduces an innovative practical approach to clinical trial design: evaluating aging biomarkers in parallel during trials targeting specific indications, particularly age-related diseases. This strategy holds great promise for accelerating the discovery and validation of longevity interventions.
Finally, my congratulations on the breakthrough achieved with rentosertibāan innovative drug discovered in China and clinically evaluated primarily in Chinese patient cohorts. As a domestic Chinese research team behind the development of aging clocks, we look forward to witnessing more industry-academia-research collaborations driving future clinical trials in aging interventions.ā
Reference
[1] Zhavoronkov, A., Galkin, F., Chen, S. et al. Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment. Nat Biotechnol (2026). doi.org/10.1038/s41587-026-03286-y
[2] Pun, F. W., Leung, G. H. D., Leung, H. W. et al. Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine. Aging (Albany NY) 14, 2475ā2506 (2022). doi.org/10.18632/aging.203960
[3] Tang, Q., Xiao, D., Veviorskiy, A. et al. AI-Driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic Agent. Aging Dis 17, 432ā451 (2026). doi.org/10.14336/AD.2024.1492
[4] Ren, F., Aliper, A., Chen, J. et al. A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models. Nat Biotechnol 43, 63ā75 (2025). doi.org/10.1038/s41587-024-02143-0
[5] Xu, Z., Ren, F., Wang, P. et al. A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial. Nat Med 31, 2602ā2610 (2025). doi.org/10.1038/s41591-025-03743-2
About Rentosertib (ISM001-055)
Rentosertib is a potentially first-in-class small molecule targeting TNIK, developed using Insilico Medicine's generative AI platform pharma.ai. TNIK was identified through AI-powered target discovery as a gene involved in six hallmarks of aging, making it a dual-purpose target for both aging biology and idiopathic pulmonary fibrosis (IPF). The drug's discovery, design, preclinical validation, and Phase I results were published in Nature Biotechnology in March 2024. Phase IIa results were published in Nature Medicine in June 2025. Rentosertib has entered Phase III clinical development in China.
About Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis is a chronic, scarring lung disease characterized by progressive and irreversible decline in lung function. Affecting approximately 5 million people worldwide, IPF carries a poor prognosis with a median survival of 3ā4 years. Current approved treatments can slow disease progression but cannot stop or reverse it, leaving a significant unmet need for disease-modifying therapies.
About Insilico Medicine
Insilico Medicine is a pioneering global biotechnology company dedicated to integrating artificial intelligence and automation technologies to accelerate drug discovery, drive innovation in the life sciences, and extend healthy longevity to people on the planet. The company was listed on the Main Board of the Hong Kong Stock Exchange on December 30, 2025, under the stock code 03696.hk.
By integrating AI and automation technologies and deep in-house drug discovery capabilities, Insilico is delivering innovative drug solutions for unmet needs including fibrosis, oncology, immunology, pain, and obesity and metabolic disorders. Additionally, Insilico extends the reach of Pharma. AI across diverse industries, such as advanced materials, agriculture, nutritional products and veterinary medicine.
For more information, please visit www.insilico.com
Nature Biotechnology
@NatureBiotech
Early data indicates an AI-generated drug could slow aging #nbtinthenews www.nytimes.com/2026/09/07/science/ai-generated-drug-longā¦
Nature Biotechnology
@NatureBiotech
Proteomic aging clocks go to trial #nbtnv www.nature.com/articles/s41587-026-03361-4
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
Study suggests AI-generated drug could slow aging #nbtinthenews gizmodo.com/study-suggests-ai-generated-drug-could-slow-aā¦
Nature Biotechnology
@NatureBiotech
HK-listed firm-developed AI lung drug reverses aging markers in study #nbtinthenews www.chinadailyhk.com/hk/article/639216
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
Insilico's AI-designed lung drug shows signs of biological age reversal #nbtinthenews www.thepharmaletter.com/pharma-news/insilicos-ai-designedā¦
Nature Biotechnology
@NatureBiotech
Rentosertib puts aging clocks to the clinical test #nbtinthenews longevity.technology/news/rentosertib-puts-aging-clocks-tā¦
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
Blood protein analysis suggests a lung disease drug could be fighting aging at the same time #nbtinthenews medicalxpress.com/news/2026-09-blood-protein-analysis-lunā¦
Nature Biotechnology
@NatureBiotech
Rentosertib shifts multiple proteomic aging clocks toward younger age profiles in IPF trial #nbtinthenews www.news-medical.net/news/20260910/Rentosertib-shifts-mulā¦
-
Nature Biotechnology
@NatureBiotech
SaprotHub is a community repository for protein language models go.nature.com/47lrRSX
rdcu.be/haoUoENZakxa -
Nature Biotechnology
@NatureBiotech
Detectrons convert transient RNA sequences into stable DNA barcodes for high-throughput analysis of RNA-dependent processes www.nature.com/articles/s41587-026-03334-7
Nature Biotechnology
@NatureBiotech
Novel biosensor uses DNA ābarcodesā to uncover disease signals in cells #nbtinthenews gladstone.org/news/novel-biosensor-uses-dna-barcodes-uncoā¦
Nature Biotechnology
@NatureBiotech
Detectrons turn fleeting RNA signals into lasting DNA barcodes inside living cells #nbtinthenews scienmag.com/detectrons-turn-fleeting-rna-signals-into-laā¦
-
Nature Biotechnology
@NatureBiotech
Research Highlight: Engrafting human cortical organoids www.nature.com/articles/s41587-026-03355-2
rdcu.be/1Rumz1MRUdEa
Sergiu P. Pasca
@Sergiu_P_Pasca
Today in @Nature, we report a new approach to studying human brain development and modeling disease in vivo.
Human neural #assembloids and #organoids have opened new ways to study development in vitro, but they also have important limitations. Transplantation can provide a more physiological environment, yet human cortical cells then develop within a rodent brain that matures much faster, constraining their growth and integration.
To address some of these limitations and obtain more advanced functional readouts relevant to disease biology, we generated #apallial mice, in which ~98% of the cortex and hippocampus fail to form, creating space for transplanted human cortical organoids to grow and integrate extensively.
We call these #xenocortical mice (XCX).
Nearly 7 years in the making. Congratulations to an extraordinary team and wonderful collaborators!
Link to the article below š -
Nature Biotechnology
@NatureBiotech
The global patent landscape of CRISPRāCas applications in medicine www.nature.com/articles/s41587-026-03337-4
-
Nature Biotechnology
@NatureBiotech
Discovery and engineering of avian R2 retrotransposons for all-RNA-mediated targeted DNA integration in human cells www.nature.com/articles/s41587-026-03315-w
Nature Biotechnology
@NatureBiotech
Bird-derived jumping gene rewritten to insert DNA into human cells with RNA alone #nbtinthenews scienmag.com/bird-derived-jumping-gene-rewritten-to-inserā¦
-
Nature Biotechnology
@NatureBiotech
Ten years, tens of millions of cells www.nature.com/articles/s41587-026-03365-0
-
Nature Biotechnology
@NatureBiotech
The October issue is live www.nature.com/nbt/volumes/44/issues/10
On the cover, engineered inhalable exosomes display a bispecific T cell activator targeting a cancer cell along with a T cell. PD1 and FZD on the exosomes block tumor-cell PD-L1 signaling and neutralize tumor-secreted Wnt, respectively go.nature.com/496Ins7
rdcu.be/avnjBsFZKzFa -
Nature Biotechnology reposted
Sudarshan Pinglay
@sudpinglay
Excited to share Shotgun Genetic Engineering, developed by @julie_trolle, out in @NatureBiotech!
Read on to learn how Julie enabled mammalian cells to grow without 2 essential amino acids for the first time in >500 million years using highly multiplexed metabolic engineering!
Nature Biotechnology
@NatureBiotech
Highly multiplexed mammalian metabolic engineering with a shotgun approach - @sudpinglay @JefBoeke www.nature.com/articles/s41587-026-03318-7
-
Nature Biotechnology reposted
Gladstone Institutes
@GladstoneInst
šØ NEW PUBLICATION šØ "Detectrons convert transient RNA sequences into stable DNA barcodes for high-throughput analysis of RNA-dependent processes"
@seth_shipman
@jihoon_han_phd
@UCSF
@NatureBiotech
www.nature.com/articles/s41587-026-03334-7 -
Nature Biotechnology reposted
Eric Topol
@EricTopol
The richness of the retina photo or OCT predictive data, as interpretable by AI, but not expert physicians, is extraordinary. Today a new report on retina AI for preeclampsia and pregnancy vascular risks @NatureBiotech www.nature.com/articles/s41587-026-03303-0
My summary of the key 15 publications on this topic here -
Nature Biotechnology reposted
Jihoon Han
@jihoon_han_phd
Detectrons are now published in Nature Biotechnology!
Programmable RNA sensing meets DNA barcode production in living bacteria.
www.nature.com/articles/s41587-026-03334-7 -
Nature Biotechnology
@NatureBiotech
AI-enhanced adaptive virtual screening of large libraries for ligand discovery www.nature.com/articles/s41587-026-03217-x
Nature Biotechnology
@NatureBiotech
AI-informed AdaptiveFlow redefines large-scale cloud computing for drug discovery #nbtinthenews via @StJudeResearch www.stjude.org/media-resources/news-releases/2026-medicinā¦
Nature Biotechnology
@NatureBiotech
Drug discovery in Q3 2026 ā what changed and why it matters #nbtinthenews via @DrugTargetRev www.drugtargetreview.com/drug-discovery-in-q3-2026-what-cā¦
-
Nature Biotechnology
@NatureBiotech
Behind (cell) walls www.nature.com/articles/s41587-026-03356-1
-
Nature Biotechnology
@NatureBiotech
Congratulations to Karl Deisseroth, Peter Hegemann and Georg Nagel on the 2026 Nobel Prize in Physiology or Medicine
The Nobel Prize
@NobelPrize
BREAKING NEWS
The 2026 #nobelprize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel āfor their discoveries concerning light-gated ion channels and optogenetics.ā
Nature Biotechnology
@NatureBiotech
Read one of Karl Deisseroth's publications in the journal here
Nature Biotechnology
@NatureBiotech
Deep brain optogenetics without intracranial surgery go.nature.com/3jzvv1o
Nature Biotechnology
@NatureBiotech
Listen to our 2021 podcast with Deisseroth and Viviana Gradinaru here
Nature Biotechnology
@NatureBiotech
Karl Deisseroth of Stanford and Caltech's Viviana Gradinaru speak with senior editor Markus Elsner about the current state of #optogenetics and how it can be used to better understand and treat human disease, on our latest #nbtforum podcast play.acast.com/s/forum/optogeneticsroundtable-deisserothaā¦
-
Nature Biotechnology
@NatureBiotech
Join pioneering researchers at RNA at the Bench and Bedside V on December 8-10, 2026. Examine advances in RNA biology, therapies and clinical applications improving modern science and patient treatments. Early-bird rates available until October 8. Register and submit your abstract: go.nature.com/4vvBZDL
-
Nature Biotechnology
@NatureBiotech
The FDA cannot approve generic drugs for marketing until brand-name drug patents on its list expire or are successfully challenged, but courts have recently found that certain device-only patents are impermissible and should not be listed www.nature.com/articles/s41587-026-03280-4
-
Nature Biotechnology reposted
Bowen LI
@BowenLi_Lab
𧬠Excited to share our new work in @NatureBiotech!
Paper: www.nature.com/articles/s41587-026-03298-8 Research Briefing: www.nature.com/articles/s41587-026-03297-9
Large gene editors require large mRNAs, but LNPs are typically discovered using much smaller reporter RNAs. We asked: does RNA size matter when discovering delivery lipids?
Using a large base-editor mRNA for high-throughput screening, we identified LC-1, an ionizable lipid that enabled efficient gene editing in the liver, lung, and brain via different administration routes in mice, with up to 4Ć higher Cas9 editing than benchmark LNPs. LC-1 also efficiently delivered base editors for disease-relevant targets in hypercholesterolemia, cystic fibrosis, and Angelman syndrome.
Why does LC-1 work so well? Cryo-EM and X-ray scattering revealed that LC-1 LNPs form an ordered, inverted-hexagonal structure that persists with large RNA cargo. This membrane-fusing structure helps RNA escape from endosomes, the compartments that can trap it inside cells. In cell studies, LC-1 released roughly twice as much large mRNA into the cytosol as the benchmark formulations. We show that LC-1's key design features also apply to ionizable lipids made through other synthetic routes.
These findings show that accounting for RNA size from the start can change which lipids we discover and improve delivery of large gene editors. This could help expand the delivery options available for future gene-editing medicines.
Thank you to all our co-authors, collaborators and funders @CIHR_IRSC @NSERC_CRSNG @UofTPharmacy @LisaDolovich @PMResearch_UHN @bradwouters #lipidnanoparticles #geneediting #rnatherapeutics -
Nature Biotechnology reposted
Princess Margaret Cancer Centre Research
@PMResearch_UHN
A new lipid nanoparticle, LC-1, overcame gene editing barriers and efficiently delivered large RNA tools to the preclinical models of liver, lungs, and brain.
The @NatureBiotech study was led by @BowenLi_Lab @UHN @pmcancercentre & @UofTPharmacy:
www.nature.com/articles/s41587-026-03298-8
Nature Biotechnology
@NatureBiotech
Lipid nanoparticles optimized for large RNA cargo and tissue targeting enhance in vivo genome editing www.nature.com/articles/s41587-026-03298-8
-
Nature Biotechnology
@NatureBiotech
Stem cell differentiation is controlled by manipulating RNA condensates go.nature.com/3X215du
rdcu.be/QMNfdKz92Ypa
Nature Biotechnology
@NatureBiotech
RNA sequestration in P-bodies stabilizes cell-fate transitions by repressing past identities ā a process that can be harnessed to control cell fate #nbtnv go.nature.com/4iyZmGv
rdcu.be/FfEUHSdy8Noa -
Nature Biotechnology
@NatureBiotech
Interpreting transcript diversity requires moving beyond āknownā versus ānovelā and towards a multidimensional framework based on technical credibility, contextual prevalence, reproducibility, molecular consequence and phenotypic relevance www.nature.com/articles/s41587-026-03321-y
-
Nature Biotechnology
@NatureBiotech
Somatic small variants in cancer genomes are identified in both short-read and long-read data go.nature.com/4qa6m0d
rdcu.be/XXFkEQLLSs5a -
Nature Biotechnology
@NatureBiotech
The emerging reproducibility crisis in AI-driven biomedicine will only intensify unless the community redefines multiomics data quality www.nature.com/articles/s41587-026-03267-1
rdcu.be/a3yYAYF4vAya -
Nature Biotechnology
@NatureBiotech
Sustained epigenetic silencing in monkeys is made more efficient with optimized regulators go.nature.com/46uDMyK
rdcu.be/LRyz3xvXnWxa
Nature Biotechnology
@NatureBiotech
Transient expression of a transcription activator-like effector (TALE)-based epigenetic editor demonstrates durable therapeutic silencing in non-human primates #nbtnv go.nature.com/4q3YvRE
rdcu.be/V8i87enURqMa -
Nature Biotechnology reposted
Nature Conferences
@NatureConf
24 hours left to submit your abstract. Don't miss the opportunity to present your work alongside leaders in RNA biology, nucleic acid therapeutics, and clinical translation. go.nature.com/4zcVYIN
@NatureBiotech @ionispharma @Alnylam @ucsd_rna_center -
Nature Biotechnology
@NatureBiotech
Biotech news from around the world: United Kingdom, South Korea, South Africa, Guatemala www.nature.com/articles/s41587-026-03304-z
rdcu.be/YoAK6s1KPkba -
Nature Biotechnology
@NatureBiotech
Lipid nanoparticles optimized for large RNA cargo and tissue targeting enhance in vivo genome editing www.nature.com/articles/s41587-026-03298-8
Nature Biotechnology
@NatureBiotech
Research Briefing: Cargo size matters when designing lipid nanoparticles for delivery of large gene editors www.nature.com/articles/s41587-026-03297-9
-
Nature Biotechnology
@NatureBiotech
A scalable blueprint for postdoctoral training embeds entrepreneurial venture mechanics and industry mobility directly into academic infrastructure to cultivate āT-shapedā scientific leaders www.nature.com/articles/s41587-026-03292-0
rdcu.be/AaEiyDRp9cSa -
Nature Biotechnology
@NatureBiotech
Recent moves of note in and around the biotech and pharma industries www.nature.com/articles/s41587-026-03299-7
rdcu.be/3p7MDZwAyVxa -
Nature Biotechnology
@NatureBiotech
Research Highlight: On-demand glycemic control by engineered bacteria www.nature.com/articles/s41587-026-03323-w
nature
@Nature
Nature research paper: Glucose-responsive probiotics for glycaemic modulation in mice and monkeys
go.nature.com/3RMvSMJ -
Nature Biotechnology
@NatureBiotech
Transferable genetic toolsets for nonmodel gut Clostridia enable in vivo reversible control of metabolite production www.nature.com/articles/s41587-026-03269-z
Nature Biotechnology
@NatureBiotech
Developing a genetic toolkit for manipulating abundant intestinal microbes #nbtinthenews via @WeillCornell news.weill.cornell.edu/news/2026/08/developing-a-genetic-ā¦
Nature Biotechnology
@NatureBiotech
New genetic tools enable reversible metabolite control in nonmodel gut Clostridia #nbtinthenews bioengineer.org/new-genetic-tools-enable-reversible-metabā¦
Nature Biotechnology
@NatureBiotech
Genetic toolkit may improve study of gut bacteriaās role in disease #nbtinthenews news.feinberg.northwestern.edu/2026/09/17/genetic-toolkitā¦
-
Nature Biotechnology
@NatureBiotech
DIAL designs synthetic promoters for generation of heritable setpoints of gene expression across a range of cell types go.nature.com/4h9wlR1
rdcu.be/ruJgZuhLT6ra -
Nature Biotechnology
@NatureBiotech
Scientists uncover thousands of previously missed proteins, many of which appear to be relevant to human health ā including promising new targets for cancer immunotherapies www.nature.com/articles/s41587-026-03306-x
rdcu.be/kUYzGHZ13eea -
Nature Biotechnology reposted
nature
@Nature
AlphaFold is being upgraded to better represent some of the least known and deadliest species: viruses
go.nature.com/4dZcYK7 -
Nature Biotechnology reposted
HerAnova Lifesciences @Heranovalifesci
What makes endometriosis so hard to detect, even when its impact is unmistakable?
In @NatureBiotech, Carrie Arnold explores the search for biological clues in blood and menstrual fluid, including HerAnova's blood-based approach.
Our Chief Medical Officer ā Head of Diagnostics, Farideh Bischoff, PhD, shares why diagnosis remains a major unmet need and why a single biological marker may not be enough to detect a complex disease.
Read what researchers are looking for, and why it matters: www.nature.com/articles/s41587-026-03265-3
#endometriosis #womenshealth #diagnostics -
Nature Biotechnology
@NatureBiotech
Photolabile oligonucleotides with topological light gradients enable spatially resolved single-cell transcriptomics and epigenomics www.nature.com/articles/s41587-026-03328-5
-
Nature Biotechnology
@NatureBiotech
Recent patents relating to systems, methods and compositions for use in synthetic biology www.nature.com/articles/s41587-026-03289-9
rdcu.be/8zo6rPEdWxga -
Nature Biotechnology
@NatureBiotech
In Brief: US @NSF launches a pilot program that gives doctoral students real-world experience in industry as part of their PhD www.nature.com/articles/s41587-026-03320-z
rdcu.be/LspikVc66kTa -
Nature Biotechnology
@NatureBiotech
A breast cancer drug linked with a test to detect ESR1 mutations in circulating tumor DNA is one of a wave of new drugs developed to tackle resistance to estrogen-receptor-targeted therapies www.nature.com/articles/s41587-026-03333-8
-
Nature Biotechnology
@NatureBiotech
Guidance for optimizing lipid nanoparticle formulations is derived using sophisticated biophysical techniques go.nature.com/4oTt639
rdcu.be/uDLByL6JPFha -
Nature Biotechnology
@NatureBiotech
Research Highlight: Biomimetic cells for studying T cell mechanotransduction www.nature.com/articles/s41587-026-03312-z
Nature Methods
@naturemethods
kpiCells: biomimetic artificial cells for investigating mechanoregulation in cell-cell interactions.
www.nature.com/articles/s41592-026-03199-3 -
Nature Biotechnology
@NatureBiotech
The novel transcripts we keep rediscovering www.nature.com/articles/s41587-026-03321-y
-
Nature Biotechnology
@NatureBiotech
A method to label cultured human embryos finds chromosome segregation errors in placenta-fated cells go.nature.com/3JdRdu8
rdcu.be/yBFYZhRuCvja
Nature Biotechnology
@NatureBiotech
An optimized approach for live imaging of human embryos enables visualization of mitotic errors during blastocyst development #nbtnv go.nature.com/48PpE4O
rdcu.be/eSPZd -
Nature Biotechnology
@NatureBiotech
In Brief: @FDA approves @Replimune's #tudriqev, an oncolytic immunotherapy for treating patients with unresectable advanced melanoma whose disease has progressed after PD-1 immunotherapy www.nature.com/articles/s41587-026-03316-9
rdcu.be/FJTEwpcN6KUa -
Nature Biotechnology
@NatureBiotech
Pharmaceutical products with device-only patents: a cross-sectional analysis www.nature.com/articles/s41587-026-03280-4
-
Nature Biotechnology
@NatureBiotech
A new generation of RNA therapies delivered by lipid nanoparticles takes aim at extrahepatic tissues www.nature.com/articles/s41587-026-03305-y
[šread free with login] -
Nature Biotechnology reposted
Nature Japan
@NatureJapan
ē“°čć®ęé·ćØč²ē“ ēē£ćē“ēµ åøå°åē©č²ē“ ććµć³ćć³ććć³ć®å¾®ēē©ēē£ćå®ē¾š§¬šØ
Bradley S. Moorećć®@naturebiotech #č«ę
Growth-coupled microbial biosynthesis of the animal pigment xanthommatin
www.nature.com/articles/s41587-025-02867-7
č«ęé²č¦§ēØćŖć³ćÆļ¼rdcu.be/cqLqR5vGP9Xa
#åęēē©å¦ #代č¬å·„å¦
ę„ēµćµć¤ćØć³ć¹
@NikkeiScience
迷彩ć®åäŗŗććæć³ćØć¤ć«ćććććé©ćć®ę°ęč”ćē¶ć - ę„ę¬ēµęøę°č www.nikkei.com/article/DGXZQOSG141YK0U6A810C2000000/
-
Nature Biotechnology reposted
NonExomics @NonExomics
NonExomics is featured in @NatureBiotechās September survey of the dark proteome, among the companies turning the dark genome into new drug targets.
~3,000 novel dark antigens across 1,365 human diseases, prioritized and experimentally validated.
www.nature.com/articles/s41587-026-03306-x -
Nature Biotechnology
@NatureBiotech
Property guidance for protein sequence generative models with ProteinGuide www.nature.com/articles/s41587-026-03207-z
Nature Biotechnology
@NatureBiotech
QB3-Berkeley
@QB3Berkeley
.@UCBerkeley researchers developed ProteinGuide, an AI strategy that steers protein generative models toward specific properties using experimental dataāwithout retraining the underlying models.
Read more about this research in QB3-Berkeley faculty labs: qb3.berkeley.edu/news/guiding-ai-toward-better-protein-de⦠-
Nature Biotechnology reposted
ProFoundTx @ProFoundTx
Featured in @NatureBiotech: CEO John Lepore, MD, explains how novel proteins beyond the annotated proteome could open new paths for medicines. ProFound is building the largest atlas of novel proteins to help advance first-in-class therapies. www.nature.com/articles/s41587-026-03306-x
-
Nature Biotechnology reposted
Farmaceutiska fakulteten
@FFakulteten
In the latest edition of #nature Biotechnology, Nathan Poongavanam & Kristian Sandberg explain how the SciLifeLab PULSE entrepreneurial model can bring academia & industry together to accelerate the journey from groundbreaking research to new treatments ā¶ļø www.nature.com/articles/s41587-026-03292-0
-
Nature Biotechnology
@NatureBiotech
Q&A: Gene editing using large insertions www.nature.com/articles/s41587-026-03319-6
-
Nature Biotechnology
@NatureBiotech
Mutation of conserved prolines enhances correct pairing of light and heavy chains for bispecific IgG-like antibody production go.nature.com/48NEM2o
rdcu.be/uRHZj23xqvya -
Nature Biotechnology
@NatureBiotech
A pervasive RTāqPCR artifact inflates RNA knockdown by RNA-targeting CRISPR www.nature.com/articles/s41587-026-03291-1
Nature Biotechnology
@NatureBiotech
CRISPRās ability to knock down RNA may be artificially inflated #nbtinthenews www.the-scientist.com/crispr-s-ability-to-knock-down-rna-ā¦
-
Nature Biotechnology
@NatureBiotech
Research Highlight: AI-guided design of complete bacteriophage genomes www.nature.com/articles/s41587-026-03311-0
Samuel King
@samuelhking
Today in @ScienceMagazine, we report the first functional AI-generated genomes. š§µ
www.science.org/doi/10.1126/science.aec2657 -
Nature Biotechnology
@NatureBiotech
FDA approves pioneering breast cancer drug that nips resistance in the bud www.nature.com/articles/s41587-026-03333-8
-
Nature Biotechnology
@NatureBiotech
High-throughput synthesis of DNA fragments by molecular self-assembly of overlapping oligonucleotides www.nature.com/articles/s41587-026-03266-2
Nature Biotechnology
@NatureBiotech
Research Briefing: Massive-scale parallel gene synthesis with oligonucleotide hybridization www.nature.com/articles/s41587-026-03290-2
rdcu.be/zwQLf1Uunnja -
Nature Biotechnology
@NatureBiotech
Engineered bacterial siderophore production accelerates rock weathering for carbon removal www.nature.com/articles/s41587-026-03288-w
Nature Biotechnology
@NatureBiotech
Pulling carbon into seawater using engineered bacteria #nbtinthenews via @wyssinstitute wyss.harvard.edu/news/pulling-carbon-into-seawater-using-ā¦
Nature Biotechnology
@NatureBiotech
Engineered bacteria could speed rock weathering to combat climate change #nbtinthenews via @harvardmed hms.harvard.edu/news/engineered-bacteria-could-speed-rockā¦
Nature Biotechnology
@NatureBiotech
Synthetically engineered marine bacteria could play key role in decarbonizing the atmosphere at industrial scales #nbtinthenews www.genengnews.com/topics/bioprocessing/synthetically-engā¦
Nature Biotechnology
@NatureBiotech
Research Briefing: Accelerating natural CO2 removal from the atmosphere with ocean bacteria www.nature.com/articles/s41587-026-03287-x
rdcu.be/KsnS6LVqLHYa -
Nature Biotechnology
@NatureBiotech
Ensuring safety and accountability in Chinaās biomedical translation system www.nature.com/articles/s41587-026-03314-x
-
Nature Biotechnology
@NatureBiotech
An engineered nanopore identifies saccharides, amino acids, peptides and ribonucleotides www.nature.com/articles/s41587-026-03308-9
Nature Biotechnology
@NatureBiotech
Research Briefing: A versatile nanopore identifies four classes of analytes simultaneously www.nature.com/articles/s41587-026-03322-x
-
Nature Biotechnology
@NatureBiotech
Multiplexed editing in primary human T cells generates enhanced immune cell therapies go.nature.com/3WOJJAJ
rdcu.be/g1HrBz9jCh1a -
Nature Biotechnology
@NatureBiotech
A new class of biotech buyer is emerging, as frontier AI and big tech companies acquire early-stage biology foundational platforms. How do big tech acquisitions differ from traditional pharma exits, and what are the potential implications for founders, investors and the pharmaceutical industry? www.nature.com/articles/s41587-026-03214-0
rdcu.be/URMEtSZqA84a -
Nature Biotechnology
@NatureBiotech
Adaptive model-guided protein evolution with sparse data optimizes compact eukaryotic genome editors - @XueSherryGao www.nature.com/articles/s41587-026-03272-4
Nature Biotechnology
@NatureBiotech
AI helps improve a gene-editing tool, even with limited data #nbtinthenews penntoday.upenn.edu/news/penn-engineering-ai-helps-improvā¦
-
Nature Biotechnology
@NatureBiotech
Lipid nanoparticles chart path beyond the liver www.nature.com/articles/s41587-026-03305-y
[šread free with login] -
Nature Biotechnology
@NatureBiotech
CIRI3 speeds up circRNA detection with low memory requirements go.nature.com/42jUdLK
rdcu.be/6iALwigrfcka -
Nature Biotechnology
@NatureBiotech
The SciLifeLab PULSE entrepreneurial model: accelerating drug discovery by bridging academia and industry www.nature.com/articles/s41587-026-03292-0
-
Nature Biotechnology
@NatureBiotech
The @FDA approves @moderna_tx's mFlusiva, the first seasonal flu vaccine to use mRNA-based production, which allows vaccines to be quickly updated to match circulating influenza strains and could result in improved protection www.nature.com/articles/s41587-026-03313-y
rdcu.be/h6wBbwogSsya -
Nature Biotechnology reposted
Springer Nature
@SpringerNature
One of our top-rated articles on @altmetric this past week was published open access in @NatureBiotech. You can read 'Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment' here: spklr.io/6010ETJGY
-
Nature Biotechnology reposted
Nature Japan
@NatureJapan
ē“°čć®ęé·ćØč²ē“ ēē£ćē“ēµ åøå°åē©č²ē“ ććµć³ćć³ććć³ć®å¾®ēē©ēē£ćå®ē¾š§¬šØ
Bradley Moorećć®@naturebiotech #č«ę
Growth-coupled microbial biosynthesis of the animal pigment xanthommatin
www.nature.com/articles/s41587-025-02867-7
é²č¦§rdcu.be/cqLqR5vGP9Xa
#åęēē©å¦
@UCSanDiego @Scripps_Ocean
ćć·ć§ćć«ćøćŖć°ć©ćć£ććÆę„ę¬ē
@NatGeoMagJP
迷彩ć®åäŗŗććæć³ćØć¤ć«ćććććé©ćć®ę°ęč”ćē¶ć : č²ćå¤ććč²ē“ ćÆć¹ćć³ć±ć¢ēØåćØćć¦å®ēØåćč¦éć«ćå®å®ćé²č”ć«ćåæēØćęå¾ ććć¾ććććéęćć³ćććÆä½ććļ¼ććŖć©ćå°éå®¶ć«čćć¾ććć natgeo.nikkeibp.co.jp/atcl/news/26/012100045/?rss
-
Nature Biotechnology reposted
Nathan Poongavanam @ivasanthaNathan
Thrilled to share our latest paper "The SciLifeLab PULSE entrepreneurial model... ," is officially published in @NatureBiotech !
@scilifelab @uppsalauni @lunduniversity @goteborgsuni @karolinskainst
#drugdiscovery #biotechnology #postdoctoralfellowship
www.nature.com/articles/s41587-026-03292-0 -
Nature Biotechnology reposted
Insilico LAIR
@precious_gpt
We started working on this paper as soon as phase 2a results went out, which means that it has been almost a year in production. Many thanks to @NatureBiotech , our editor, and reviewers for helping us make this study what it is.
So exciting to see so many KOLs talk about rentosertib's geroprotector potenatial, and even more importantly, about the integration of aging endpoints into classical trials.
www.nature.com/articles/s41587-026-03286-y -
Nature Biotechnology
@NatureBiotech
From reading to writing
DNA writing is entering a period of rapid innovation, with enzymatic and cellular approaches challenging decades-old chemistry. Although none yet delivers long, accurate DNA at the scale biology ultimately requires, continued advances promise to remove one of the fieldās most persistent bottlenecks and enable experiments that are currently out of reach www.nature.com/articles/s41587-026-03300-3 -
Nature Biotechnology
@NatureBiotech
Startups mine ādark proteomeā for new drug targets www.nature.com/articles/s41587-026-03306-x
[šread free with login] -
Nature Biotechnology
@NatureBiotech
The September issue is live www.nature.com/nbt/volumes/44/issues/9
On the cover, Bushin et al. present a growth-coupling system in which bacteria survive only if they make both a key metabolite and xanthommatin, an animal pigment difficult to obtain at scale without extraction from animal tissues or chemical synthesis go.nature.com/3Ll0VeT
rdcu.be/yK755byv7zca -
Nature Biotechnology
@NatureBiotech
Engineered genomic attachment sites for site-specific recombinases enable high-efficiency integration in plants and human cells www.nature.com/articles/s41587-026-03294-y
Nature Biotechnology
@NatureBiotech
Redesigned landing sites lift Bxb1 integration efficiency #nbtinthenews via @CrisprMedicine crisprmedicinenews.com/news/redesigned-landing-sites-liftā¦
-
Nature Biotechnology
@NatureBiotech
An analysis of FDA-approved drugs reveals uneven timing and concentration of revenue life cycles across modalities and therapeutic areas, offering evidence to guide innovation strategy and policy design in a post-Inflation Reduction Act world www.nature.com/articles/s41587-026-03278-y
-
Nature Biotechnology reposted
Irvin Garza @Irvin_TGarza
Neurons have dominated neuroscience, but glia arenāt just support cells. They actively shape nervous system health and disease. As we deepen our understanding of this other half of the brain, we also need to develop tools built with glial biology in mind.
www.nature.com/articles/s41587-026-03193-2 -
Nature Biotechnology reposted
Akshat Nigam
@akshat_ai
Check out our new work out in @NatureBiotech š
Billions of molecules + AI-guided selection + biophysical tools = Faster drug discovery
Check out the paper:
www.nature.com/articles/s41587-026-03217-x -
Nature Biotechnology reposted
Kevin Zhao
@kevintzhao93
𧬠Excited to share our new study in @NatureBiotech that improves the efficiency of targeted insertion of large DNA fragments. Placing a whole stretch of DNA precisely at a designated safe site is one of the most important operations in genome editing.
www.nature.com/articles/s41587-026-03294-y -
Nature Biotechnology reposted
Amr Ali AL-Hossary @alhossary
Our Nature Biotechnology paper is finally published today. Thank God.
Nature Biotechnology
@NatureBiotech
AI-enhanced adaptive virtual screening of large libraries for ligand discovery www.nature.com/articles/s41587-026-03217-x
-
Nature Biotechnology reposted
nature
@Nature
Top artificial-intelligence models failed to predict the biological consequences of rewriting a virus's entire DNA code.
go.nature.com/4xsX9Dj -
Nature Biotechnology reposted
Bin Wu Lab @binwu1
Excited to share that the work spearheaded by my graduate student Leslie Watkins from @BCMB_JHMI has been published in @NatureBiotech. She showed that gRNA co-purified in RNA extraction can artificially report knockdown efficiency for RNA-targeting CRISPR.
-
Nature Biotechnology reposted
Columbia - Irving Institute for Cancer Dynamics
@Cancer_dynamics
IICD Core Faculty @elhamazizi is featured in @NatureBiotech! š§¬
She discusses her multidisciplinary scientific journey and her work at the intersection of machine learning, AI, and cancer research.
Read the career feature: cancerdynamics.columbia.edu/news/five-questions-elham-azi⦠-
Nature Biotechnology reposted
UWāMadison School of Pharmacy
@UWMadPharmacy
šØ New "McR-TACs" by Associate Professor Quanyin Hu & collabs recycle. The degrader pulls its target protein into the cell, then releases it & exits via ERāGolgi transcytosis for another round. Durable PD-L1 & MIF degradation slowed tumors in triple-negative breast #cancer model.
Nature Biotechnology
@NatureBiotech
Macropinocytosis-mediated recyclable LYTACs (McR-TACs) for receptor-independent protein degradation www.nature.com/articles/s41587-026-03302-1
-
Nature Biotechnology reposted
Joint Genome Institute
@jgi
New AI Tool Maps the Global Catalog of Microbial Symbionts
Today in @NatureBiotech: The publicly available Symbiont Genomes catalog is one of the most comprehensive guides to bacteria and archaea living in partnership with other organisms: jgi.doe.gov/user-science/science-stories/new-ai-tool-mapsā¦
@frederikschu -
Nature Biotechnology reposted
Frederik Schulz @frederikschu
New study from our lab, out now in Nature Biotechnology: Genome-resolved metagenomics and single-cell genomics have yielded millions of microbial genomes. Could a large fraction of these uncultivated bacteria and archaea be symbionts? We identified genomic signatures of host dependence across global metagenomic data, suggesting that 15ā23% may live in symbiosis. The resulting SymGs catalog and our symclatron software provide new resources for studying and engineering hostāmicrobe interactions. www.nature.com/articles/s41587-026-03213-1
-
Nature Biotechnology reposted
UChicago Medicine Comprehensive Cancer Center
@UCCancerCenter
In a new @NatureBiotech article, Dr. Ratain, and co-authors examines how minor changes to existing cancer drugs may extend market exclusivity without clear innovation, highlighting the need for patent policies that protect patients and scientific progress.
pubmed.ncbi.nlm.nih.gov/42581119/ -
Nature Biotechnology reposted
nature
@Nature
China's biotechnology companies are producing medicines at a speed and cost that has drawn interest from the worldās largest pharmaceutical groups
go.nature.com/4wIRyaH -
Nature Biotechnology reposted
Xue Sherry Gao
@XueSherryGao
Thrilled to share our Fanzor2 genome-editing work @NatureBiotech! We developed FanzMAX, a compact genome editor, by combining AI-assisted protein evolution, ĻRNA engineering, and in vivo delivery. Huge thanks to all co-authors, and collaborators for making this work possible!
Nature Biotechnology
@NatureBiotech
Adaptive model-guided protein evolution with sparse data optimizes compact eukaryotic genome editors - @XueSherryGao www.nature.com/articles/s41587-026-03272-4
-
Nature Biotechnology
@NatureBiotech
A genomic catalog of Earthās bacterial and archaeal symbionts www.nature.com/articles/s41587-026-03213-1
Nature Biotechnology
@NatureBiotech
Research Briefing: Machine learning interprets genome sequences to map possible microbial symbionts www.nature.com/articles/s41587-026-03212-2
rdcu.be/VJ76sLyg4Q6a -
Nature Biotechnology
@NatureBiotech
Obvious chemical substitutions could be used to generate powerful new composition-of-matter patents, highlighting the need for patent and antitrust policy reforms that better separate strategic pursuit of exclusivity from true therapeutic innovation www.nature.com/articles/s41587-026-03242-w
-
Nature Biotechnology
@NatureBiotech
Menstrualome aids difficult endometriosis diagnosis www.nature.com/articles/s41587-026-03265-3
rdcu.be/tA9LemGWcsMa -
Nature Biotechnology
@NatureBiotech
Recent moves of note in and around the biotech and pharma industries www.nature.com/articles/s41587-026-03257-3
rdcu.be/6Poyh9ewBAia -
Nature Biotechnology
@NatureBiotech
Ensuring multiomics data reproducibility for artificial intelligence with reference materials as a common calibrator www.nature.com/articles/s41587-026-03267-1
-
Nature Biotechnology
@NatureBiotech
This multidisciplinary biomedical engineer hopes to bridge data-driven discovery and mechanistic understanding, advancing precision oncology through interpretable, biologically grounded machine learning and artificial intelligence www.nature.com/articles/s41587-026-03255-5
rdcu.be/VHGvHbgYyhGa -
Nature Biotechnology
@NatureBiotech
DNA writing is entering a period of rapid innovation, with enzymatic and cellular approaches challenging decades-old chemistry. Although none yet delivers long, accurate DNA at the scale biology ultimately requires, continued advances promise to remove one of the fieldās most persistent bottlenecks and enable experiments that are currently out of reach www.nature.com/articles/s41587-026-03300-3
-
Nature Biotechnology
@NatureBiotech
Biotech news from around the world: Germany, Pakistan, United Kingdom, France www.nature.com/articles/s41587-026-03268-0
rdcu.be/fBPLX -
Nature Biotechnology
@NatureBiotech
Macropinocytosis-mediated recyclable LYTACs (McR-TACs) for receptor-independent protein degradation www.nature.com/articles/s41587-026-03302-1
-
Nature Biotechnology
@NatureBiotech
A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability www.nature.com/articles/s41587-026-03238-6
Nature Biotechnology
@NatureBiotech
AI antibody design just got its first honest report card ā and the grade is complicated #nbtinthenews via @ctrialvanguard www.clinicaltrialvanguard.com/article/trend-watch/ai-antiā¦
Nature Biotechnology
@NatureBiotech
AI antibody design struggles to beat simple baselines in 29-organization benchmark #nbtinthenews via @allsci_corp allsci.com/news/research/ai-antibody-design-specifica-ledā¦
-
Nature Biotechnology
@NatureBiotech
Megascale microbiome analysis with DartUniFrac www.nature.com/articles/s41587-026-03260-8
-
Nature Biotechnology
@NatureBiotech
Donor-complementary prime editing enables precise kilobase and library-compatible DNA insertions www.nature.com/articles/s41587-026-03296-w
-
Nature Biotechnology
@NatureBiotech
Precise genomic integration of large DNA fragments by donor-directed annealing using prime editing www.nature.com/articles/s41587-026-03301-2
-
Nature Biotechnology
@NatureBiotech
LexicMap uses a fixed set of probes to efficiently query gene sequences for fast and low-memory alignment go.nature.com/3K09TgJ
rdcu.be/fCx5J -
Nature Biotechnology
@NatureBiotech
In Brief: @PrimeMedicine wins a legal dispute with @BeamTx over its gene-editing therapy for α1-antitrypsin deficiency, giving Prime the go-ahead to launch a clinical trial with its AATD drug without owing monetary damages to Beam www.nature.com/articles/s41587-026-03276-0
rdcu.be/fBPHT -
Nature Biotechnology
@NatureBiotech
Embryonic stem cells for chicken and seven other avian species are derived go.nature.com/4gLAGcZ
rdcu.be/fCiZk
Nature Biotechnology
@NatureBiotech
A method to produce embryonic stem cells for a range of bird species opens up opportunities in agriculture, developmental biology and species conservation #nbtnv go.nature.com/4ntGnih
rdcu.be/eJagy -
Nature Biotechnology
@NatureBiotech
Research Highlight: AI-assisted design of synthetic gene editors www.nature.com/articles/s41587-026-03273-3
-
Nature Biotechnology
@NatureBiotech
An AI-enabled structural atlas decodes kinase specificity across the human proteome www.nature.com/articles/s41587-026-03239-5
Nature Biotechnology
@NatureBiotech
3D map of cell signaling sites could help improve cancer treatment #nbtinthenews via @harvardmed hms.harvard.edu/news/3d-map-cell-signaling-sites-could-heā¦
-
Nature Biotechnology
@NatureBiotech
Bonsai reconstructs tree representations for distortion-free visualization and exploration of high-dimensional data www.nature.com/articles/s41587-026-03220-2
Nature Biotechnology
@NatureBiotech
Seeing the unseen: A new tool for exploring complex biological data #nbtinthenews via @biozentrum www.biozentrum.unibas.ch/news/detail/seeing-the-unseen-a-ā¦
-
Nature Biotechnology
@NatureBiotech
Recent patents relating to microbiome-associated identification, modulation and treatment of diseases www.nature.com/articles/s41587-026-03250-w
rdcu.be/fBPOh -
Nature Biotechnology
@NatureBiotech
Haploid embryonic stem cells for cattle and sheep are produced, opening new reproductive possibilities go.nature.com/42wdD05
rdcu.be/fB3OR
Nature Biotechnology
@NatureBiotech
Spermatid-like haploid stem cells produce genome-edited farm animals in one generation #nbtnv go.nature.com/4mR49nv
rdcu.be/eJ3JN -
Nature Biotechnology
@NatureBiotech
Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells www.nature.com/articles/s41587-026-03258-2
Nature Biotechnology
@NatureBiotech
New toolkit turns macrophages into better cancer fighters #nbtinthenews via @GladstoneInst gladstone.org/news/new-toolkit-turns-macrophages-better-cā¦
-
Nature Biotechnology
@NatureBiotech
Survey data document US visa types and burdens of time, cost and mental health among international postdocs www.nature.com/articles/s41587-026-03252-8
rdcu.be/fB1tP -
Nature Biotechnology
@NatureBiotech
RNA stability enhancers for durable base-modified mRNA therapeutics go.nature.com/4opTAsV
Nature Biotechnology
@NatureBiotech
Stable RNA elements open new possibilities for mRNA therapeutics #nbtinthenews www.ibs.re.kr/cop/bbs/BBSMSTR_000000000738/selectBoardArtā¦
-
Nature Biotechnology
@NatureBiotech
A survey of biological foundation models reveals current trends and provides an outlook for future developments in this rapidly evolving field go.nature.com/4cLK7sE
rdcu.be/fBPN9 -
Nature Biotechnology
@NatureBiotech
In Brief: @FDA gives the go-ahead to @tissiumtech to market its light-activated polymer for repairing peripheral nerve injuries without the damage caused by stitches www.nature.com/articles/s41587-026-03279-x
rdcu.be/fBPF6 -
Nature Biotechnology
@NatureBiotech
Optimized long-read sequencing constructs megabase-scale genome assemblies from complex soil samples go.nature.com/4606ozA
rdcu.be/fA6Jc -
Nature Biotechnology
@NatureBiotech
Magicpenās genetically engineered plants have a heightened bioluminescence www.nature.com/articles/s41587-026-03270-6
-
Nature Biotechnology
@NatureBiotech
From cabozantinib to zanzalintinib: obvious chemical modifications as a new frontier in product hopping www.nature.com/articles/s41587-026-03242-w
Nature Biotechnology
@NatureBiotech
John D Carroll
@JohnCendpts
A group of researchers/oncologists are taking a shot at Exelixisās ($EXEL) second-gen TKI zanzalintinib, saying they made a ātrivialā modification to cabo and gained a fresh patent on it as a new chemical entity. One of the authors, UChicago Med professor Mark Ratain, wants to get the FDA directly involved in the patent office to sort out these cases for obviousness. Exelixis, meanwhile, has a whole lot riding on this. Cabo is its meal ticket, and losing the race on zanza for any reason would leave itā¦. Well.
endpoints.news/did-exelixis-use-a-trivial-modification-to⦠-
Nature Biotechnology
@NatureBiotech
Each year, we highlight companies that received sizeable early-stage funding in the previous year. Dispatch Bio delivers antigens to solid tumors for CAR T immunotherapy www.nature.com/articles/s41587-026-03293-z
-
Nature Biotechnology reposted
NimwegenLab
@NimwegenLab
Remember Bonsai?
x.com/NimwegenLab/status/1920802571075105108
Rigorous visualization of the structure in your high-dimensional data. Now, with help of the reviewers of Nat Biotech, it has been updated, extended and officially published here:
www.nature.com/articles/s41587-026-03220-2
1/n
NimwegenLab
@NimwegenLab
Here it is! Bonsai. No more excuse to use t-SNE/UMAP. Bonsai not only makes cool pictures of your data. It actually rigorously preserves its structure. No tunable parameters. Absolutely incredible work of @dhdegroot.bsky.social. I'm so excited about this. www.biorxiv.org/content/10.1101/2025.05.08.652944v1
-
Nature Biotechnology reposted
Julia Carnevale
@jccarnevale
Another major milestone for my lab - our second paper is out today in Nature Biotechnology! Co-led by @pascal_devant & @HyuncheolJung, with Alex Marson: www.nature.com/articles/s41587-026-03258-2
-
Nature Biotechnology reposted
Pascal Devant
@pascal_devant
The final version of my first postdoc paper is out today in @NatureBiotech! www.nature.com/articles/s41587-026-03258-2
Together with @HyuncheolJung @jccarnevale we established a virus-like particle toolkit for genetic engineering and pooled CRISPR screening in primary human myeloid cells 𧬠-
Nature Biotechnology reposted
Rong
@_RongL
Check out our August digital issue here: mp.weixin.qq.com/s/0677koQdmfYVshAg3uaqeQ @NatureBiotech
Nature Biotechnology
@NatureBiotech
The August issue is live www.nature.com/nbt/volumes/44/issues/8
The cover shows an illustration of hemorrhagic stroke debris being cleared from the mouse brain by ultrasound. Azadian et al. develop a focused ultrasound protocol that clears pathogenic debris from the brain through the meningeal lymphatics in two mouse models of stroke go.nature.com/4nO5s71
rdcu.be/fzlEz -
Nature Biotechnology
@NatureBiotech
Harmful debris and inflammation in the brain caused by hemorrhagic stroke are treated by ultrasound therapy in a mouse model #nbtnv go.nature.com/4hWkUwE
rdcu.be/eSP1Q -
Nature Biotechnology
@NatureBiotech
Five questions with Elham Azizi www.nature.com/articles/s41587-026-03255-5
-
Nature Biotechnology
@NatureBiotech
From reading to writing www.nature.com/articles/s41587-026-03300-3
-
Nature Biotechnology
@NatureBiotech
cSplotch compares spatial transcriptomics data across ages and regions of mouse colon tissue go.nature.com/47I1RBF
rdcu.be/fAWIt -
Nature Biotechnology
@NatureBiotech
Lessons from drug revenue life cycles: distributions across modalities and therapeutic areas www.nature.com/articles/s41587-026-03278-y
-
Nature Biotechnology
@NatureBiotech
Enhanced antitumor immunity of mRNA vaccines by bioorthogonal-like delayed activation of exogeneous STING - @PKU1898 www.nature.com/articles/s41587-026-03224-y
-
Nature Biotechnology
@NatureBiotech
Register now for Reframing Precision Medicine: Innovation to Implementation,Ā a flagship Nature Conference in London from 13ā15 Oct 2026. Learn more at go.nature.com/471AdQb
-
Nature Biotechnology
@NatureBiotech
Photovoltaic devices attached to immune cells travel through the blood to inflamed brain regions go.nature.com/3JuSNYH
rdcu.be/fAqKL -
Nature Biotechnology
@NatureBiotech
The public health impact of the Medicines Patent Pool increases with the fragmentation of intellectual property rights www.nature.com/articles/s41587-026-03156-7
Nature Biotechnology
@NatureBiotech
The Medicines Patent Pool is improving access to essential medication where itās most needed, but does it make economicĀ sense? #nbtinthenews via @ConversationUS theconversation.com/the-medicines-patent-pool-is-improvinā¦
-
Nature Biotechnology
@NatureBiotech
Proteome-wide identification of the druggable CRBN interactome www.nature.com/articles/s41587-026-03237-7
Nature Biotechnology
@NatureBiotech
Research Briefing: A scalable platform to discover and characterize substrates of molecular glue degraders www.nature.com/articles/s41587-026-03256-4
rdcu.be/fAxo5 -
Nature Biotechnology
@NatureBiotech
Research Highlight: Magnetic microrobots for gastrointestinal drug delivery www.nature.com/articles/s41587-026-03274-2
-
Nature Biotechnology
@NatureBiotech
Join @NatureConf at Princeton University this October to hear the latest electron microscopy instrumentation and methods driving progress in the physical and life sciences. Abstract submission deadline extended til August 21! go.nature.com/4h0zAME
Nature Biotechnology
@NatureBiotech
Meet the speakers
-
Nature Biotechnology
@NatureBiotech
From circulating microRNAs to menstrual-fluid transcriptomics, biotech companies are betting on radically different biomarkers to detect a disease that still lacks a clear molecular definition www.nature.com/articles/s41587-026-03265-3
rdcu.be/fAzyq -
Nature Biotechnology
@NatureBiotech
A protein foundation model represents protein sequence, structure and function go.nature.com/4pSGJRf
rdcu.be/fAqAX -
Nature Biotechnology reposted
Nature Conferences
@NatureConf
The final agenda for Reframing Precision Medicine is live. Join 400+ attendees in London this October to tackle a defining question: how do we turn precision medicine into real clinical impact?
Curated by Nature editors. See the final full agenda -go.nature.com/4hyeQw9 -
Nature Biotechnology reposted
Daniel Blankenberg @DBlankenberg
Delighted to share our paper in Nature Biotechnology, led by @cumbofabio !
MetaSBT organizes >190,000 viral genomes and defines >40,000 candidate species, ~80% unmatched in reference databases.
Congratulations, Fabio! It is a privilege to work with you!
www.nature.com/articles/s41587-026-03245-7 -
Nature Biotechnology reposted
David R. Liu
@davidrliu
Today in @NatureBiotech we report OptiPrime, a mechanism-based machine learning model for predicting prime editing (PE) efficiencies and suggesting pegRNAs to achieve a user-specified edit. OptiPrime incorporates biochemical knowledge about PE into its mathematical structure, enabling training on ~300,000 PE efficiencies collected using 40 experimental conditions in multiple labs, and outcome predictions of PE variants such as twin prime editing not used in its training. OptiPrime enabled the rapid identification of efficient PE strategies across a variety of applications in vitro and in vivo, and could outperform months or years of manual experimental optimization.
Try out OptiPrime here: optipri.me
PDF: drive.google.com/file/d/13JZWWI6-lJwJC9bNFXp8IXwcUFtNGIx5ā¦
1/15 -
Nature Biotechnology
@NatureBiotech
Join @NatureConf at Princeton University this October to hear the latest electron microscopy instrumentation and methods driving progress in the physical and life sciences go.nature.com/4h0zAME
-
Nature Biotechnology
@NatureBiotech
Light up your space with glowing houseplants www.nature.com/articles/s41587-026-03270-6
-
Nature Biotechnology
@NatureBiotech
Phylogenetic mining and protein language models uncover improved PiggyBac transposase sequences go.nature.com/4gXLGEw
rdcu.be/fzNSK -
Nature Biotechnology
@NatureBiotech
Research Highlight: Killing resistant tumors with a click www.nature.com/articles/s41587-026-03275-1
nature
@Nature
Nature research paper: Modular in vivo antibodyāADC click to reverse drug resistance in tumours
go.nature.com/4fEc4nC -
Nature Biotechnology
@NatureBiotech
The invisible tax of US visa bureaucracy on international scholars www.nature.com/articles/s41587-026-03252-8
-
Nature Biotechnology
@NatureBiotech
Tech giants plunge into life sciences with AI-powered platforms and agents www.nature.com/articles/s41587-026-03271-5
rdcu.be/fzKXa -
Nature Biotechnology
@NatureBiotech
Characterization of microbial dark matter at scale with MetaSBT and taxonomy-aware Sequence Bloom Trees www.nature.com/articles/s41587-026-03245-7
-
Nature Biotechnology
@NatureBiotech
Di Carlo and colleagues discuss technologies required to map and engineer the human cellācell interactome and the therapeutic avenues such an atlas could unlock www.nature.com/articles/s41587-026-03177-2
rdcu.be/fzyiv -
Nature Biotechnology
@NatureBiotech
Reversible epiblast regionalization determines differentiation potential of human pluripotent stem cells www.nature.com/articles/s41587-026-03254-6
Nature Biotechnology
@NatureBiotech
Restoring pluripotency to pluripotent stem cells #nbtnv www.nature.com/articles/s41587-026-03253-7
-
Nature Biotechnology
@NatureBiotech
Simultaneous single-cell profiling of chromatin, transcriptome and surface markers with OneCell CUT&Tag captures epigenomic reprogramming www.nature.com/articles/s41587-026-03259-1
-
Nature Biotechnology
@NatureBiotech
Mechanistic machine learning for prediction of prime editing outcomes www.nature.com/articles/s41587-026-03261-7
-
Nature Biotechnology
@NatureBiotech
Discovery and design of potent cell surface display elements www.nature.com/articles/s41587-026-03144-x
-
Nature Biotechnology
@NatureBiotech
Menstrualome aids difficult endometriosis diagnosis www.nature.com/articles/s41587-026-03265-3
-
Nature Biotechnology
@NatureBiotech
The August issue is live www.nature.com/nbt/volumes/44/issues/8
The cover shows an illustration of hemorrhagic stroke debris being cleared from the mouse brain by ultrasound. Azadian et al. develop a focused ultrasound protocol that clears pathogenic debris from the brain through the meningeal lymphatics in two mouse models of stroke go.nature.com/4nO5s71
rdcu.be/fzlEz -
Nature Biotechnology
@NatureBiotech
Non-invasive nanoparticle barcoding in nonhuman primates www.nature.com/articles/s41587-026-03262-6
-
Nature Biotechnology reposted
Nature Conferences
@NatureConf
Present your latest work in nucleic acid medicines at RNA at the Bench and Bedside 5. Become an integral part of the program, connect with speakers, and have your research reviewed by @NatureBiotech editors.
šā”ļøgo.nature.com/4xgXqJZ -
Nature Biotechnology reposted
David R. Liu
@davidrliu
Today in @NatureBiotech we report the use of phage-assisted evolution (PACE) to reprogram botulinum neurotoxin (BoNT) proteases to trigger cancer cell death. We evolved proteases to cleave procaspase-1 or gasdermin D, inducing cell death and slowing tumor growth in a highly drug-resistant mouse model.
drive.google.com/file/d/1KQfc19gxbeB1hNGKR7UM1P9s26SkVHMaā¦
1/13 -
Nature Biotechnology
@NatureBiotech
EU relaxes rules for gene-edited crops
The new laws break away from 20-year-old restrictive GMO directives to give an official nod to plants made with new genomic techniques www.nature.com/articles/s41587-026-03264-4 -
Nature Biotechnology
@NatureBiotech
RNA-binding motifs in eukaryotic proteins are presented in a comprehensive resource go.nature.com/4mc1SmQ
rdcu.be/fxFp9 -
Nature Biotechnology
@NatureBiotech
Biotechās digital twin dilemma www.nature.com/articles/s41587-026-03211-3
rdcu.be/fx5Fm -
Nature Biotechnology
@NatureBiotech
A multi-institute, multi-platform initiative generates standard metrics and best practices for spatial transcriptomics analysis go.nature.com/4rBC1Z0
rdcu.be/fxFoM -
Nature Biotechnology
@NatureBiotech
Chinaās innovation in translational medicine: rethinking early-stage clinical development go.nature.com/4agbEkG
Nature Biotechnology
@NatureBiotech
The new rules of global drug development #nbtinthenews via @medicine_maker themedicinemaker.com/issues/2026/articles/july/the-new-ruā¦
-
Nature Biotechnology
@NatureBiotech
Hybrid quantumāclassical computer systems act as a bridge to achieving quantum advantage, but they are not likely to scale well to the number of qubits required for use cases that are projected to eventually benefit most from quantum computing, such as molecular simulation and drug design, or protein or RNA folding www.nature.com/articles/s41587-026-03233-x
-
Nature Biotechnology
@NatureBiotech
As biotech becomes one of the defining technologies that will shape economic strength, national resilience and geopolitical influence over the coming decades, the industry must commit to rebuilding and preserving public trust in the face of growing pressures on the institutions that underpin scientific leadership www.nature.com/articles/s41587-026-03251-9
rdcu.be/fxOKG -
Nature Biotechnology
@NatureBiotech
A resource of human RNA-protein associations is produced using a sequencing-based method go.nature.com/4gmf1Ii
rdcu.be/fxFn1 -
Nature Biotechnology
@NatureBiotech
Single-cell spatial pharmacobiology identifies conserved stromal barriers to therapeutic antibody delivery in human solid tumors go.nature.com/4atBJML
Nature Biotechnology
@NatureBiotech
Research addressesāÆbarriers toāÆsuccess for antibody-based therapies for solid head,āÆneckāÆand pancreatic tumors #nbtinthenews news.vumc.org/2026/06/05/research-addresses-barriers-to-sā¦
Nature Biotechnology
@NatureBiotech
Spatial singleācell platform reveals barriers to antibody delivery in solid tumors #nbtinthenews via @genbio www.genengnews.com/topics/cancer/spatial-singleācell-platā¦
Nature Biotechnology
@NatureBiotech
Single-cell spatial pharmacobiology just changed what ādrug deliveryā means in solid tumor trialsĀ #nbtinthenews viaĀ @ctrialvanguard www.clinicaltrialvanguard.com/article/intel-brief/single-ā¦
Nature Biotechnology
@NatureBiotech
Pinpointing the location of cancer-fighting antibodies in human tumors with unprecedented detailĀ #nbtinthenews via @stanfordmed med.stanford.edu/news/all-news/2026/07/pinpointing-cancerā¦
Nature Biotechnology
@NatureBiotech
How spatial biology is tracking antibody drugs inside tumoursĀ #nbtinthenews viaĀ @DrugTargetRevĀ www.drugtargetreview.com/home/how-spatial-biology-is-tracā¦
Nature Biotechnology
@NatureBiotech
Research Briefing: Single-cell spatial pharmacobiology for imaging antibody-based therapies in solid tumors www.nature.com/articles/s41587-026-03171-8
-
Nature Biotechnology
@NatureBiotech
Each year, we highlight companies that received sizeable early-stage funding in the previous year. Excelsior Sciences is developing a closed-loop system for drug discovery using carbon building bloccs www.nature.com/articles/s41587-026-03249-3
-
Nature Biotechnology
@NatureBiotech
Evolution of botulinum neurotoxin serotype X proteases to induce inflammatory cell death in cancer cells www.nature.com/articles/s41587-026-03243-9
-
Nature Biotechnology reposted
Keasling Lab š³ļøāšš³ļøāā§ļø
@Keasling_Lab
We're thrilled to share our new manuscript in @NatureBiotech, led by former postdoc Zilong Wang! We engineered #polyketidesynthases to produce renewable monomers for plastics with programmable properties, enabling materials-by-design for a circular and sustainable future. 1/2
-
Nature Biotechnology reposted
Parallel Bio
@ParallelBio
"[Animal testing] has never worked, and it will never work."
20 years ago, 6 healthy volunteers nearly died in a clinical trial.
In a new @NatureBiotech feature, our co-founders explain why animal testing is broken.
Read more: www.nature.com/articles/s41587-026-03226-w -
Nature Biotechnology reposted
Maria Lukarska @MariaLukarska
Our ProteinGuide paper is finally out! Thanks to all the co-authors @junhaobearxiong, @Ishan__Gaur, Hunter Nisonoff, @loltrogge, @dfsavage, @jlistgarten! @SavageCatsOnly
Nature Biotechnology
@NatureBiotech
Property guidance for protein sequence generative models with ProteinGuide www.nature.com/articles/s41587-026-03207-z
-
Nature Biotechnology reposted
Nature Asia-Pacific
@NatureAsia
Fetal monitoring for high-risk pregnancies using a wearable ultrasound patch
www.nature.com/articles/s41587-026-03140-1
@naturebiotech paper by Sheng Xu et al.
For reading: rdcu.be/fwBhc
@UCSanDiego @Stanford
#pregnancy #fetalmonitoring #maternalhealth #obstetrics #perinatalcare
Nature Portfolio
@NaturePortfolio
A paper in Nature Biotechnology presents a wearable ultrasound device that is optimized for continuous monitoring of pregnancies. go.nature.com/43zre6I
-
Nature Biotechnology reposted
Jennifer Listgarten
@jlistgarten
ProteinGuide is finally officially out. Congrats to the amazing team of @junhaobearxiong, @Ishan__Gaur, @MariaLukarska, and Hunter Nisonoff, in our continued great collaboration with @SavageCatsOnly.
Nature Biotechnology
@NatureBiotech
Property guidance for protein sequence generative models with ProteinGuide www.nature.com/articles/s41587-026-03207-z
-
Nature Biotechnology reposted
Isabel Zhang
@zhang_isaruihan
Regulation held back progress on food security. Hopefully, that's beginning to change.
June's European heatwave wiped out 9 million tonnes of grain, cost farmers ā¬2bn, and is expected to contribute to the smallest EU-UK harvest since 2018, raising concerns over food prices.
Nature Biotechnology
@NatureBiotech
EU relaxes rules for gene-edited crops www.nature.com/articles/s41587-026-03264-4
-
Nature Biotechnology reposted
Ishan Gaur @Ishan__Gaur
ProteinGuide is in print!
Nature Biotechnology
@NatureBiotech
Property guidance for protein sequence generative models with ProteinGuide www.nature.com/articles/s41587-026-03207-z
-
Nature Biotechnology reposted
Helms Research Group
@GroupHelms
Just out in @NatureBiotech! New PKS-engineered route to chiral monomers for PDKs: tunable Tg and programmable depolymerization, all from corn stover feedstock. Cheaper & lower-GHG than dimedone. Biosynthesis meets circular plastics. @jbei @molecularfndry www.nature.com/articles/s41587-026-03229-7
-
Nature Biotechnology reposted
Toni Choueiri, MD
@DrChoueiri
Congratulations to the #wulab, @BraunMDPhD #giacomooliveira and 1st authors @AdiNagler +@AAfeyan @DanaFarber @harvardmed + many colleagues on 2 "same day" papers in @Nature & @NatureBiotech:
1) Tertiary lymphoid structures in Kidney Cancer are reservoirs of tumor-specific T cells with stem-like progenitor features with an interplay with immunosuppressive macrophages that could be leveraged by T cell immunotherapies.
2) New technology: Slide-GoTags that establishes a framework for in situ mapping of T cellātumor interactions directly from individual tissue. -
Nature Biotechnology
@NatureBiotech
The new laws break away from 20-year-old restrictive GMO directives to give an official nod to plants made with new genomic techniques www.nature.com/articles/s41587-026-03264-4
-
Nature Biotechnology
@NatureBiotech
Research Highlight: An RNA-guided āchromatin shredderā for selective cell killing www.nature.com/articles/s41587-026-03236-8
nature
@Nature
Scientists have exploited a peculiar CRISPR enzyme so that it fights cancer by shredding the DNA in cancer cells.
go.nature.com/4yFEZz5 -
Nature Biotechnology
@NatureBiotech
Recent moves of note in and around the biotech and pharma industries www.nature.com/articles/s41587-026-03210-4
rdcu.be/fw6w6 -
Nature Biotechnology
@NatureBiotech
Append editing of ADP-ribosyl to thymine is used for precise modifications in bacteria and eukaryotes go.nature.com/4n7zDpG
rdcu.be/fwxAh -
Nature Biotechnology
@NatureBiotech
Efficient site-specific gene addition using R2 retrotransposons in tobacco and rice www.nature.com/articles/s41587-026-03181-6
Nature Biotechnology
@NatureBiotech
KAUST researchers develop newāÆmethodāÆforāÆmore precise plant engineering #nbtinthenews www.kaust.edu.sa/en/news/kaust-researchers-develop-new-meā¦
Nature Biotechnology
@NatureBiotech
KAUST researchers create more precise method for engineering plants #nbtinthenews bioengineer.org/kaust-researchers-create-more-precise-metā¦
-
Nature Biotechnology
@NatureBiotech
Biotech news from around the world: South Africa, India, Philippines, Uganda www.nature.com/articles/s41587-026-03232-y
rdcu.be/fwVOO -
Nature Biotechnology
@NatureBiotech
Ten commitments for a bold biotechnology industry - @jmaxlevin www.nature.com/articles/s41587-026-03251-9
-
Nature Biotechnology
@NatureBiotech
Antibacterial compounds are discovered by combining phenotypic screening with deep learning www.nature.com/articles/s41587-025-02814-6
rdcu.be/fuZXX
Nature Biotechnology
@NatureBiotech
A deep learning model trained on experimental data from high-throughput screening identifies structurally novel antimicrobial compounds #nbtnv go.nature.com/47fxSSv
rdcu.be/fwxyi -
Nature Biotechnology
@NatureBiotech
Diverse stakeholders were surveyed to characterize three key factors influencing healthcare innovation, including the role of institutional players, projected areas of development and persistent barriers to implementation www.nature.com/articles/s41587-026-03208-y
rdcu.be/fwI8K -
Nature Biotechnology
@NatureBiotech
Standardized metrics for assessment and reproducibility of imaging-based spatial transcriptomics datasets go.nature.com/4rBC1Z0
Nature Biotechnology
@NatureBiotech
Spatial Touchstone brings quality control to spatial transcriptomics #nbtinthenews via @StJudeResearch www.stjude.org/media-resources/news-releases/2025-medicinā¦
Nature Biotechnology
@NatureBiotech
Mapping the microworld to reveal biology's hidden networksĀ #nbtinthenews viaĀ @StJudeResearch www.stjude.org/research/why-st-jude/scientific-report/202ā¦
-
Nature Biotechnology
@NatureBiotech
Recent patents relating to bispecific antibody compositions and methods of use www.nature.com/articles/s41587-026-03205-1
rdcu.be/fwItG -
Nature Biotechnology
@NatureBiotech
Single-nucleus multimodal spatial transcriptomics reveals spatial colocalization of neoantigen-expressing tumor cells and cognate T cells www.nature.com/articles/s41587-026-03194-1
Nature Biotechnology
@NatureBiotech
Research Briefing: A spatial view of tumor neoantigen recognition www.nature.com/articles/s41587-026-03203-3
rdcu.be/fwGUj -
Nature Biotechnology
@NatureBiotech
EU relaxes rules for gene-edited crops www.nature.com/articles/s41587-026-03264-4
-
Nature Biotechnology
@NatureBiotech
High numerical aperture confocal volumetric mesoscope reveals mesoscale subcellular dynamics in vivo www.nature.com/articles/s41587-026-03231-z
Nature Biotechnology
@NatureBiotech
How electroacupuncture calms inflammation and the super microscope that showed it #nbtinthenews viaĀ @SCMPNews www.scmp.com/news/china/science/article/3361159/first-supā¦
Nature Biotechnology
@NatureBiotech
Video: Chinaās super microscope shows how electroacupuncture calms inflammation #nbtinthenews www.scmp.com/video/science/3361424/chinas-super-microscopā¦
-
Nature Biotechnology
@NatureBiotech
Skin metagenomic and metatranscriptomic analysis shows divergence between microbial abundance and activity go.nature.com/4fVg95j
rdcu.be/fwxuI -
Nature Biotechnology
@NatureBiotech
Frontier AI companies as biotech acquirers www.nature.com/articles/s41587-026-03214-0
Nature Biotechnology
@NatureBiotech
Unpacking Anthropic's 100-day sprint into biopharma: Nobel hires, M&A and major ambitionĀ #nbtinthenewsĀ
endpoints.news/anthropics-life-sciences-plans-mystery-pro⦠-
Nature Biotechnology
@NatureBiotech
Molecular and technical considerations for developing mechanistically grounded virtual immune cell models www.nature.com/articles/s41587-026-03139-8
rdcu.be/fwwlC -
Nature Biotechnology
@NatureBiotech
In Brief: @MHRAgovuk proposes Rare Disease Therapies Regulatory Framework, an ambitious new pathway for regulating therapies that treat diseases too rare to be considered commercially viable www.nature.com/articles/s41587-026-03244-8
rdcu.be/fwwhM -
Nature Biotechnology
@NatureBiotech
Engineered polyketide synthases enable a microbial chassis for recyclable plastics with tunable properties www.nature.com/articles/s41587-026-03229-7
-
Nature Biotechnology reposted
Rong
@_RongL
New online in @NatureBiotech: Spatial relationships between neoantigens and cognate T cells are studied.
Nature Biotechnology
@NatureBiotech
Single-nucleus multimodal spatial transcriptomics reveals spatial colocalization of neoantigen-expressing tumor cells and cognate T cells www.nature.com/articles/s41587-026-03194-1
-
Nature Biotechnology reposted
Rong
@_RongL
Check out the brief digital edition of @NatureBiotech July issue here: mp.weixin.qq.com/s/mYgJDrWKRLW1f5BHy872WA
Nature Biotechnology
@NatureBiotech
The July issue is live nature.com/nbt/volumes/44/issues/7
On the cover, the microbiome is depicted as an interconnected network in which relationships among genes and proteins provide context for uncovering hidden biological functions. Zhang et al. introduce FUGAsseM, a method that uses microbial community data to infer the functions of previously uncharacterized gene products go.nature.com/435C4lp
rdcu.be/ftNUV -
Nature Biotechnology reposted
Jiamin Wu @JiaminWu7
The confocal scanning light-field imaging framework with a high-NA objective enables long-term high-speed 3D subcellular imaging at mesoscale FOV, which improves the efficiency of wet experiments by two orders of magnitude.
www.nature.com/articles/s41587-026-03231-zThis media couldn't be displayed. See it on the original post.
Nature Biotechnology
@NatureBiotech
High numerical aperture confocal volumetric mesoscope reveals mesoscale subcellular dynamics in vivo www.nature.com/articles/s41587-026-03231-z
-
Nature Biotechnology
@NatureBiotech
From virtual patients to simulated cells and organs-on-chips, digital twins are forecasting disease and guiding drug development. Scientists now must figure out how to define, validate and deploy these models www.nature.com/articles/s41587-026-03211-3
[šread free with login] -
Nature Biotechnology
@NatureBiotech
Engineered ADARs enable precision A-to-G base editing of DNA www.nature.com/articles/s41587-026-03223-z
Nature Biotechnology
@NatureBiotech
Research Briefing: ADAR-based DNA adenine base editing with single-nucleotide precision www.nature.com/articles/s41587-026-03228-8
rdcu.be/fvJt2 -
Nature Biotechnology
@NatureBiotech
An open-source platform for data-independent acquisition proteomics adapts predicted libraries to experimental settings go.nature.com/4qmEQMM
rdcu.be/fvytw -
Nature Biotechnology
@NatureBiotech
Biotech is back. But continued investor caution, the rise of China and fast-moving AI are changing the sectorās contours www.nature.com/articles/s41587-026-03179-0
[šread free with login] -
Nature Biotechnology
@NatureBiotech
AI model using AlphaFold3-predicted contact probabilities maps and reduces genome editor off-targets, enabling highly precise DNA base editing with improved specificity #nbthighlight www.nature.com/articles/s41586-026-10794-z
-
Nature Biotechnology
@NatureBiotech
Multiscale in vivo imaging of tumor evolution using a germline conditional triple-reporter mouse www.nature.com/articles/s41587-026-03184-3
Nature Biotechnology
@NatureBiotech
Imaging offers clearer insights to cancer #nbtinthenews via @UofGlasgow www.gla.ac.uk/news/headline_1283099_en.html
-
Nature Biotechnology
@NatureBiotech
Clinical trials gain intelligence go.nature.com/46HLHci
Nature Biotechnology
@NatureBiotech
DeepMind CEO says AI speeds drug discovery #nbtinthenews via @techinasia www.techinasia.com/news/deepmind-ceo-says-ai-speeds-drug-ā¦
Nature Biotechnology
@NatureBiotech
AI in drug discovery: From target identification to clinical translation #nbtinthenews www.drugdiscoverynews.com/ai-in-drug-discovery-from-targeā¦
-
Nature Biotechnology
@NatureBiotech
Delivery of an in vivoāselected AAV into the glymphatics achieves broad transduction of human glial cells in chimeric mice #nbtnv www.nature.com/articles/s41587-026-03193-2
-
Nature Biotechnology
@NatureBiotech
In Brief: @SangamoTx, a pioneer in genome editing, files for bankruptcy while securing agreements with @EliLillyandCo and @AstellasUS to maintain the value of some assets www.nature.com/articles/s41587-026-03240-y
rdcu.be/fvbvs -
Nature Biotechnology
@NatureBiotech
ENVnet provides a global molecular resource of dissolved organic matter www.nature.com/articles/s41587-026-03230-0
-
Nature Biotechnology
@NatureBiotech
A screen for protein degraders discovers hits by imaging cell survival go.nature.com/4mTBGhr
rdcu.be/fuD1k -
Nature Biotechnology
@NatureBiotech
A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells www.nature.com/articles/s41587-026-03199-w
Nature Biotechnology
@NatureBiotech
Open-access genetic map provides reference for what almost every stem cell gene does #nbtinthenews viaĀ @UCSanDiego today.ucsd.edu/story/open-access-genetic-map-provides-refā¦
-
Nature Biotechnology
@NatureBiotech
Efficient targeting of human glial progenitor cells in vivo with engineered AAV vectors and glymphatic delivery www.nature.com/articles/s41587-026-03185-2
Nature Biotechnology
@NatureBiotech
New platform combines precision gene targeting with brain-wide delivery #nbtinthenews via @UR_Med www.urmc.rochester.edu/news/story/new-platform-combines-pā¦
Nature Biotechnology
@NatureBiotech
Engineered AAVs harness glymphatic system to reach brain targets in miceĀ #nbtinthenews via @genbio www.genengnews.com/topics/omics/engineered-aavs-harness-gā¦
Nature Biotechnology
@NatureBiotech
An AAV vector for glial cells #nbtnv www.nature.com/articles/s41587-026-03193-2
-
Nature Biotechnology
@NatureBiotech
Research Highlight: Form follows function for RNA editing www.nature.com/articles/s41587-026-03235-9
Nature Biotechnology
@NatureBiotech
Structure-guidedĀ arRNAĀ design enables precise and expanded endogenous ADAR-mediated RNA editing #nbthighlight www.cell.com/cell/fulltext/S0092-8674(26)00514-3
-
Nature Biotechnology
@NatureBiotech
Survey-based insights on overcoming barriers in healthcare innovation ecosystems www.nature.com/articles/s41587-026-03208-y
-
Nature Biotechnology reposted
CorrectSequence Therapeutics @Correctseq
New in @NatureBiotech from our Scientific Founder Dr. Chen Jia' team: They developed tBE-VLP4, a novel base editing system enabling efficient in vivo C-to-T base editing in mice.š§¬
šwww.nature.com/articles/s41587-026-03227-9 #geneediting #baseediting #biotech #invivo #naturebiotech #correctseq -
Nature Biotechnology reposted
David Lewis @DavidYLewis
Great to see this highlighted by @NatureBiotech.
The key point for me is the ability to image both the forest and the trees, so tracking cancer across the body, then zooming in to study tumour cells, their microenvironment and how disease evolves in context.
Nature Biotechnology
@NatureBiotech
Multiscale in vivo imaging of tumor evolution using a germline conditional triple-reporter mouse www.nature.com/articles/s41587-026-03184-3
-
Nature Biotechnology reposted
Jiamin Wu @JiaminWu7
Our recent work pushes mesoscale intravital imaging towards sub-cellular level to observe large-scale sub cellular dynamics across a mammalian organ. www.nature.com/articles/s41587-026-03231-z
Nature Biotechnology
@NatureBiotech
High numerical aperture confocal volumetric mesoscope reveals mesoscale subcellular dynamics in vivo www.nature.com/articles/s41587-026-03231-z
-
Nature Biotechnology reposted
Eira Initiative
@EiraInitiative
From Kristina Acri's new correspondence in @NatureBiotech: "Timely generic entry is essential, and, if reform is needed, that need should be established with rigorous evidence and reliable data. An issue identified in less than 1% of the unique drugs that account for substantial federal drug spending does not constitute such evidence."
Check it out: idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat⦠-
Nature Biotechnology reposted
nature
@Nature
General purpose AI tools for science, such as Claude Science, promise to accelerate research. But which is right for you?
go.nature.com/4pdGH6o -
Post not available here, view on XPost not available here, view on X
Nature Biotechnology
@NatureBiotech
An AI-designed drug is moving toward approval at an impressive clip #nbtinthenews via @singularityhub singularityhub.com/2024/03/18/an-ai-designed-drug-is-moviā¦
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
AI-driven drug discovery achieves milestone with Insilico Medicineās phase IIa success in treating pulmonary fibrosis #nbtinthenews via @UniteAi www.unite.ai/ai-driven-drug-discovery-achieves-milestone-ā¦
Nature Biotechnology
@NatureBiotech
Insilico initiates phase III clinical trial for Rentosertib, its AI-empowered TNIK inhibitor for idiopathic pulmonary fibrosis #nbtinthenews insilico.com/news/xmjsn4l091-insilico-initiates-phase-iiiā¦
Nature Biotechnology
@NatureBiotech
Insilico Medicine launches phase III trial of AI-designed Rentosertib drug #nbtinthenews via @DrugTargetRev www.drugtargetreview.com/insilico-medicine-launches-phaseā¦
-
Nature Biotechnology
@NatureBiotech
The @SynCellAsia Initiative outlines a strategy for developing core functional modules followed by their systems-level integration through the establishment of a centralized, AI-driven biofoundry go.nature.com/4tW9FZg
rdcu.be/fugoc -
Nature Biotechnology
@NatureBiotech
Each year, we highlight companies that received sizeable early-stage funding in the previous year. @stylus_medicine is engineering novel recombinases for in vivo CAR T cell cancer therapy www.nature.com/articles/s41587-026-03225-x
[šread free with login] -
Nature Biotechnology
@NatureBiotech
Obituary: J. Craig Venter 1946ā2026 www.nature.com/articles/s41587-026-03248-4
-
Nature Biotechnology
@NatureBiotech
Ribonucleoproteins, nucleic acids and proteins are delivered into target cell types with nanosyringes go.nature.com/46OFcoj
rdcu.be/ft8Rp -
Nature Biotechnology
@NatureBiotech
Research Highlight: Integrating chromatin architecture and functional analysis www.nature.com/articles/s41587-026-03234-w
Nature Methods
@naturemethods
HiCFoundation: a foundation model trained on Hi-C data for comprehensive 3D genome and epigenomics analysis.
www.nature.com/articles/s41592-026-03097-8 -
Nature Biotechnology
@NatureBiotech
The FDAās drive to reduce animal testing in drug development has coincided with a boom in AI-powered biosimulation techniques such as multi-agent virtual scientists and digital twins, while organoids and other mature methods embrace AI to ramp up predictive power
-
Nature Biotechnology
@NatureBiotech
The global patent landscape of bispecific antibodies: technological innovations and therapeutic applications www.nature.com/articles/s41587-026-03204-2
-
Nature Biotechnology
@NatureBiotech
This Perspective positions cellular self-organization as a foundational principle for the origin of multicellular life and discusses how decoding this concept with stem cell-based models will advance biological engineering go.nature.com/4e1m3Br
rdcu.be/ftZeL -
Nature Biotechnology
@NatureBiotech
High-fidelity fast fluorescence lifetime imaging by event-based denoising www.nature.com/articles/s41587-026-03222-0
-
Nature Biotechnology
@NatureBiotech
In Brief: Chinaās drug regulator gives green light to @CARsgen_Therās satri-cel (satricabtagene autoleucel) for gastric cancer ā the first chimeric antigen receptor (CAR) T cell therapy approved for solid tumors www.nature.com/articles/s41587-026-03241-x
rdcu.be/ftVq1 -
Nature Biotechnology
@NatureBiotech
Quantum computing in transition
Hybrid quantumāclassical computers will achieve quantum advantage in biotechnology, bridging the time until a full quantum computer becomes available www.nature.com/articles/s41587-026-03233-x -
Nature Biotechnology
@NatureBiotech
The July issue is live nature.com/nbt/volumes/44/issues/7
On the cover, the microbiome is depicted as an interconnected network in which relationships among genes and proteins provide context for uncovering hidden biological functions. Zhang et al. introduce FUGAsseM, a method that uses microbial community data to infer the functions of previously uncharacterized gene products go.nature.com/435C4lp
rdcu.be/ftNUV -
Nature Biotechnology
@NatureBiotech
AI-powered methods shake up animal testing www.nature.com/articles/s41587-026-03226-w
[šread free with login] -
Nature Biotechnology
@NatureBiotech
Site-specific DNA insertion into the human genome with engineered recombinases go.nature.com/43kdvBg
Nature Biotechnology
@NatureBiotech
The quest for large-scale DNA #nbtinthenews via @genbio www.genengnews.com/topics/genome-editing/the-quest-for-laā¦
-
Nature Biotechnology
@NatureBiotech
Retargeted serine integrases for one-step, precise integration of large DNA sequences in human cells www.nature.com/articles/s41587-026-03186-1
Nature Biotechnology
@NatureBiotech
A retargeted recombinase for precise insertion of large DNA #nbtnv www.nature.com/articles/s41587-026-03198-x
Nature Biotechnology
@NatureBiotech
Retargeted serine integrases enable precise large-gene insertion #nbtinthenews via @CrisprMedicine crisprmedicinenews.com/news/retargeted-serine-integrases-ā¦
-
Nature Biotechnology
@NatureBiotech
High-resolution reconstruction of cell-type-specific transcriptional regulatory processes from bulk sequencing samples www.nature.com/articles/s41587-026-03218-w
-
Nature Biotechnology reposted
Amelia Palermo Briosi, PhD @Amelia_Palermo
āļøA new class of biotech buyer is emerging: frontier AI acquiring biology for talent, data and model expansion.
šI have been thinking about this topic for some time. My latest piece, on the implications &outlook, is out in @NatureBiotech as of July 7.
Nature Biotechnology
@NatureBiotech
Frontier AI companies as biotech acquirers www.nature.com/articles/s41587-026-03214-0
-
Nature Biotechnology reposted
Mike Mitchell
@MJMitchell_Lab
Thank you Iris Marchal for the excellent writeup in @NatureBiotech on Liberate Bio! Grateful for Shawn Davis's incredible leadership as we translate our LNP platform for in vivo CAR monocyte reprogramming into clinical trials by the end of the year!
www.nature.com/articles/s41587-026-03201-5 -
Nature Biotechnology
@NatureBiotech
Mapping and engineering the human cellācell interactome www.nature.com/articles/s41587-026-03177-2
Nature Biotechnology
@NatureBiotech
Can scientists learn cells' language? UCLA-led team aims to decode cellular conversations #nbtinthenews via @UCLAengineering samueli.ucla.edu/can-scientists-learn-cells-language-uclaā¦
Nature Biotechnology
@NatureBiotech
New article highlights the need for cell-cell interaction data in AI biology #nbtinthenews via @partillion_bio www.prnewswire.com/news-releases/new-nature-biotechnologyā¦
-
Nature Biotechnology
@NatureBiotech
Biotechās digital twin dilemma www.nature.com/articles/s41587-026-03211-3
[šread free with login] -
Nature Biotechnology
@NatureBiotech
Efficient in vivo cytosine base editing using virus-like particles with uracil DNA glycosylase inhibition www.nature.com/articles/s41587-026-03227-9
-
Nature Biotechnology
@NatureBiotech
Prime editing for precise genome engineering and modulation of fungal metabolism - @XueSherryGao @DrYihuiShen www.nature.com/articles/s41587-026-03202-4
Nature Biotechnology
@NatureBiotech
Research Briefing: Unlocking the chemical potential of filamentous fungi using prime editing www.nature.com/articles/s41587-026-03219-9
rdcu.be/fslIn
Nature Biotechnology
@NatureBiotech
Unearthing new cancer treatments from fungi #nbtinthenews via @Penn penntoday.upenn.edu/news/unearthing-new-cancer-treatmentsā¦
-
Nature Biotechnology
@NatureBiotech
High-quality phage assembly from metagenomes with PALACE www.nature.com/articles/s41587-026-03188-z
-
Nature Biotechnology
@NatureBiotech
Antibodyābottlebrush conjugates expand the options for drug cargos compared to antibodyādrug conjugates go.nature.com/46d1T3t
rdcu.be/fpOS5 -
Nature Biotechnology
@NatureBiotech
Silhouette score is unsuitable as a metric for single-cell data integration go.nature.com/4fcQzZr
rdcu.be/fpOKP -
Nature Biotechnology
@NatureBiotech
Quantum computing in transition www.nature.com/articles/s41587-026-03233-x
-
Nature Biotechnology
@NatureBiotech
Each year, we highlight companies that received sizeable early-stage funding in the previous year. Liberate Bio is developing a lipid nanoparticle toolbox to deliver genetic medicine to previously inaccessible cells inside the body www.nature.com/articles/s41587-026-03201-5
-
Nature Biotechnology reposted
Rong
@_RongL
The brief digital edition of @NatureBiotechās June issue is live now! Check it out here: mp.weixin.qq.com/s/eXJfskj-pGrjzeOmzzGhUQ
Nature Biotechnology
@NatureBiotech
The June issue is live nature.com/nbt/volumes/44/issues/6
The cover shows an illustration of vascularized tumors on a chip. Liu et al. present a longāterm, perfused system for human solid tumors that supports CARāT delivery and realātime analysis of tumorāCARāT dynamics, evaluation of engineering strategies, and identification of druggable targets go.nature.com/3Jc62gv
rdcu.be/foISS -
Nature Biotechnology reposted
Xue Sherry Gao
@XueSherryGao
Excited to share our latest work, now published in @NatureBiotech! We established the first prime editing platform for filamentous fungi, achieving average editing efficiencies approaching 90% across diverse loci and species. www.nature.com/articles/s41587-026-03202-4
-
Nature Biotechnology reposted
Jeff Miller @wraithnot
We are thrilled that an article describing our #mintplatform has just been published in @NatureBiotech!: www.nature.com/articles/s41587-026-03186-1
-
Nature Biotechnology reposted
Sanketh Vedula @sankethvedula
Excited to share that experiment-guided AlphaFold is now published in @NatureBiotech!
Nature Biotechnology
@NatureBiotech
Experiment-guided AlphaFold3 resolves measurement-consistent protein ensembles www.nature.com/articles/s41587-026-03166-5
-
Nature Biotechnology
@NatureBiotech
An evaluation framework isolates perturbation-specific effects in perturbation datasets go.nature.com/4791kda
rdcu.be/fpOWU -
Nature Biotechnology
@NatureBiotech
The New Clinical Investigation exclusivity: a substantial source of monopoly time for brand drugs idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.natā¦
Nature Biotechnology
@NatureBiotech
Methodological concerns and a lack of evidence for reforming regulatory exclusivities for pharmaceuticals www.nature.com/articles/s41587-026-03165-6
Nature Biotechnology
@NatureBiotech
Reply to āMethodological concerns and a lack of evidence for reforming regulatory exclusivities for pharmaceuticalsā www.nature.com/articles/s41587-026-03164-7
-
Nature Biotechnology
@NatureBiotech
Each year, we highlight companies that received sizeable early-stage funding in the previous year. Trogenix has developed a platform for generating āsynthetic super-enhancersā that could drive highly cell-specific gene therapy-based treatment of solid tumors such as glioblastoma
-
Nature Biotechnology
@NatureBiotech
A plug-and-play system fine-tunes multiple targets simultaneously for secondary metabolite production in Streptomyces go.nature.com/3HdTOTV
rdcu.be/fpOVH -
Nature Biotechnology
@NatureBiotech
With endless curiosity and persistence, this biologist is motivated by the prospect of developing stem cell technologies that could one day repair damaged organs or even create new organs for transplantation www.nature.com/articles/s41587-026-03169-2
rdcu.be/fpQOo -
Nature Biotechnology
@NatureBiotech
Experiment-guided AlphaFold3 resolves measurement-consistent protein ensembles www.nature.com/articles/s41587-026-03166-5
Nature Biotechnology
@NatureBiotech
Toward experiment-guided AlphaFold: @ISTAustria researchers enhance Nobel Prize-winning structural prediction model #nbtinthenews ist.ac.at/en/news/toward-experiment-guided-alphafold/
-
Nature Biotechnology
@NatureBiotech
Biotech news from around the world: United Kingdom, Vietnam, United Arab Emirates, Brazil, Japan www.nature.com/articles/s41587-026-03178-1
rdcu.be/frxni -
Nature Biotechnology
@NatureBiotech
Genomic integration of DNA templates is made more precise through microhomology-focused design go.nature.com/41GoBiX
rdcu.be/fpOUC -
Nature Biotechnology
@NatureBiotech
Large-scale, spatially resolved panoramic CRISPR screening in native tissue environments using Perturb-DBiT www.nature.com/articles/s41587-026-03127-y
Nature Biotechnology
@NatureBiotech
Spatial CRISPR screens map total RNA in tissue #nbtnv www.nature.com/articles/s41587-026-03126-z
Nature Biotechnology
@NatureBiotech
Spatial CRISPR screening just made your preclinical models look like guesswork #nbtinthenews via @ctrialvanguard www.clinicaltrialvanguard.com/opinion/spatial-crispr-screā¦
Nature Biotechnology
@NatureBiotech
Spatial CRISPR unveils RNA roles in tumor growth and immunityĀ #nbtinthenews viaĀ @YaleCancer medicine.yale.edu/cancer/publication-details/spatial-crisā¦
-
Nature Biotechnology
@NatureBiotech
Recent patents relating to methods and systems for using artificial intelligence in drug discovery www.nature.com/articles/s41587-026-03163-8
rdcu.be/frihO -
Nature Biotechnology
@NatureBiotech
Mass spectrometry and wearable sensor technology are complementary approaches that, when integrated, can co-evolve to open new possibilities for noninvasive health monitoring go.nature.com/4rvOjAS
rdcu.be/fpQNs -
Nature Biotechnology
@NatureBiotech
Spatially resolved profiling of extracellular vesicles in tissues with Spatial-EV-seq www.nature.com/articles/s41587-026-03192-3
Nature Biotechnology
@NatureBiotech
Research Briefing: Mapping the spatial landscape of extracellular vesicles in tissues with Spatial-EV-seq www.nature.com/articles/s41587-026-03206-0
rdcu.be/fq1cg -
Nature Biotechnology reposted
nature
@Nature
Scientists have used a machine-learning strategy to discover antibiotics with fresh mechanisms
go.nature.com/4gF9BKu -
Nature Biotechnology reposted
nature
@Nature
A 'megacluster' of genes found in a common soil bacterium can produce a range of antibiotics that can act against multi-drug-resistant bacteria
go.nature.com/3QrtH0m -
Nature Biotechnology reposted
nature
@Nature
Amid chaos in US science and geopolitical turmoil, Europe wants to position itself as a research haven ā but questions about funding and innovation remain
go.nature.com/4eJ0k1k -
Nature Biotechnology reposted
Avi Roy
@agingroy
Keytruda is the worldās best-selling cancer drug. $31.7B a year.
It helps about 1 in 4 patients, and nobody can tell which 1 in 4 until we try.
The fix everyone wants is a virtual immune cell: simulate the patient, test the drug first. The bet is the bitter lesson of AI, that enough data and compute will teach a model the biology by itself.
This team says no. A T-cellās choice to attack a tumor is a precise molecular switch. More data never finds it. You have to teach the model how that switch works, not just show it more cells.
Nature Biotechnology
@NatureBiotech
Toward mechanistic virtual immune cells www.nature.com/articles/s41587-026-03139-8
-
Nature Biotechnology reposted
Arc Institute
@arcinstitute
Congrats to @BrianHie, @SynBioGaoLab, and team on Germinal, now out in @NatureBiotech. Their pipeline designs epitope-targeted antibodies with nanomolar affinity while testing only tens of designs per target, making antibody design far more accessible.
www.nature.com/articles/s41587-026-03187-0
Arc Institute
@arcinstitute
In another preprint from the @brianhie Lab and @SynBioGaoLab, they introduce Germinal, a generative AI system for de novo antibody design.
Germinal produces functional nanobodies in just dozens of tests, making custom antibody design more accessible than ever before. -
Nature Biotechnology reposted
Brian Hie
@BrianHie
In other news, our work on Germinal has been published today in @NatureBiotech!
New in the published manuscript are scFv design and data on polyspecificity, epitope targeting, and structure determination.Claudia Driscoll @driscoll_cl
Germinal is out today in Nature Biotechnology! Important additions to VHH design from the preprint: we demonstrate scFv design, evaluate binder polyreactivity, and characterise epitope specificity by alanine mutagenesis and a beautiful cryo-EM structure⦠www.nature.com/articles/s41587-026-03187-0
-
Nature Biotechnology
@NatureBiotech
Sub-zero technologies that reduce ice damage in organs could extend donor-graft shelf life ā offering transplant centers more time to match recipients www.nature.com/articles/s41587-026-03173-6
[šread free with login] -
Nature Biotechnology
@NatureBiotech
For years, the idea of targeted protein degradation stalled because PROTACs were too large and unstable for clinical use. However, in the beginning of May, @US_FDA approved the use of the first PROTAC for adults with a certain form of metastatic breast cancer
-
Nature Biotechnology
@NatureBiotech
PepMLM designs peptide binders against diverse targets using masked language modeling go.nature.com/3UtVc7N
rdcu.be/fpOQD -
Nature Biotechnology
@NatureBiotech
Recent moves of note in and around the biotech and pharma industries www.nature.com/articles/s41587-026-03176-3
rdcu.be/fqq4U -
Nature Biotechnology
@NatureBiotech
Toward mechanistic virtual immune cells www.nature.com/articles/s41587-026-03139-8
-
Nature Biotechnology
@NatureBiotech
Zero-shot de novo peptide sequencing with open posttranslational modification discovery go.nature.com/4ujx08d
Nature Biotechnology
@NatureBiotech
Unlocking disease-linked protein changes using AIĀ #nbtinthenews via @UWaterloo uwaterloo.ca/news/unlocking-disease-linked-protein-changeā¦
-
Nature Biotechnology
@NatureBiotech
In Brief: British startup Meatly will build what it says will be Europeās largest cultivated meat factory, to produce bioreactor-grown chicken meat for the pet food market www.nature.com/articles/s41587-026-03190-5
rdcu.be/foKVH -
Nature Biotechnology
@NatureBiotech
Transcriptome-scale maps of RNA secondary structure ensembles in living cells detect candidate RNA structural switches go.nature.com/4lLtIX8
rdcu.be/fpOO7 -
Nature Biotechnology
@NatureBiotech
Optimized R2 retroelement complexes for DNA insertion into plant genomes www.nature.com/articles/s41587-026-03197-y
Nature Biotechnology
@NatureBiotech
Improving plants with a tool borrowed from birdsĀ #nbtinthenews viaĀ @CaltechĀ www.caltech.edu/about/news/improving-plants-with-a-tool-bā¦
-
Nature Biotechnology
@NatureBiotech
Hybrid solidāliquid optics enable scalable, high-resolution light-sheet microscopy across diverse immersion media go.nature.com/4xdDkQR
Nature Biotechnology
@NatureBiotech
New 3D microscope technology captures high-resolution tissue images at a fraction of the cost #nbtinthenews via @Columbia news.columbia.edu/news/new-3d-microscope-technology-captuā¦
Nature Biotechnology
@NatureBiotech
UP-born Columbia University professor 'reinvents microscope for brain, cancer research' #nbtinthenews via @TOICitiesNewsĀ timesofindia.indiatimes.com/city/meerut/up-born-columbia-ā¦
Nature Biotechnology
@NatureBiotech
Research Briefing: Affordable centimeter-scale 3D microscopy with submicrometer resolution www.nature.com/articles/s41587-026-03209-x
rdcu.be/fp6iP -
Nature Biotechnology
@NatureBiotech
Joint profiling of chromatin and splicing in the brain uncovers shared and distinct patterns go.nature.com/3IKlcJn
rdcu.be/fpONd -
Nature Biotechnology
@NatureBiotech
If translational medicine is to fulfill its promise, educational programs must evolve to prepare a workforce not only capable of discovery, but capable of moving discovery toward the patients who need it www.nature.com/articles/s41587-026-03168-3
rdcu.be/foTHd -
Nature Biotechnology
@NatureBiotech
Fetal monitoring for high-risk pregnancies using a wearable ultrasound patch go.nature.com/3PKl7cr
Nature Biotechnology
@NatureBiotech
Wearable ultrasound patch monitors fetal blood flow, detects pregnancy complications in real time #nbtinthenews via @StanfordMed med.stanford.edu/news/all-news/2026/05/fetal-monitor-patcā¦
Nature Biotechnology
@NatureBiotech
Wearable ultrasound patch could help doctors spot danger signs in pregnancy earlier #nbtinthenews via @UniofOxford www.ox.ac.uk/news/2026-05-26-wearable-ultrasound-patch-coā¦
Nature Biotechnology
@NatureBiotech
Wearable ultrasound patch could improve care for high-risk pregnancies #nbtinthenews via @UCSanDiego today.ucsd.edu/story/wearable-ultrasound-patch-could-imprā¦
Nature Biotechnology
@NatureBiotech
Engineers say ultrasound patch could enhance fetal monitoring #nbtinthenews via @MedTechDaily www.medicaldesignandoutsourcing.com/ucsd-ultrasound-patchā¦
Nature Biotechnology
@NatureBiotech
Wearable ultrasound patch enables continuous fetal monitoring, finds research #nbtinthenews medicaldialogues.in/obstetrics-gynaecology/news/wearable-ā¦
-
Nature Biotechnology
@NatureBiotech
Five questions with Ya-Wen Chen www.nature.com/articles/s41587-026-03169-2
-
Nature Biotechnology
@NatureBiotech
Efficient generation of epitope-targeted antibodies with Germinal - @BrianHie @SynBioGaoLab www.nature.com/articles/s41587-026-03187-0
-
Nature Biotechnology
@NatureBiotech
The race to bring new organ-cooling solutions to the clinic is intensifying, with the latest āsubzeroā innovations promising to preserve organs days longer than traditional cold storage, potentially turning transplantation from a ājust-in-timeā to an elective surgery www.nature.com/articles/s41587-026-03173-6
[šread free with login] -
Nature Biotechnology
@NatureBiotech
The promises and pitfalls of biological AI algorithms, and a vision for generalist biological artificial intelligence in which models can perform diverse tasks across biological domains go.nature.com/3NdkqaE
rdcu.be/fpQM4 -
Nature Biotechnology
@NatureBiotech
In Brief: An experimental mRNA vaccine against infection from three species of ebolavirus, including the Bundibugyo ebolavirus causing the outbreak in the Democratic Republic of the Congo, has been protective in mice www.nature.com/articles/s41587-026-03191-4
rdcu.be/foIs2 -
Nature Biotechnology reposted
Gƶzde S. Demirer
@Demirer_GozdeS
Targeted DNA insertion remains a major bottleneck in plant engineering. We developed the R2 retrotransposon as an efficient plant genome editor to precisely insert large DNA payloads at targeted sites:
www.nature.com/articles/s41587-026-03197-y
Congratulations to @kimuchenje03 and the team!
š§µš -
Nature Biotechnology reposted
VISTEC @VISTEC_Thailand
š Proud to congratulate Prof. Dr. Pimchai Chaiyen for being part of the SynCell Asia Initiative ā 100+ scientists from 6 Asian nations publishing a 10-year roadmap to build a synthetic cell in @NatureBiotech!
A giant leap for science. A gift to humanity. šš¬
š Read here ā www.nature.com/articles/s41587-026-03153-w
@pchaiyen -
Nature Biotechnology
@NatureBiotech
AI-guided redesign of laboratory-evolved reverse transcriptases enhances prime editing go.nature.com/49yUr5t
Nature Biotechnology
@NatureBiotech
Scientists improve nearly every aspect of prime editing, moving it closer to treating more genetic diseases #nbtinthenews via @broadinstituteĀ www.broadinstitute.org/news/scientists-improve-nearly-eveā¦
-
Nature Biotechnology
@NatureBiotech
Multiple genes are efficiently edited simultaneously inĀ soybeanĀ with a prime editing system #nbthighlight www.nature.com/articles/s41477-026-02315-7
-
Nature Biotechnology
@NatureBiotech
Structure-guidedĀ arRNAĀ design enables precise and expanded endogenous ADAR-mediated RNA editing #nbthighlight www.cell.com/cell/fulltext/S0092-8674(26)00514-3
-
Nature Biotechnology
@NatureBiotech
A method for spatial CRISPR perturbation screening reveals how genetic changes alter coding and non-coding RNA in a native tissue context, including the tumor microenvironment #nbtnv www.nature.com/articles/s41587-026-03126-z
rdcu.be/fotFb -
Nature Biotechnology
@NatureBiotech
Structural motif search across the protein universe with Folddisco go.nature.com/4g8lCb0
Nature Biotechnology
@NatureBiotech
Hundreds of millions of AI-generated protein maps... "functional fingerprints" identified in seconds #nbtinthenews www.asiae.co.kr/en/article/2026061110053638883
-
Nature Biotechnology
@NatureBiotech
Improving multimodal wearable sensing for healthcare with artificial intelligence: key data-science challenges and disease contexts in which these systems could support therapeutic interventions go.nature.com/3RudjMJ
rdcu.be/fo8Ja -
Nature Biotechnology
@NatureBiotech
Novel microbial species in metagenomes are identified using conserved regions within universal marker genes go.nature.com/3IwOxHh
rdcu.be/foZyX -
Nature Biotechnology
@NatureBiotech
Historic FDA approval brings first gene therapy for genetic deafness www.nature.com/articles/s41587-026-03145-w
-
Nature Biotechnology
@NatureBiotech
Research Highlight: Prime assembly uses a Gibson-like strategy for large DNA insertions www.nature.com/articles/s41587-026-03196-z
Nature Biotechnology
@NatureBiotech
Prime Assembly integrates twinPE with a Gibson-like strategy to assemble multiple overlapping DNA templates within cells for large DNA insertionĀ of up to 11 kb #nbthighlight www.nature.com/articles/s41586-026-10460-4
-
Nature Biotechnology
@NatureBiotech
Educating for translation www.nature.com/articles/s41587-026-03168-3
-
Nature Biotechnology
@NatureBiotech
In Brief: London-based @IsomorphicLabs secures $2.1 billion in one of the largest private rounds in biotech history. Unveiled in February, the company's drug design engine surpassed the predictive accuracy of AlphaFold 3 www.nature.com/articles/s41587-026-03189-y
rdcu.be/foKPF -
Nature Biotechnology
@NatureBiotech
Marked for destruction
The significance of the first FDA-approved PROTAC lies not in proving that targeted protein degradation is superior to conventional therapies, but in proving that degrading proteins is possible as a therapeutic go.nature.com/4x3NYt7 -
Nature Biotechnology
@NatureBiotech
The June issue is live nature.com/nbt/volumes/44/issues/6
The cover shows an illustration of vascularized tumors on a chip. Liu et al. present a longāterm, perfused system for human solid tumors that supports CARāT delivery and realātime analysis of tumorāCARāT dynamics, evaluation of engineering strategies, and identification of druggable targets go.nature.com/3Jc62gv
rdcu.be/foISS -
Nature Biotechnology
@NatureBiotech
AI in drug discovery has always been a swirl of lofty language and real progress. Many earlier generation AI-powered biotech companies fell short of the hype. This time may be different www.nature.com/articles/s41587-026-03170-9
[šread free with login] -
Nature Biotechnology
@NatureBiotech
mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression go.nature.com/4eSjV0N
Nature Biotechnology
@NatureBiotech
Tuning the immune response to mRNA vaccines #nbtnv go.nature.com/42EDQZT
Nature Biotechnology
@NatureBiotech
Study overturns assumption about how mRNA vaccines work #nbtinthenews via @Labcompare www.labcompare.com/617-News/625474-Study-Overturns-Assumpā¦
Nature Biotechnology
@NatureBiotech
New research challenges understanding of mRNA vaccines and establishes innovative way to make them more effective #nbtinthenews www.mountsinai.org/about/newsroom/2026/new-research-challā¦
Nature Biotechnology
@NatureBiotech
Hepatocyte detargeting improves mRNA vaccine immunity in lymphoma model #nbtinthenews via @genengnews www.genengnews.com/topics/drug-discovery/hepatocyte-detarā¦
Nature Biotechnology
@NatureBiotech
Cancer vaccines based on mRNA advance, despite US cuts #nbtinthenews www.reuters.com/legal/litigation/cancer-vaccines-based-mrā¦
-
Nature Biotechnology reposted
Rong Fan
@RongFan8
𤩠spatial panoramic in vivo CRISPR screen via Perturb-DBiT 𤩠Excited to share our collaborative work with @sidichen lab and many outstanding collaborators, now published in Nature Biotechnology!
www.nature.com/articles/s41587-026-03127-y -
Nature Biotechnology reposted
MBF Bioscience
@MBFBioscience
š¬ Celebrating a breakthrough from Dr. Raju Tomer's lab @Columbia, just published in @NatureBiotech!
SCOPE technology + SLICE microscopy = affordable, high-resolution 3D imaging for all.
Dr. Tomer's team developed SCOPE, which transforms inexpensive air objectives into submicron-resolution tools. Combined with SLICE (which we commercialized from his pLSM invention), researchers can image centimeter-scale samples at nanoscale detail.
The research teamāspanning Columbia, NIH, Lehigh, NYU Langone, and MBFādemonstrated:
⢠Whole mouse & salamander brains
⢠Human tissue 3D histopathology
⢠Brain organoids with microglia
⢠Multi-immersion compatibility
This collaboration shows what's possible when academic innovation meets commercial accessibility. Dr. Tomer invented the platform; we help make it available to labs worldwide.
Huge congratulations to Dr. Tomer, the biologist collaborators, and the entire research team! This is the kind of science that expands what's possible for everyone. š
Read the full paper: www.nature.com/articles/s41587-026-03172-7
#microscopy #neuroscience #lightsheet #scientificimaging #innovation #slicelightsheetmicroscope -
Nature Biotechnology
@NatureBiotech
Artificial allosteric protein switches with machine-learning-designed receptors go.nature.com/4cshpM3
Nature Biotechnology
@NatureBiotech
Scientists turn AI-generated proteins into smart molecular sensors #nbtinthenews via @ARC_CoESB www.coesb.com.au/scientists-turn-ai-generated-proteins-inā¦
Nature Biotechnology
@NatureBiotech
.@ClarksonUniv researchers contribute to breakthrough biosensor technology #nbtinthenews via @northcountrynow northcountrynow.com/stories/clarkson-university-researcheā¦
-
Nature Biotechnology
@NatureBiotech
A deep convolutional neural network model predicts the influence of the full-length mRNA sequence on translation efficiency go.nature.com/4mgXR0C
rdcu.be/flWMe -
Nature Biotechnology
@NatureBiotech
Biotechās coming of age
Biotech is back. But continued investor caution, the rise of China and fast-moving AI are changing the sectorās contours www.nature.com/articles/s41587-026-03179-0 -
Nature Biotechnology
@NatureBiotech
High-content screening datasets are integrated within a shared latent space, enabling cross-dataset predictions www.nature.com/articles/s41587-025-02729-2
rdcu.be/fmbnK -
Nature Biotechnology reposted
Nature Conferences
@NatureConf
RNA at the Bench and Bedside is back for a 5th time!
Covering all the latest advances in nucleic acid medicines, from clinical trials to AI methods, join @ionispharma, @UCSDMedSchool, @Alnylam, & @NatureBiotech for an event you won't want to miss.
go.nature.com/4xgXqJZ -
Nature Biotechnology
@NatureBiotech
Multiplexed, precise genome engineering in monocots with twin prime editing systems go.nature.com/4ax0mrU
Nature Biotechnology
@NatureBiotech
Scientists create versatile āall-in-oneā platform for stacking multiple traits in crops #nbtinthenews bioengineer.org/scientists-create-versatile-all-in-one-plā¦
Nature Biotechnology
@NatureBiotech
Twin prime editing enables rapid trait stacking in crops #nbtinthenews via @GENbio www.genengnews.com/topics/genome-editing/twin-prime-editiā¦
-
Nature Biotechnology
@NatureBiotech
A graph neural network framework enables individualized genetic risk prediction at the single-cell level go.nature.com/3H6pAlr
rdcu.be/fmbnx -
Nature Biotechnology
@NatureBiotech
Optically detected and radio wave-controlled spin chemistry in flavoproteins go.nature.com/4nYgTuG
Nature Biotechnology
@NatureBiotech
Protein-based quantum sensors can be specifically controlled using radio waves #nbtinthenews via @TU_Muenchen www.tum.de/en/news-and-events/all-news/press-releases/detā¦
-
Nature Biotechnology
@NatureBiotech
A decade on, while the basic principles discussed in the first review of the patent landscape of antibodyādrug conjugates still apply, the ADC landscape has dramatically evolved and diversified go.nature.com/3RKQ691
rdcu.be/fl6wN -
Nature Biotechnology
@NatureBiotech
Next-gen cryo promises transplant surgeons more time www.nature.com/articles/s41587-026-03173-6
[šread free with login] -
Nature Biotechnology
@NatureBiotech
Selection of human hematopoietic stem cells bearing the intended functional edit by transient AND-gate reporters go.nature.com/3RFnL42
Nature Biotechnology
@NatureBiotech
How the SMArT platform redefines quality control for CRISPR workflows #nbtinthenews via @LabManager www.labmanager.com/new-quality-control-platform-improves-ā¦
-
Nature Biotechnology
@NatureBiotech
New approaches to antivenoms for snakebite lean on cutting-edge techniques, but can they successfully be brought to market? www.nature.com/articles/s41587-026-03157-6
[šread free with login] -
Nature Biotechnology
@NatureBiotech
A prime editor screen systematically identifies deleterious synonymous variants in human cells www.nature.com/articles/s41587-025-02710-z
rdcu.be/fmbna -
Nature Biotechnology
@NatureBiotech
Programmable, multiplexed and orthogonal gene control in bacteria with attenuated Cas13d systems go.nature.com/4u8kW8U
Nature Biotechnology
@NatureBiotech
Research Briefing: Programmable control of bacterial operons with a single Cas13 RNA effector www.nature.com/articles/s41587-026-03159-4
-
Nature Biotechnology reposted
HBKgenomics @HKgenomics
Does your designed active site already exist in nature? Is an uncharacterized protein hiding a catalytic site or a pocket? Folddisco can answer both, searching millions of structures for a 3D motif in seconds.
@NatureBiotechš§¬
š www.nature.com/articles/s41587-026-03162-9
š§µ1/7š -
Nature Biotechnology reposted
Rong
@_RongL
The brief digital edition of @NatureBiotechās May issue is live now! Check it out here: mp.weixin.qq.com/s/nIyLxLYlmwkZqxhjmFtqzA
Nature Biotechnology
@NatureBiotech
The May issue is live www.nature.com/nbt/volumes/44/issues/5
On the cover, Zhang et al. describe an antibody-based therapy against drug-resistant S. aureus. The antibody conjugate selectively binds to the wall teichoic acid of the bacteria and enriches calcium on the cell envelope, induces bacterial death and boosts immunogenicity go.nature.com/3UaGItg -
Nature Biotechnology reposted
Guolan Lu
@GuolanLu
1/8 āØThrilled to share that our paper is now online
@NatureBiotech
āSingle-cell spatial pharmacobiology identifies conserved stromal barriers to therapeutic antibody delivery in human solid tumorsā
nature.com/articles/s41587-026-03152-x
(open access): rdcu.be/fmkQp -
Nature Biotechnology reposted
Yaojun Tong @TongYaojun
Excited to share that our article is online in Nature Biotechnology @NatureBiotech .
We developed SONAR, a programmable RNA-guided platform for bacterial translational regulation. www.nature.com/articles/s41587-026-03160-x
Grateful to all co-authors, reviewers, and editors for their support. -
Nature Biotechnology reposted
Magdalena Zernicka-Goetz
@ZernickaGoetz
New idea: multicellularity may have begun not when cells stuck together ā but when a single cell became unequal inside itself. Introducing the Asymmetric Initiation Hypothesis, with @QiChenUtah
Nature Biotechnology
@NatureBiotech
Decoding the origins of cellular self-organization for engineered biology go.nature.com/4e1m3Br
-
Nature Biotechnology reposted
Qi Chen @qichen_lab
After years of crystallization, now in @NatureBiotech, @ZernickaGoetz and I discuss the evolutionary origins of multicellularity and how physical constraints inevitably drive cellular self-organization.
Harnessing these rules may help us better understand and engineer life ā Build to understand. rdcu.be/flTKa
Magdalena Zernicka-Goetz
@ZernickaGoetz
Thanks Qi for the heartfelt words and bringing back fond memories of our discussion of self-assembly in our first 2014 and 2017 models. Chatting with you always inspires a deeper understanding of lifeās complexities. Letās keep reflecting on ancient wisdom and carry it forward ..
This post is unavailable. See it on X. -
Nature Biotechnology reposted
Samuele Ferrari @ferrari_sam93
𤩠Thrilled to share our new paper from @NaldiniLab in @NatureBiotech!
šLearn more: www.nature.com/articles/s41587-026-03142-z
We developed #smart, an AND logic gate that enables enrichment of #crispr-edited cells, boosting efficiency and precision of #geneediting for therapeutics.
š§µ below! -
Nature Biotechnology
@NatureBiotech
A framework for building a synthetic cell from the SynCell Asia Initiative - @SynCellAsia go.nature.com/4tW9FZg
Nature Biotechnology
@NatureBiotech
Asian scientists unveil 10-year roadmap to build synthetic cells #nbtinthenews via @CAS__Science english.cas.cn/newsroom/research-news/202605/t20260528_11ā¦
Nature Biotechnology
@NatureBiotech
Asia unveils 10-year roadmap for artificial life research #nbtinthenews qazinform.com/news/asia-unveils-10-year-roadmap-for-artifā¦
Nature Biotechnology
@NatureBiotech
China-led team unveils Asia's first synthetic cell roadmap #nbtinthenews news.cgtn.com/news/2026-05-26/China-led-team-releases-Asiā¦
Nature Biotechnology
@NatureBiotech
ShanghaiEyešofficial
@ShanghaiEye
A Chinese-led international team of scientists has presented #asia's first 10-year roadmap for synthetic cell technology development, published in the scientific journalĀ @NatureBiotech on May 26. More than 100 laboratories from China, Japan, South Korea, Singapore, Malaysia and Thailand participated in the project through the SynCell Asia Initiative alliance.
This media couldn't be displayed. See it on the original post. -
Nature Biotechnology
@NatureBiotech
End-of-life nonhuman primates can be used to screen pools of lipid nanoparticles for clinical safety studies www.nature.com/articles/s41587-025-02711-y
rdcu.be/fmbmJ -
Nature Biotechnology
@NatureBiotech
Almost two hundred years after the Irish Potato Famine wiped out nearly a quarter of Irelandās population, @ResurrectBio has figured out how to help the potato defeat the blight pathogen Phytophthora infestans www.nature.com/articles/s41587-026-03133-0
-
Nature Biotechnology
@NatureBiotech
Marked for destruction go.nature.com/4x3NYt7
-
Nature Biotechnology
@NatureBiotech
Decoding the origins of cellular self-organization for engineered biology go.nature.com/4e1m3Br
Nature Biotechnology
@NatureBiotech
.@Caltech researchers propose a new origin story for multicellular life #nbtinthenews www.caltech.edu/about/news/caltech-researchers-propose-a-ā¦
-
Nature Biotechnology
@NatureBiotech
Biotech news from around the world: Singapore, United Kingdom, Germany, Spain www.nature.com/articles/s41587-026-03143-y
rdcu.be/fmwEx -
Nature Biotechnology
@NatureBiotech
Matched ribosome profiling and RNA sequencing data quantify translation efficiency patterns across 140 human and mouse cell lines go.nature.com/3TXvmZy
rdcu.be/fmbmg -
Nature Biotechnology
@NatureBiotech
Circling back to RNA vaccines
While circRNA is often framed as a more stable, longer-lasting alternative to linear mRNA, its real-world advantages remain largely theoretical, and it is unclear whether greater molecular stability will translate into meaningful clinical gains -
Nature Biotechnology
@NatureBiotech
Translating biotech innovation from academia and scaling spinout companies requires appropriate IP management capabilities at every growth stage go.nature.com/4fBhTCy
rdcu.be/fl7HR -
Nature Biotechnology
@NatureBiotech
Faster drug discovery, optimized drug design, even programmable therapeutics: AI is impacting R&D. Data and development bottlenecks remain www.nature.com/articles/s41587-026-03170-9
[šread free with login] -
Nature Biotechnology
@NatureBiotech
A combination of engineering approaches is used to improve the function of IscB for a variety of editing activities in vivo go.nature.com/44XVBph
rdcu.be/fjOtb
Nature Biotechnology
@NatureBiotech
The ancestral protein of the CRISPRāCas9 system ā less than half the size of its famous descendant ā is engineered into an effective DNA-targeting tool that can be delivered by AAV as an epigenome editor for in vivo gene silencing #nbtnv go.nature.com/43JRgno
-
Nature Biotechnology
@NatureBiotech
Recent moves of note in and around the biotech and pharma industries go.nature.com/4fo01ev
rdcu.be/fmblf -
Nature Biotechnology
@NatureBiotech
An update on patent issues regarding antibodyādrug conjugates go.nature.com/3RKQ691
-
Nature Biotechnology
@NatureBiotech
Surveying recent progress in neoantigen cancer vaccine development, this Review highlights areas where further technological advances and optimized trial design could enhance clinical impact go.nature.com/3NipMkF
rdcu.be/flWKK -
Nature Biotechnology
@NatureBiotech
Programming biology: next-gen AI firms raise billions to design better medicines www.nature.com/articles/s41587-026-03170-9
[šread free with login] -
Nature Biotechnology reposted
Tae Seok Moon
@Moon_Synth_Bio
Interesting to see my Asian colleagues are suggesting ideas for constructing synthetic cells, while my JCVI coworkers are almost finishing up the last touch to achieve the Holy Grail goal.
@NatureBiotech
www.nature.com/articles/s41587-026-03153-w -
Nature Biotechnology reposted
Recursion
@RecursionPharma
š AI drug discovery is in acceleration mode.
A new article from @RealEndptsMel in @NatureBiotech highlights how next-generation AI companies like Recursion are transforming biology into an engineering discipline.
Commenting on efficiency, Recursion CEO and President Najat Khan said:Ā āOn average, we go from project start to advanced candidate in 17 months.ā
That acceleration signals a fundamental shift. Across the industry, drug discovery is becoming data-driven, iterative, and scalable.
The story highlights Recursionās approach:
āŖļø Leveraging machine learning to uncover previously āinvisibleā biological signals
āŖļø Repurposing and advancing compounds with new mechanistic insight
āŖļø Building an end-to-end platform that connects discovery, biology, and development
Itās a critical point for the industry: Real impact comes from integrating AI across the full R&D lifecycle ā from data generation to clinical execution.
š Read more: www.nature.com/articles/s41587-026-03170-9 -
Nature Biotechnology reposted
Christopher Garris
@csgarrix
Very excited to share an amazing body of work now out in Nature Biotechnology!
For many years, the field of cancer immunology has recognized that immune-stimulatory dendritic cells, in particular cDC1, sit at the center of productive anti-tumor immunity. This is well conserved between mechanistic mouse models and humans, and high resolution single cell RNA seq studies have confirmed these cell states in a broad range of cancers.
These cells sit at the core of controlling and facilitating T cell responses and tumor recognition, illustrating how DCs āshepherdā T cells across their lifecycle. These T: DC interactions lie at the center of the Cancer Immunity Cycle. Yet, so far, we only have efficient methods to push on T cells for immunotherapy. Boosting DC responses has been more difficult where treatments need to more carefully balance the toxicity associated with immune activation and efficacy. These concerns, balancing toxicity and efficacy, have led to significant challenges in drug development
Here, we present a new approach enabled by catalytic advances in RNA therapeutics, where information gleaned from single-cell RNA seq cell states can be programmed into therapeutics to remodel the immune environment.
We find that mRNA encoding cDC1-related factors such as interferon regulatory factor 8 (IRF8) and the NFkB-inducing kinase (NIK) can activate antigen presentation and trigger inflammation of tumors by T cells, leading to tumor-immune rejection. Notably, sustained expression of IRF8 is needed for maintaining cDC1 lineage identity, and elegant prior studies demonstrate that enforced IRF8 expression can reprogram diverse cell types into cDC1-like cells. Likewise, we had previously identified NIK expression within IL-12-producing tumor DCs, and others showed that NIK deficiency impaired IL-12 production and the ability to stimulate CD8+ T cell responses. NIK lies downstream of CD40-based licensing, which is an essential step towards generating functional CD8+ T cells.
Here, we show that the application of these immune remodeling mRNAs (IR-mRNAs; either IRF8 or NIK) can synthetically activate antigen presentation and boost DC responses, triggering anti-tumor immunity. These IR-mRNAs shape the tumor microenvironment to be receptive to T cells, encouraging their accumulation and activity, further showing how DCs āshepherdā T cell responses. These can turn immune ācoldā tumors āhotā and responsive to immune checkpoint blockade therapies.
Perhaps the most fascinating aspect of these studies is when IR-mRNA is delivered alongside antigen in vaccination settings. We find that robust CD8+ T cell responses are generated with IR-mRNA encoded immune adjuvants. This fits with the role of IRF8 and NIK supporting cDC1 responses, and raises the potential for a new class of cDC1-oriented immune therapeutics.
This was all part of an amazing collaboration between the Anderson Lab at MIT Koch Institute for Integrative Cancer Research and the Center for Systems Biology at Massachusetts General Hospital/Harvard Medical School. @kochinstitute @MGHPathology @MGHCSB @MGBResearchNews
#cancer #immunotherapy #vaccines #dendritic_cells #myeloid
Extra kudos to the lead authors, @akashh_gupta and @Das_Riddha now at @UHEngineering
The Article @NatureBiotech can be found here: www.nature.com/articles/s41587-026-03115-2
Lay Summaries can be found here: news.mit.edu/2026/new-approach-cancer-vaccination-yields-⦠; www.massgeneralbrigham.org/en/about/newsroom/articles/mrn⦠-
Nature Biotechnology reposted
Vadim Demichev
@DemichevLab
Our machine learning driven quantification algorithm for proteomics now published in Nature Biotechnology. Optimal protein quantification and, for the first time, error estimates for individual quantities. Paper link in comments below.
-
Nature Biotechnology
@NatureBiotech
DNA-guided CRISPRāCas12 for cellular RNA targeting go.nature.com/49SP29d
Nature Biotechnology
@NatureBiotech
Guide DNA ā not RNA ā expands the CRISPR toolkit #nbtnv go.nature.com/3PzLIJ8
Nature Biotechnology
@NatureBiotech
DNAāguided CRISPR suggests a new direction for RNA editing #nbtinthenews via @GENbio www.genengnews.com/topics/genome-editing/dnaāguided-crispā¦
Nature Biotechnology
@NatureBiotech
DNA-guided CRISPR system targets RNA and expands Cas12 beyond gene editing #nbtinthenews via @NewsMedical www.news-medical.net/news/20260518/DNA-guided-CRISPR-systā¦
Nature Biotechnology
@NatureBiotech
UF breakthrough could reshape RNA editing with world's first DNA-guided CRISPR #nbtinthenews via @UFNews news.ufl.edu/2026/05/dna-guided-crispr/
Nature Biotechnology
@NatureBiotech
DNA-guided CRISPR breakthrough could reshape RNA editing and diagnostics #nbtinthenews via @pulse2news pulse2.com/university-of-florida-dna-guided-crispr-breaktā¦
-
Nature Biotechnology
@NatureBiotech
Research Highlight: An in vivo electromagnetic field-responsive gene switch www.nature.com/articles/s41587-026-03147-8
Nature Biotechnology
@NatureBiotech
An electromagnetic field-inducible gene switch is applied to in vivo partial reprogramming, and enables the modeling of Alzheimerās disease and the neuromodulation of depressive disorder in mice #nbthighlight www.cell.com/cell/fulltext/S0092-8674(26)00330-2
-
Nature Biotechnology
@NatureBiotech
In Brazil, podcasts, live sessions, artificial intelligence and non-peer conversations serve as pedagogical tools to train biotechnology students for dialog go.nature.com/4dXiPjr
rdcu.be/fkccr -
Nature Biotechnology
@NatureBiotech
TopoVelo infers cell differentiation stages and rate parameters of gene expression using spatially coupled differential equations go.nature.com/4lyR02w
rdcu.be/fjOvI -
Nature Biotechnology
@NatureBiotech
Improving multimodal wearable sensing for healthcare with artificial intelligence go.nature.com/3RudjMJ
-
Nature Biotechnology
@NatureBiotech
Scoring gene importance by interpreting single-cell foundation models - @genentech go.nature.com/3RyZ6hs
-
Nature Biotechnology
@NatureBiotech
Accurate quantification in proteomics with QuantUMS go.nature.com/4wPiE1j
-
Nature Biotechnology
@NatureBiotech
In Brief: Shanghai-based Excalipoint Therapeutics launches with $68.7M from HongShan Capital Group, Lilly Asia Ventures and Eisai Innovation to develop next-generation T cell-engaging antibodies against solid tumors and autoimmune diseases www.nature.com/articles/s41587-026-03151-y
-
Nature Biotechnology
@NatureBiotech
Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models go.nature.com/42td2fh
Nature Biotechnology
@NatureBiotech
A new approach to cancer vaccination yields more powerful T cells #nbtinthenews news.mit.edu/2026/new-approach-cancer-vaccination-yields-ā¦
Nature Biotechnology
@NatureBiotech
New mRNA vaccine strategy eradicates tumors by reprogramming immune cells #nbtinthenews via @UHouston www.uh.edu/news-events/stories/2026/may/05192026-gupta-tcā¦
Nature Biotechnology
@NatureBiotech
Research spotlight: Researchers develop mRNA strategy to turn ācoldā tumors āhotā #nbtinthenews via @MGBResearchNews www.massgeneralbrigham.org/en/about/newsroom/articles/mrnā¦
-
Nature Biotechnology
@NatureBiotech
Research Highlight: Programming B cell immunity from hematopoietic stem cells www.nature.com/articles/s41587-026-03148-7
Nature Biotechnology
@NatureBiotech
Engineered hematopoietic stem cells generate B cell precursors that expand through immunization to produce therapeutic antibodies in mice #nbthighlight www.science.org/doi/10.1126/science.adz8994
-
Nature Biotechnology reposted
Allen Jiang
@AllenYJiang
Excited to share the first co-first author paper from my postdoc in @davidrliuās group @broadinstitute, out now in @NatureBiotech! We used AI-guided computational redesign to develop new PE8 prime editors. See Davidās thread below!
David R. Liu
@davidrliu
Today in @NatureBiotech we report a new suit of PE8 prime editor proteins. PE8 variants were developed from laboratory-evolved PE6 proteins using AI-guided protein redesign. This approach combines recent advances in computational protein design and directed evolution to increase prime editing efficiency, especially in transient therapeutically relevant delivery settings such as mRNA+pegRNA electroporation into primary cells, eVLP delivery of prime editing RNPs, and LNP-mediated mRNA+pegRNA delivery in mice.
drive.google.com/file/d/13VTcAsfs1pQ-rqbu1jYBYbs9om_YXUlyā¦
1/11 -
Nature Biotechnology reposted
Parker Institute
@parkerici
New research published in @NatureBiotech from PICI researcher K. Christopher Garcia from @StanfordMed and collaborators introduces a new way to better understand how T cells recognize disease.
Using a combination of high-throughput screening and AI-based modeling, the team mapped how individual T cell receptors respond to millions of peptides. Their approach helped identify potential disease-linked autoantigens connected to ankylosing spondylitis and acute anterior uveitis and could help accelerate future discoveries in immunotherapy and precision medicine.
Read the study: www.nature.com/articles/s41587-026-03128-x -
Nature Biotechnology reposted
Holt Sakai @HoltSakai
Excited to share this work, out today in @NatureBiotech. We use iterative pooled prime editing screens to discover and engineer RNA motifs that enhance editing efficiencies in cells and in vivo. Many thanks to co-lead @Sarah_E_Pierce and other key contributors from the Liu lab!
David R. Liu
@davidrliu
Today in @NatBiotech, we report the directed evolution of structured RNA motifs that enhance the efficiency of prime editing. Iterated high-throughput pooled screens and mutagenesis of these small RNA elements improved transient pegRNA lifetime.
drive.google.com/file/d/1Nyt_SSvOMDlp75LiFluBbL2bHHYLfhVqā¦
1/11 -
Nature Biotechnology reposted
Eric Topol
@EricTopol
Expanding the CRISPR genome editing toolkit:
A flip from RNA-guided DNA targeting to DNA-guided RNA targeting @NatureBiotech
www.nature.com/articles/s41587-026-03129-w
www.nature.com/articles/s41587-026-03120-5
www.nature.com/articles/s41587-026-03138-9 -
Nature Biotechnology
@NatureBiotech
A Brazilian approach to training stakeholder engagement skills in biotechnology undergraduates through curricular innovation go.nature.com/4dXiPjr
-
Nature Biotechnology
@NatureBiotech
In Brief: The most advanced clinical trial for an in vivo gene editor, @intelliatx's lonvoguran ziclumeran (lonvo-z), reported positive phase 3 results in hereditary angioedema www.nature.com/articles/s41587-026-03154-9
-
Nature Biotechnology
@NatureBiotech
Photosynthesis in mammalian corneal cells boosts energy production and reduces inflammation #nbthighlight www.cell.com/cell/fulltext/S0092-8674(26)00469-1
-
Nature Biotechnology
@NatureBiotech
Colorectal cancer is discriminated by measuring cell-free RNA methylation in plasma idp.nature.com/authorize?response_type=cookie&client_id=gā¦
rdcu.be/fjOqz -
Nature Biotechnology
@NatureBiotech
Novel antivenoms bite back www.nature.com/articles/s41587-026-03157-6
[šread free with login] -
Nature Biotechnology
@NatureBiotech
Engineered E. coli trapped in a hydrogel scaffold release antibacterial proteins to clear a PseudomonasĀ infection in mice #nbthighlight www.science.org/doi/10.1126/science.aec2071
-
Nature Biotechnology
@NatureBiotech
Hughes and colleagues present a developmentally inspired tissue engineering strategy to overcome barriers in kidney tissue generation, enhancing prospects for renal replacement therapies go.nature.com/46tacJq
rdcu.be/fjOmA -
Nature Biotechnology
@NatureBiotech
Plant breeding regulations should focus on the characteristics of the genome editing outcome, rather than specific methods used in the development process. Such a science-based, outcome-focused regulatory approach would future-proof the risk-proportionate oversight of plant breeding innovations and enable a more efficient delivery of improved crop varieties amidst growing concerns of climate change and evolving pests and diseases go.nature.com/4rhghjQ
rdcu.be/fjPR1 -
Nature Biotechnology
@NatureBiotech
Research Highlight: MitoCatch targets healthy mitochondria to diseased cells www.nature.com/articles/s41587-026-03146-9
Nature Biotechnology
@NatureBiotech
The mitochondrion-targeting tool MitoCatchĀ brings mitochondria into specific cell types through cell-surface-targeted binders. #nbthighlight www.nature.com/articles/s41586-026-10391-0
-
Nature Biotechnology
@NatureBiotech
Directed evolution of small RNA-stabilizing motifs that improve prime-editing efficiency go.nature.com/4wLWKMu
-
Nature Biotechnology
@NatureBiotech
In Brief: UK issues regulatory approval for @Rothamsted's gene-edited barley, the first under its new rules for precision breeding. The landmark approval marks a shift away from the EU's restrictive approach toward GMOs www.nature.com/articles/s41587-026-03150-z
-
Nature Biotechnology
@NatureBiotech
How biotech companies evolve intellectual property management capabilities: lessons from Cambridge Antibody Technology go.nature.com/4fBhTCy
-
Nature Biotechnology
@NatureBiotech
AstraZenecaās IL-33 antibody tozorakimab targets two distinct signaling pathways engaged in COPD: inflammation and epithelial dysfunction www.nature.com/articles/s41587-026-03136-x
[šread free with login] -
Nature Biotechnology
@NatureBiotech
While circRNA is often framed as a more stable, longer-lasting alternative to linear mRNA, its real-world advantages remain largely theoretical, and it is unclear whether greater molecular stability will translate into meaningful clinical gains go.nature.com/3RzqxHN
-
Nature Biotechnology
@NatureBiotech
The May issue is live www.nature.com/nbt/volumes/44/issues/5
On the cover, Zhang et al. describe an antibody-based therapy against drug-resistant S. aureus. The antibody conjugate selectively binds to the wall teichoic acid of the bacteria and enriches calcium on the cell envelope, induces bacterial death and boosts immunogenicity go.nature.com/3UaGItg -
Nature Biotechnology reposted
Piyush Jain @JainLaboratory
1/ Today in @NatureBiotech, we published the first DNA-guided CRISPR that we originally reported in our 2024 preprint for detecting and targeting RNA in cells
www.medrxiv.org/content/10.1101/2024.11.21.24317744v1
Nature Biotechnology
@NatureBiotech
DNA-guided CRISPRāCas12 for cellular RNA targeting go.nature.com/49SP29d
-
Nature Biotechnology reposted
Cancer Grand Challenges
@CancerGrand
Exciting new work from Professor Chris Garcia, co-investigator on MATCHMAKERS š
The study published in @NatureBiotech shows that deep peptide-recognition profiling, combined with machine learning, can decode T-cell receptor specificity, predict activating antigens, uncover new candidate targets, and even estimate confidence for novel receptors.
Importantly, this work suggests T-cell receptors can be grouped by functional recognition patterns, not just sequence similarity - an important step towards MATCHMAKERS grand challenge of cracking the antigen-recognition code.
Team MATCHMAKERS is funded through Cancer Grand Challenges by @CR_UK, @theNCI and @TheMarkFdn
ā¬ļø www.nature.com/articles/s41587-026-03128-x -
Nature Biotechnology reposted
Igor Ulitsky
@IgorUlitsky
Now out in @NatureBiotech ! Do lncRNAs commonly bind 1000s of genomic sites? Maybe they do, but the dozens of studies that report genomic binding maps of lncRNAs are deeply flawed, with probes binding suprious DNA sites rather than RNA-bound ones. www.nature.com/articles/s41587-026-03130-3
Igor Ulitsky
@IgorUlitsky
A preprintā¼ļøthat's bound to ruffle some šŖ¶ "Widespread DNA off-targeting confounds studies of RNA chromatin occupancy" led by our @MicahGoldrich and Louis Delhaye from @pieter_mestdagh. TL;DR we show that many of lncRNA chromatin occupancy maps are flawedš§µwww.biorxiv.org/content/10.1101/2025.11.11.687850v1
-
Nature Biotechnology reposted
Riddha @Das_Riddha
Thanks @MGBResearchNews for highlighting our work published in @NatureBiotech.
This Q&A highlights how immune-remodeling mRNAs could help turn ācoldā tumors āhotā and potentially expand immunotherapy options for patients.
Here is the link to the Q&A-www.massgeneralbrigham.org/en/about/newsroom/articles/mrn⦠-
Nature Biotechnology reposted
Recursion
@RecursionPharma
𧬠Bridging the gap in AI drug discovery.
@AlisandraDenton, Staff Machine Learning Scientist at Recursion and one of the authors on our recent paper in @NatureBiotech, explains how the AI model TxPert predicts how a cell will respond to perturbations.
Predicting a cellās RNA activity, or transcriptome, is key to bridging the gap between cellular changes and clinical outcomes and advancing the potential for AI drug discovery. As Ali says, āwith hundreds of cell types and so much disease variation, the total possibilities are too vast to measure in a lab.ā
She describes how TxPert allows us to perform a āVirtual Assay,ā taking the mathematical signature of a healthy cell called the Basal State and adding the perturbationās embedding to deliver a highly accurate prediction of what the cellās transcriptome will look like after treatment.
TxPert uses layered graph-based models that integrate phenomics ā or how a cell looks ā and transcriptomics ā which genes are expressed ā along with massive public biological knowledge resources.
The model can even predict how a perturbation will work in entirely new cell lines it hasnāt seen before as well as accurately forecast the effects of ādouble perturbations,ā consistently identifying "unknown unknowns" that traditional models ā and even massive general-purpose AI ā often miss.
Ali notes that TxPert is currently predicting genetic perturbations, but more flexible models ā Ā including those predicting drug effects ā are in the works.
š Check out the full paper in Nature Biotech: www.nature.com/articles/s41587-026-03113-4This media couldn't be displayed. See it on the original post. -
Nature Biotechnology reposted
UF Diabetes Institute
@ufdiabetes
Please join us in congratulating Dr. Holger Russ on his appointment as the Department of Pharmacology & Therapeuticsā inaugural Vice Chair for Scientific Innovation!
Dr. Russās pioneering research in thymus regeneration and immune health was recently featured in Nature Biotechnology @NatureBiotech, highlighting innovative work from his lab focused on advancing therapies for immune deficiency, cancer, and healthy aging.
We are excited to see the continued impact of Dr. Russās leadership and grateful for his service to the department.
www.nature.com/articles/s41587-026-03137-w -
Nature Biotechnology reposted
biohub
@biohub
New in @NatureBiotech from Aly Khan: a platform combining yeast display with fine-tuned protein language models to identify antigens driving autoimmune disease. In collaboration with Chris Garcia at @Stanford / @hhmi_science š§µ
-
Nature Biotechnology
@NatureBiotech
Widespread DNA off-targeting confounds RNA chromatin occupancy studies go.nature.com/3Pvbf6e
-
Nature Biotechnology
@NatureBiotech
Evidence linking thymic function with health and longevity is piling up, and a cluster of biotechnology companies is trying to regenerate the thymus directly or recapitulate its function to reinvigorate patientsā immunity www.nature.com/articles/s41587-026-03137-w
[šread free with login] -
Nature Biotechnology
@NatureBiotech
Structure-centric searching enables global mapping of the public metabolome go.nature.com/481Sbmk
Nature Biotechnology
@NatureBiotech
From molecules to meaning: a search engine for the chemistry of life #nbtinthenews today.ucsd.edu/story/from-molecules-to-meaning-a-search-eā¦
-
Nature Biotechnology
@NatureBiotech
Deep peptide recognition profiling decodes TCR specificity and enables disease-associated antigen discovery go.nature.com/3QWMRet
-
Nature Biotechnology reposted
Human Cell Atlas
@humancellatlas
Are you joining us at the 2026 HCA General Meeting in 5 weekās time in Boston? If so, youāll have the opportunity to engage directly with editors from scientific journals during āmeet-the-editorsā sessions.
events.humancellatlas.org/2026HCAGM/agenda
#hca2026gm -
Nature Biotechnology
@NatureBiotech
Single-cell and spatial proteomics are rapidly maturing. Yet, as measurement resolution, depth and throughput improve, progress is increasingly constrained not by experimental sensitivity but by the ability to integrate proteomic data across experiments, modalities and spatial contexts go.nature.com/3NHDkGP
rdcu.be/fij7N -
Nature Biotechnology
@NatureBiotech
The US Supreme Courtās decision in Loper Bright, along with federal spending cuts, may limit the potential of synthetic biology to provide innovative solutions for environmental challenges, medicine and biomanufacturing go.nature.com/4cE794D
rdcu.be/fikex -
Nature Biotechnology
@NatureBiotech
A new translational research unit at @WeizmannScience complements the work of the technology transfer office and bridges the translation gap with strategic, operational and resource frameworks that go beyond traditional commercialization infrastructure go.nature.com/4cJwcn4
-
Nature Biotechnology
@NatureBiotech
Circling back to RNA vaccines go.nature.com/3RzqxHN
-
Nature Biotechnology
@NatureBiotech
How can we translate our growing understanding of the dark genome into therapeutics? We asked experts in the field for their thoughts go.nature.com/4tQ1zTn rdcu.be/e8Eci
-
Nature Biotechnology
@NatureBiotech
Sharing of big data is a vital driver of innovation in the agri-food sector. @novonordiskfond scientists discuss the main challenges and propose steps to enhance data sharing and exploration from a research funderās perspective go.nature.com/4raUN86
rdcu.be/fh6mr -
Nature Biotechnology
@NatureBiotech
A builder and problem solver at heart, she is developing technologies to understand and engineer the roles of cell-surface sugars, called glycans, in the immune system go.nature.com/42sA99y
rdcu.be/fh6cx -
Nature Biotechnology
@NatureBiotech
Progress toward a true virtual cell will depend on uniting AIās pattern-finding power with the causal rigor of mechanistic models go.nature.com/48muYvd
rdcu.be/fh599 -
Nature Biotechnology reposted
Gladstone Institutes
@GladstoneInst
For a long time, scientists have been looking for ways to precisely edit the genomes of bacteria.
It would allow researchers to engineer bacteria for manufacturing, studying how gut microbes interact, or fighting drug-resistant infections. -
Nature Biotechnology reposted
Bo Wang
@BoWang87
What if you could test a drug on a human organ and simultaneously know what would have happened without it?
That's what we built.
Proud to share our work in @NatureBiotech: digital twins of human lungs š«š„ (paper: nature.com/articles/s41587-026-03121-4)
We created digital twins of ex vivo human lungs: multimodal AI models trained on 951 human lungs from the world's largest EVLP dataset at @UHN. Physics-informed ML across physiology, biochemistry, transcriptomics, proteomics, metabolomics, and imaging, all forecasting together.
The key insight: the physical lung receives the treatment. The twin is the untreated control. Paired causal inference on the same organ. No separate cohort. No intersubject noise.
Result: we detected drug efficacy with 6 lungs. Traditional methods would need 18.
This is what precision preclinical evaluation looks like.
From Virtual Cells ā Virtual Organs ā Virtual Patients.
One step toward virtual organs replacing animal testing.
Huge congratulations to Elly Zhou (a phd student I co-supervise) for leading this work with exceptional rigor, and to Andrew Sage and @SKeshavjee for building the foundation that made it possible. -
Nature Biotechnology reposted
Valence Labs
@valence_ai
1/ Our most recent Inside Valence blog post delves into TxPert, a SOTA model published in @NatureBiotech.
The key finding: scale alone is insufficient, even smaller model architectures can achieve top performance when coupled with biological priors.
@IhabBendid35780 -
Nature Biotechnology reposted
Icahn School of Medicine at Mount Sinai
@IcahnMountSinai
Published in Nature Biotechnology, new research from the Icahn School of Medicine at Mount Sinai challenges long-held assumptions about how mRNA vaccines workārevealing that non-immune cells play a critical role in shaping vaccine effectiveness.
Led by Brian D. Brown, PhD, the study shows that cells such as muscle and liver cells help regulate immune responses, rather than relying solely on traditional immune cells. Using a novel technology to control where mRNA is expressed in the body, researchers were able to enhance vaccine performanceāsignificantly improving anti-tumor responses in preclinical lymphoma models.
The findings introduce a powerful new framework for designing mRNA vaccines and therapeutics, with implications for cancer immunotherapy, infectious disease, and gene-based treatments. By fine-tuning where and how mRNA is activated, scientists may be able to create more effectiveāand more preciseānext-generation therapies.
Read more here: mshs.co/3OveSsI -
Nature Biotechnology reposted
Miriam Merad, MD, PhD
@MiriamMerad
Thrilled to see a new paper led by the outstanding @Brown_lab1, now out in Nature Biotechnology.
We provide mechanistic insights into how mRNA vaccines work. challenging key assumptions and offering new ways to control vaccine activity. (1/3)
Read here: www.nature.com/articles/s41587-026-03099-z -
Nature Biotechnology
@NatureBiotech
A transformer model is used to construct the DreaMS Atlasāa molecular network of 201 million MS/MS spectra go.nature.com/4k1n5iC
rdcu.be/feuB9
Nature Biotechnology
@NatureBiotech
A self-supervised approach to learning from 24 million spectra generates a foundation model for detecting and characterizing small molecules by tandem mass spectrometry #nbtnv go.nature.com/3FnI4NB
rdcu.be/eouSy -
Nature Biotechnology
@NatureBiotech
Newcomer anti-IL-33 makes strides in COPD www.nature.com/articles/s41587-026-03136-x
-
Nature Biotechnology
@NatureBiotech
DNA-guided CRISPRāCas12a effectors for programmable RNA recognition and cleavage go.nature.com/3P1TxHh
Nature Biotechnology
@NatureBiotech
.@HKUST researchers flip the CRISPR script to develop world's first DNA-guided gene editing tool for precise infectious disease diagnosis and advancing antiviral therapies #nbtinthenews hkust.edu.hk/news/hkust-researchers-flip-crispr-script-deā¦
-
Nature Biotechnology
@NatureBiotech
Thymus renaissance poised to boost health and longevity www.nature.com/articles/s41587-026-03137-w
[šread free with login] -
Nature Biotechnology
@NatureBiotech
A single-cell screening platform accelerates functional genetics in plants go.nature.com/4n8wzLv
Nature Biotechnology
@NatureBiotech
Research Briefing: A PIVOT towards single-cell functional genetic screening in plants www.nature.com/articles/s41587-026-03141-0
-
Nature Biotechnology
@NatureBiotech
Proteināprotein interactions specific to 11 individual tissues are presented in a comprehensive resource go.nature.com/3Z1q0PM
rdcu.be/feuEP -
Nature Biotechnology
@NatureBiotech
Despite being a revolutionary technology, optogenetics faces translational challenges, but integrating various advanced technologies has the potential to overcome these obstacles and drive its development to new frontiers go.nature.com/3OpukGM
rdcu.be/fglHl -
Nature Biotechnology
@NatureBiotech
Prime Assembly integrates twinPE with a Gibson-like strategy to assemble multiple overlapping DNA templates within cells for large DNA insertionĀ of up to 11 kb #nbthighlight www.nature.com/articles/s41586-026-10460-4
-
Nature Biotechnology
@NatureBiotech
Digital twins of ex vivo human lungs enable accurate and personalized evaluation of therapeutic efficacy go.nature.com/3R1KDKy
Nature Biotechnology
@NatureBiotech
Advancing care with digital lungs
Scientists at @UHN develop digital twins of human lungs using Ex Vivo Lung Perfusion data #nbtinthenews www.uhnresearch.ca/news/5-04-2026/advancing-care-with-dig⦠-
Nature Biotechnology
@NatureBiotech
Protein structures are predicted by integrating deep learning potentials with iterative threading fragment assembly simulations go.nature.com/4kwCaIK
rdcu.be/feuCK -
Nature Biotechnology
@NatureBiotech
Texas-based startup Hiro Technologies gets to the bottom of the problem of diaper-filled landfills with the MycoDigestible diaper, which can be broken down by fungi www.nature.com/articles/s41587-026-03096-2
rdcu.be/fgSvP -
Nature Biotechnology
@NatureBiotech
Recent patents relating to methods and devices for optogenetic control of cells go.nature.com/42GXNPG
rdcu.be/fglTt -
Nature Biotechnology
@NatureBiotech
TxPert: using multiple knowledge graphs for prediction of transcriptomic perturbation effects go.nature.com/3QZW9WQ
-
Nature Biotechnology reposted
Roozbeh Dehghannasiri
@roozbehdn
Excited to share our latest paper out in @NatureBiotech with @marekkoki and @sdeorowicz, introducing sc-SPLASH: a reference-free statistical method for variation detection beyond gene expression in barcoded scRNA-seq (10x) and spatial transcriptomics. www.nature.com/articles/s41587-026-03084-6
-
Nature Biotechnology reposted
Recursion
@RecursionPharma
𧬠Closing the translation gap between cells and patients. š·
@NatureBiotech just published a new paper from Recursion on TxPert ā a deep learning framework that accurately simulates the transcriptomic shift in unseen biological contexts. TxPert represents an important step in our ongoing work to accurately model transcriptomics and bridge the gap between in vitro discovery and clinical reality ā which is critical for improving and scaling AI drug discovery.
š¹ TxPert address this translational gap through:
āŖļø Graph Neural Networks (GNNs): Rather than treating genes as isolated lines of code, TxPert uses an advanced Exphormer-MG architecture to map genetic perturbations across multiple, massive knowledge graphs, forcing the model to understand both the physical (phenomic) and molecular (transcriptomic) realities of a cell simultaneously.
āŖļø Simulating the "latent shift": By mathematically applying a "perturbation embedding" to a cell's baseline state, TxPert can accurately predict the entire post-perturbation transcriptomic profileāwithout anyone ever having to touch a pipette.
āŖļø Predicting unseen biology: TxPert successfully predicts the transcriptomic outcomes of completely unseen single perturbations, complex combinatorial therapies (Double Perturbations), and even how known drugs will act in entirely new, unseen cell lines.
TxPert is one of several models at Recursion to model transcriptomics and close the translation gap between cell responses and patients in the clinic.
š Congrats to the team! Frederik Wenkel, Wilson Tu, Cassandra Masschelein, Hamed Shirzad, Liam Hodgson, Ihab Bendidi, Cian Eastwood, Shawn Whitfield, Craig T. Russell, Yassir El Mesbahi, Marta Fay, @bertonearnshaw, @ENoutahi, and @AlisandraDenton.
š Read the full publication in Nature Biotech here: www.nature.com/articles/s41587-026-03113-4 -
Nature Biotechnology reposted
Pelotonia Institute for Immuno-Oncology
@OhioStatePIIO
šØšØĀ New paper in @NatureBiotech
āTracing the rise of biomedical foundation modelsā
@QinMaBMBL & team analyzedĀ 220+ foundation modelsĀ across #nlp, imaging, #omics & molecular data, revealing aĀ major shift toward #multimodalaiĀ in #biomedicine.
Key insights:
š¬Ā 53.6% of models are now multimodal
š§ Ā Natural language is emerging as the central āinterfaceāĀ across data types
āļøĀ Encoder-based architectures dominate
šĀ Evaluation could benefit from a wider scope
The team highlightsĀ gaps in multimodal integration, benchmarking, and real-world translationĀ ā and outline where the field is heading next.
Excited to see this contribution to the evolving landscape ofĀ #ai-driven biology and medicine.
Check it out: www.nature.com/articles/s41587-026-03135-y -
Nature Biotechnology reposted
nature
@Nature
Geneticist J. Craig Venter, best known for his role in sequencing the human genome, has died aged 79.
He spoke to Nature in 2023 about AI, sequencing the ocean ā and why he had no plans to stop working.
go.nature.com/4tHEf9M -
Nature Biotechnology reposted
Bowen LI
@BowenLi_Lab
Excited to share our new paper in @NatureBiotech ! We reported MOLEA, an AI framework that simultaneously optimizes potency AND tissue selectivity for LNP design. AI Ć RNA delivery is just getting started! rdcu.be/ffPpU
#rnatherapeutics #lnp #ai #mrna
Nature Biotechnology
@NatureBiotech
A multiobjective AI model for LNP engineering enhances tissue-selective mRNA delivery go.nature.com/4ugPm9D
-
Nature Biotechnology reposted
Mount Sinai Tisch Cancer Center
@TischCancer
Findings reported in @NatureBiotech provide new framework for designing mRNA vaccines and mRNA therapeutics.
rdcu.be/ff5hw
www.mountsinai.org/about/newsroom/2026/new-research-challā¦
@Brown_lab1 @JoshuaBrodyMD @IcahnMountSinai -
Nature Biotechnology reposted
Princess Margaret Cancer Centre Research
@PMResearch_UHN
New study introduces MOLEA, an AI platform that designs lipid nanoparticles for precision RNA delivery and therapeutic gene editing. @NatureBiotech #rnatherapeutics
Read more: www.nature.com/articles/s41587-026-03109-0 -
Nature Biotechnology reposted
Fred Hutch Cancer Center
@fredhutch
In a recent study published in @NatureBiotech, Fred Hutch #rarecancer expert Dr. Taran Gujral and his team show that many FDA-approved drugs can block more than the single kinase they were designed to target, including many cancer-causing mutations. www.fredhutch.org/en/news/center-news/2026/04/gujral-fda-ā¦
-
Nature Biotechnology reposted
nature
@Nature
We have the science, the technology, the medical need ā and now the regulatory momentum ā to deliver on the global promise of gene editing on demand
go.nature.com/3QtUzfI -
Nature Biotechnology reposted
Gladstone Institutes
@GladstoneInst
šØNEWšØ "Genome editing of phylogenetically distinct bacteria using cross-species retron-mediated recombineering"
@seth_shipman @NatureBiotech @biohub @UCSF @UCSF_BTS
@alex_gonzadel @UABBarcelona @UCBerkeley
@putaupf @PittTweet @UTAustin @UWMadison
go.nature.com/4cx6ims -
Nature Biotechnology
@NatureBiotech
Recent moves of note in and around the biotech and pharma industries go.nature.com/4w42pwR
-
Nature Biotechnology
@NatureBiotech
Tracing the rise of biomedical foundation models go.nature.com/4cLK7sE
-
Nature Biotechnology
@NatureBiotech
Itās time to rethink academic innovation: why technology transfer offices canāt do it alone go.nature.com/4cJwcn4
-
Nature Biotechnology reposted
nature
@Nature
Craig Venter redrew the boundaries of biology ā sequencing DNA at unprecedented speed, engineering synthetic life and charting ocean microbes.
go.nature.com/48zxONE -
Nature Biotechnology
@NatureBiotech
The first-of-its-kind genetic medicine treats a rare and profound otoferlin-related hearing loss, and will be made available by @Regeneron for free in the US www.nature.com/articles/s41587-026-03145-w
-
Nature Biotechnology
@NatureBiotech
Biomacromolecules are delivered into cells using nanoparticles made of elastin and endosomal escape sequences go.nature.com/4mxazJw
rdcu.be/feuBH -
Nature Biotechnology
@NatureBiotech
Redefining antibody patent protection using paratope mapping and CDR-scanning go.nature.com/4gYpZ5i
Nature Biotechnology
@NatureBiotech
.@uspto allows antibody genus claims in patent enabled by @IntegralMoleclr's Paratope-PLUS⢠CDR-Scanning #nbtinthenews www.prnewswire.com/news-releases/uspto-allows-antibody-geā¦
-
Nature Biotechnology
@NatureBiotech
In Brief: @US_FDA approves the first wearable device for treating locally advanced pancreatic cancer in combination with chemotherapy. @Novocure's Optune Pax delivers alternating electrical fields to the abdomen to disrupt cancer cell division www.nature.com/articles/s41587-026-03102-7
-
Nature Biotechnology
@NatureBiotech
Combining optimized AAVs and enveloped delivery vehicles enable in vivo CARāT cell generation by integrating a CAR transgene into a T cellāspecific locus. #nbthighlight www.nature.com/articles/s41586-026-10235-x
Nature Biotechnology
@NatureBiotech
Research Highlight: Site-specific engineering to produce CAR T cells in vivo www.nature.com/articles/s41587-026-03117-0
-
Nature Biotechnology
@NatureBiotech
Historic FDA approval brings first gene therapy for genetic deafness www.nature.com/articles/s41587-026-03145-w
-
Nature Biotechnology
@NatureBiotech
Synthetic biologyās uncertain regulatory future in the wake of Loper Bright Enterprises v. Raimondo go.nature.com/4cE794D
-
Nature Biotechnology
@NatureBiotech
scGraph evaluates embeddings from single-cell omics data by capturing biological relevance and structural integrity go.nature.com/3ZX0yeH
rdcu.be/feuAk -
Nature Biotechnology
@NatureBiotech
Biotech news from around the world: Singapore, South Korea, India, Zimbabwe www.nature.com/articles/s41587-026-03103-6
rdcu.be/ffWYL -
Nature Biotechnology
@NatureBiotech
Pool-packaged AAV libraries exhibit extensive length-dependent and homology-dependent chimerism go.nature.com/4cMTnLP
-
Nature Biotechnology
@NatureBiotech
A multiobjective AI model for LNP engineering enhances tissue-selective mRNA delivery go.nature.com/4ugPm9D
-
Nature Biotechnology
@NatureBiotech
The first Nature Conference on fluorescence microscopy is now open for registration. The conference will highlight key areas in fluorescence microscopy, featuring sessions on super resolution techniques, mesoscale and intravital imaging, biological applications and AI-driven developments natureconferences.streamgo.live/next-generation-fluoresceā¦
-
Nature Biotechnology
@NatureBiotech
Cytosine base editors are made highly precise through targeted directed evolution www.nature.com/articles/s41587-025-02678-w
rdcu.be/feuyu -
Nature Biotechnology
@NatureBiotech
Comprehensive profiling of clinically approved kinase inhibitors reveals mutation-specific inhibitors and opportunities for drug repurposing go.nature.com/4904pMC
Nature Biotechnology
@NatureBiotech
.@FredHutch study dramatically expands therapeutic range of approved kinase drugs #nbtinthenews www.fredhutch.org/en/news/center-news/2026/04/gujral-fda-ā¦
-
Nature Biotechnology
@NatureBiotech
Craving speed and convenience, biopharma companies turn to providers with NMR know-how www.nature.com/articles/s41587-026-03093-5
-
Nature Biotechnology
@NatureBiotech
The global patent landscape of optogenetics: current advances, challenges and opportunities go.nature.com/3OpukGM
-
Nature Biotechnology
@NatureBiotech
Improving metagenome binning by integrating intrinsic features and taxonomy go.nature.com/3QpQ3iq
-
Nature Biotechnology
@NatureBiotech
In Brief: Japan grants conditional approval for allogeneic induced pluripotent stem cell-derived therapies in Parkinsonās disease and heart failure ā the first approved regenerative medicines developed from iPSCs www.nature.com/articles/s41587-026-03105-4
-
Nature Biotechnology reposted
Seth Shipman
@seth_shipman
Out now in @NatureBiotech! @alex_gonzadel and a fantastic team of collaborators worked across nine labs to get retron-mediated recombineering up-and-running in fifteen bacterial species.
Molecular parts are on addgene: www.addgene.org/browse/article/28259376/
Happy editing!
Nature Biotechnology
@NatureBiotech
Genome editing of phylogenetically distinct bacteria using cross-species retron-mediated recombineering go.nature.com/4tZluOU
-
Nature Biotechnology reposted
Guomics @guomics
Deeper is not always better in plasma proteomics
More proteins ā better insight. Without clean samples, ādepthā can be misleading.
A clean-first perspective on plasma proteomics
Great collaboration with Matthias Mann @labs_mann -
Nature Biotechnology reposted
Matthias Mann Lab
@labs_mann
Does identifying thousands of plasma proteins mean more biology? Not always. Over half of 210 published datasets contain contamination markers reported as disease biomarkers.
-
Nature Biotechnology reposted
Nature Careers
@NatureCareers
PhD students reflect on how their supervisors made a meaningful difference ā from quiet acts of kindness to career-shaping guidance. go.nature.com/4thk3LI
-
Nature Biotechnology
@NatureBiotech
Genome editing of phylogenetically distinct bacteria using cross-species retron-mediated recombineering go.nature.com/4tZluOU
Nature Biotechnology
@NatureBiotech
A universal toolkit for editing bacterial DNA #nbtinthenews gladstone.org/news/universal-toolkit-editing-bacterial-dna
-
Nature Biotechnology
@NatureBiotech
Five questions with Jessica Stark go.nature.com/42sA99y
-
Nature Biotechnology
@NatureBiotech
āHiddenā structures in the dynamic kinome could serve as new starting points for selective drugs www.nature.com/articles/s41587-026-03091-7
-
Nature Biotechnology
@NatureBiotech
Immune-evasive cssDNA donors combined with recombinases facilitate kilobase-scale insertion of custom genetic cargos in human cells and mice. #nbthighlight www.nature.com/articles/s41586-026-10241-z
Nature Biotechnology
@NatureBiotech
Research Highlight: Immune-stealth DNA for large cargo integration www.nature.com/articles/s41587-026-03118-z
-
Nature Biotechnology
@NatureBiotech
An in vivo gain-of-function perturbation sequencing approach enables large-scale mapping of astrocytic transcription factor function in healthy and diseased mice #nbthighlight www.science.org/doi/10.1126/science.adw2156
-
Nature Biotechnology
@NatureBiotech
moPepGen enables the detection of peptides across species, proteases and technologies go.nature.com/3HYJyyz
rdcu.be/feuw5 -
Nature Biotechnology
@NatureBiotech
Agentic AI and the rise of in silico team science in biomedical research - @moorejh go.nature.com/3ZRlP9v
Nature Biotechnology
@NatureBiotech
Will artificial intelligence replace human scientists?
@CedarsSinai computational biomedicine expert ponders the potential of āagenticā AI and its pitfalls #nbtinthenews www.cedars-sinai.org/newsroom/will-artificial-intelligenc⦠-
Nature Biotechnology
@NatureBiotech
Plastic-eating fungi dig diapers www.nature.com/articles/s41587-026-03096-2
-
Nature Biotechnology
@NatureBiotech
Establishing a commercial solution for extremely rare genetic diseases go.nature.com/4aHSIvu
-
Nature Biotechnology
@NatureBiotech
In Brief: China approves a brain implant that enables people with paralysis to move their hands ā the worldās first approval of an invasive brainācomputer interface for commercial use www.nature.com/articles/s41587-026-03101-8
-
Nature Biotechnology
@NatureBiotech
High-fidelity intravital imaging of biological dynamics with latent-space-enhanced digital adaptive optics go.nature.com/41M0qiW
-
Nature Biotechnology
@NatureBiotech
Optimized SORT LNPs enable precise and long-lasting base editing in dual organs in a disease mouse model go.nature.com/3HC9EHt
rdcu.be/feuwr -
Nature Biotechnology
@NatureBiotech
Synthetic microbial co-cultures for modular bioelectronic sensing in diverse environments go.nature.com/48bpVhg
Nature Biotechnology
@NatureBiotech
Engineered dual-bacterial sensors turn chemical signals into electricity #nbtinthenews news.rice.edu/news/2026/engineered-dual-bacterial-sensorsā¦
-
Nature Biotechnology
@NatureBiotech
Skin metatranscriptomics reveals a landscape of variation in microbial activity and gene expression across the human body go.nature.com/4fVg95j
Nature Biotechnology
@NatureBiotech
New study reveals hidden skin microbe activity, opening new possibilities for eczema, acne and skin disease research #nbtinthenews via @astar_gis www.a-star.edu.sg/gis/news-events/press-releases/press-reā¦
-
Nature Biotechnology
@NatureBiotech
Deeper is not always better in plasma proteomics go.nature.com/3QoQbyI
-
Nature Biotechnology
@NatureBiotech
Reference-free discovery with barcoded single-cell sequencing - @SalzmanLab @sdeorowicz go.nature.com/4cqxwLp
-
Nature Biotechnology
@NatureBiotech
Scientists snap kinases in motion to reveal āinvisibleā states for drug discovery www.nature.com/articles/s41587-026-03091-7
[šread free with login] -
Nature Biotechnology
@NatureBiotech
An electromagnetic field-inducible gene switch is applied to in vivo partial reprogramming, and enables the modeling of Alzheimerās disease and the neuromodulation of depressive disorder in mice #nbthighlight www.cell.com/cell/fulltext/S0092-8674(26)00330-2
-
Nature Biotechnology
@NatureBiotech
Proteoforms from 10,000 rat single-brain cells are captured directly at high throughput go.nature.com/4mi2mbX
rdcu.be/feuvT -
Nature Biotechnology
@NatureBiotech
Research Highlight: Self-amplifying RNA for cardiac protein therapy www.nature.com/articles/s41587-026-03111-6
-
Nature Biotechnology
@NatureBiotech
Deep B cell depletion is delivering transformative clinical results in autoimmune diseases. Dealmakers are wagering on the best tools for the job www.nature.com/articles/s41587-026-03069-5
rdcu.be/feEYx -
Nature Biotechnology
@NatureBiotech
NMR-as-you-go for drug hunters www.nature.com/articles/s41587-026-03093-5
-
Nature Biotechnology
@NatureBiotech
Engineered cellular immunotherapy shows great potential for treating autoimmune diseases. Payne and colleagues review emerging clinical data of the most recently developed technologies go.nature.com/4cvxe67
rdcu.be/feuuv -
Nature Biotechnology
@NatureBiotech
Single-molecule peptide sequencing through reverse translation of peptides into DNA go.nature.com/4sRPr2K
Nature Biotechnology
@NatureBiotech
Bioengineers develop novel method to read proteins #nbtinthenews via @stanford news.stanford.edu/stories/2026/03/protein-sequencing-methā¦
Nature Biotechnology
@NatureBiotech
Breakthrough in protein sequencing sheds new light on the foundations of life #nbtinthenews bioengineer.org/breakthrough-in-protein-sequencing-sheds-ā¦
Nature Biotechnology
@NatureBiotech
Breakthrough protein sequencing tech unlocks cellular secrets #nbtinthenews nationaltoday.com/us/ca/stanford/news/2026/04/10/breakthrā¦
Nature Biotechnology
@NatureBiotech
Sequencing peptides by reversing translation #nbtnv go.nature.com/48KERmB
-
Nature Biotechnology
@NatureBiotech
A new class of agents is poised to transform treatment for people with narcolepsy by mimicking missing orexin peptides www.nature.com/articles/s41587-026-03092-6
[šread free with login] -
Nature Biotechnology reposted
Pieter Dorrestein
@Pdorrestein1
If you ever want to know if your favorite molecule or molecular family has been seen in public data and what metadata is associated with it - this is now possible. It searches four major repositories using a name or structure as in put to search the molecule or substructure.
Nature Biotechnology
@NatureBiotech
Structure-centric searching enables global mapping of the public metabolome go.nature.com/481Sbmk
-
Nature Biotechnology reposted
Magnetic Resonance News
@nmr900
. @NatureBiotech NMR-as-you-go for drug hunters. Craving speed and convenience, biopharma companies turn to providers with NMR know-how, by Andrew Marshall www.nature.com/articles/s41587-026-03093-5 #nmrchat š§²
-
Nature Biotechnology reposted
Nozomu Yachie
@nzmyachie
The cover of @NatureBiotechās this month issue is our CloneSelect! Great work again @soh__i and the team! Thank you, @MKrzywinski, for the amazing artwork!
Nature Biotechnology
@NatureBiotech
The April issue is live www.nature.com/nbt/volumes/44/issues/4
On the cover, Ishiguro et al. describe CloneSelect, a multi-kingdom genetic barcoding system that uses barcode-specific CRISPR base editing to activate a reporter gene, enabling precise isolation of individual clones from complex cell populations retrospectively go.nature.com/4ksLOMD -
Nature Biotechnology reposted
ARC Centre of Excellence in Synthetic Biology
@ARC_CoESB
An international team led by researchers at @QUT has used artificial intelligence to create tiny āsmartā proteins that switch on only when they detect a chosen target.
Published inĀ @NatureBiotech, the research opens the way to a new generation of low-cost biosensors for medicine, environmental monitoring and biotechnology.
Congratulations to Prof Kirill Alexandrov @KalexandrovAU and the team! š
Story courtesy of QUT Media
ā”ļøRead the story: www.coesb.com.au/scientists-turn-ai-generated-proteins-inā¦
@arc_gov_au -
Nature Biotechnology reposted
Sebastian Deorowicz
@sdeorowicz
10 years after the first FAMSA paper, its successor is now published in Nat Biotech! We believe that FAMSA2 can enable analyses of large protein collections that were previously unattainable. Thank you, @a_zielezinski and @cnotred, for great collaboration
www.nature.com/articles/s41587-026-03095-3 -
Nature Biotechnology
@NatureBiotech
Minimal life by computer
Progress toward a true virtual cell will depend on uniting AIās pattern-finding power with the causal rigor of mechanistic models go.nature.com/48muYvd -
Nature Biotechnology
@NatureBiotech
The April issue is live www.nature.com/nbt/volumes/44/issues/4
On the cover, Ishiguro et al. describe CloneSelect, a multi-kingdom genetic barcoding system that uses barcode-specific CRISPR base editing to activate a reporter gene, enabling precise isolation of individual clones from complex cell populations retrospectively go.nature.com/4ksLOMD -
Nature Biotechnology
@NatureBiotech
Inducible, split base editors for in vivo cancer functional genomics go.nature.com/4tfu1xi
Nature Biotechnology
@NatureBiotech
Research Briefing: An inducible base editing platform for cancer functional genomics in vivo www.nature.com/articles/s41587-026-03079-3
-
Nature Biotechnology
@NatureBiotech
Engineered hematopoietic stem cells generate B cell precursors that expand through immunization to produce therapeutic antibodies in mice #nbthighlight www.science.org/doi/10.1126/science.adz8994
-
Nature Biotechnology
@NatureBiotech
Diversity-generating retroelements for programmable targeted hypermutagenesis go.nature.com/3OG2nKN
-
Nature Biotechnology
@NatureBiotech
The mitochondrion-targeting tool MitoCatchĀ brings mitochondria into specific cell types through cell-surface-targeted binders. #nbthighlight www.nature.com/articles/s41586-026-10391-0
-
Nature Biotechnology
@NatureBiotech
Sequence Display enables large-scale sequenceāactivity datasets for rapid protein evolution go.nature.com/4siazyJ
Nature Biotechnology
@NatureBiotech
Scientists uncover new method to generate protein datasets for training AI #nbtinthenews news.rice.edu/news/2026/scientists-uncover-new-method-genā¦
-
Nature Biotechnology
@NatureBiotech
Fast and accurate multiple-protein-sequence alignment at scale with FAMSA2 - @sdeorowicz go.nature.com/4muAQsh
-
Nature Biotechnology
@NatureBiotech
By integrating career programming into their funding strategies, philanthropies can serve as catalysts for change, providing resources and training that institutions may struggle to offer consistently go.nature.com/4lXKHq5
rdcu.be/fdeC8 -
Nature Biotechnology
@NatureBiotech
A lysosomal barcoding strategy to quantify endosomal escape of nucleic acids in vivo assesses the performance of branched ionizable lipids for potent liver delivery #nbtnv go.nature.com/4s4X7P7
rdcu.be/fdfzQ -
Nature Biotechnology
@NatureBiotech
Patent applications indicate a trend toward completely integrating artificial intelligence with drugs, whereby AI applications will be so tightly linked to drugs that the drugs could be effectively unusable without the AI go.nature.com/41u0p2R
rdcu.be/fdeyM -
Nature Biotechnology reposted
Bo Wang
@BoWang87
Really enjoyed @NatureBiotech's new commentary "Minimal life by computer": the road to a true virtual cell is not just bigger AI models.
Itās AI + mechanistic biology.
Pattern recognition can get you far. But if we want to simulate life, predict interventions, and actually understand cells, we need models with causal structure beyond just correlations.
paper: www.nature.com/articles/s41587-026-03110-7 -
Nature Biotechnology
@NatureBiotech
For Nature Biotechnology's 30th anniversary, we asked a selection of faculty about the most exciting frontier in their field and the most needed technologies for advancing knowledge and applications go.nature.com/4rSBl0g
rdcu.be/fcEox -
Nature Biotechnology
@NatureBiotech
Most of the worldās diseases have been forgotten by commercial drug development. Patient advocacy groups must look to new types of partnerships to develop therapies go.nature.com/4d8aDx3
rdcu.be/fcEmY -
Nature Biotechnology
@NatureBiotech
.@AmsilkG is one of a cluster of biotechs to produce bioengineered spider yarn. The company launched its first textile product with Italian fashion giant Balenciaga, who used the biodegradable silk to make a shirt and shirtdress from the environmentally friendly thread
-
Nature Biotechnology
@NatureBiotech
Functional integration of an autologous engineered esophagus in a large-animal model go.nature.com/4t2yuD8
Nature Biotechnology
@NatureBiotech
Engineered tissue offers hope for babies born with missing food pipe section #nbtinthenews www.ucl.ac.uk/news/2026/mar/engineered-tissue-offers-hopeā¦
Nature Biotechnology
@NatureBiotech
Engineered esophagus rebuilds missing organ segment in pig models #nbtinthenews via @GENbio www.genengnews.com/topics/translational-medicine/engineerā¦
Nature Biotechnology
@NatureBiotech
Esophagus engineering tackles function #nbtnv go.nature.com/4mtXYXN
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
Lab-grown food pipe offers new hope for young patients #nbtinthenews via @bbchealth www.bbc.com/news/articles/c4gdvv8j2j1o
Nature Biotechnology
@NatureBiotech
First lab-grown oesophagus successfully implanted in pigs #nbtinthenews via @SkyNews news.sky.com/story/first-lab-grown-oesophagus-successfullā¦
Nature Biotechnology
@NatureBiotech
For first time, lab-grown oesophagus replacement is successful #nbtinthenews via @Labcompare www.labcompare.com/617-News/624685-For-First-Time-Lab-groā¦
-
Nature Biotechnology
@NatureBiotech
A vascular graft enables wireless, real-time and continuous stenosis diagnosis and management go.nature.com/4krub11
rdcu.be/e9Crc
Nature Biotechnology
@NatureBiotech
Engineered blood vessels harness artificial intelligence and magnetoelasticity to continuously monitor blood flow and stenosis in real time #nbtnv go.nature.com/4rOPo7z
rdcu.be/e3F7s -
Nature Biotechnology
@NatureBiotech
DNAādrug conjugates enable logic-gated drug delivery amplified by hybridization chain reactions go.nature.com/4bVNs6Z
Nature Biotechnology
@NatureBiotech
First-of-a-kind āsmartā drugs help fight cancer cells #nbtinthenews www.innovationnewsnetwork.com/first-of-a-kind-smart-drugsā¦
Nature Biotechnology
@NatureBiotech
āāSmartāā drugs to fight cancer #nbtinthenews via @UNIGEnews www.unige.ch/medias/en/2026/des-medicaments-intelligents-ā¦
Nature Biotechnology
@NatureBiotech
Building a better ADC using affibodies #nbtinthenews via @Inside_PM www.insideprecisionmedicine.com/topics/oncology/building-ā¦
Nature Biotechnology
@NatureBiotech
A programmable DNA drug system targets cancer cells with extreme precision #nbtinthenews www.techexplorist.com/programmable-dna-drug-system-targetā¦
-
Nature Biotechnology
@NatureBiotech
First orexin agonists address root cause of narcolepsy www.nature.com/articles/s41587-026-03092-6
[šread free with login] -
Nature Biotechnology
@NatureBiotech
Far-red kinase biosensors are applied to image kinase signaling networks at super resolution go.nature.com/3GfqrzL
rdcu.be/faNLM
Nature Biotechnology
@NatureBiotech
Red-shifted chemigenetic biosensors enable sensitive, multiplexed detection of intracellular signaling in living cells across various subcellular compartments and microscopy setups #nbtnv go.nature.com/3GGYUHj
rdcu.be/fb9UC -
Nature Biotechnology
@NatureBiotech
A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumors go.nature.com/3Jc62gv
Nature Biotechnology
@NatureBiotech
Penn Engineering
@PennEngineers
A new ātumor-on-a-chipā from @PennBioeng recreates the environment of solid tumors, revealing why CAR T-cell therapy often struggles to work.
The model showed that a diabetes drug, vildagliptin, can restore immune signaling, helping engineered immune cells better infiltrate and attack tumors. Now published in @NatureBiotech, the chip gives researchers a window to observe interactions between engineered immune cells and cancer, and uncover unexpected ways to help the immune cells win.
"It's incredible how closely we can replicate the complexity of malignant human tumors and their environment using this device," says Professor Dan Huh, the paper's senior author.
penntoday.upenn.edu/news/tumor-chip-offers-insight-cancerā¦
Nature Biotechnology
@NatureBiotech
In conversation with Haijiao Liu, PhD #nbtinthenews via @Inside_PM www.insideprecisionmedicine.com/topics/oncology/in-converā¦
-
Nature Biotechnology
@NatureBiotech
Minimal life by computer go.nature.com/48muYvd
-
Nature Biotechnology
@NatureBiotech
Machine learning enables scalable and systematic hierarchical virus taxonomy go.nature.com/4qoPli9
Nature Biotechnology
@NatureBiotech
Getting a glimpse of viral dances in the dark in the Sargasso Sea #nbtinthenews via @OhioStateNews news.osu.edu/getting-a-glimpse-of-viral-dances-in-the-darā¦
-
Nature Biotechnology
@NatureBiotech
Publicly available evidence regarding the impact of artificial intelligence on drug discovery is beginning to emerge, as patents on AI-derived drugs show evidence of scientific progress while revealing new legal challenges go.nature.com/3Pw0osu
rdcu.be/fbY4b -
Nature Biotechnology
@NatureBiotech
For Nature Biotechnology's 30th anniversary, we asked a selection of leaders from across biotech to look at the future of the sector and make some predictions for the coming years go.nature.com/4uR7pVa
rdcu.be/fbW5k -
Nature Biotechnology reposted
Daniel Dan Liu @Daniel_D_Liu
Traditional single cell transcriptomics doesn't capture most non-coding RNAs. In this work, led by @alinaisakovaSci and @StephenQuake, we introduce TotalX, a @10xGenomics-compatible pipeline that captures both coding and non-coding transcripts. Out now in @NatureBiotech! 1/7
Nature Biotechnology
@NatureBiotech
Scalable single-cell total RNA sequencing unifies coding and noncoding transcriptomics go.nature.com/4tjA7MI
-
Nature Biotechnology reposted
Savage Lab @SavageCatsOnly
Can CRISPR edits enable precise tuning of plant gene expression? We think: yes.
In our newest manuscript, we measured the effects of >30,000 CRISPR-like promoter mutations in sorghum protoplasts. -
Nature Biotechnology reposted
Yongdeng Zhang @YongdengZhang
We introduce mirror-enhanced 4Pi-SMLM (me4Pi-SMLM), a streamlined single-objective configuration that leverages mirror-based retroreflection of the illumination beam to achieve near-isotropic localization precision of 2ā3 nm, resolving diverse ultrastructural features.
Nature Biotechnology
@NatureBiotech
Mirror-enhanced 4Pi-SMLM with one objective enables isotropic nanoscale imaging go.nature.com/3Ocpn3N
-
Nature Biotechnology reposted
BWFUND
@BWFUND
Foundations can play a powerful role in building stronger career pathways for early-career scientists through training, mentorship, and community.
Read more: idp.nature.com/authorize?response_type=cookie&client_id=gā¦
#bwfcareer -
Nature Biotechnology
@NatureBiotech
For Nature Biotechnologyās 30th anniversary, our editors look back at a few of their favorite papers published in the past decade go.nature.com/4sWhZs1
rdcu.be/fbCVM -
Nature Biotechnology
@NatureBiotech
Progress in agri-food systems depends on actors across sectors working together ā sharing interoperable data and investing in education and infrastructure ā to harness big dataās four Vās ā volume, variety, velocity and veracity ā and tackle global challenges more effectively
-
Nature Biotechnology
@NatureBiotech
Gene isoforms are quantified with a machine learning method that optimally integrates long and short sequencing reads go.nature.com/4dR8OTC
rdcu.be/fa3BX -
Nature Biotechnology
@NatureBiotech
Bruce Booth on the successes and failures that have shaped the biotech industry ā reflecting on past breakthroughs, changes in the funding landscape, and promising drug modalities now in development go.nature.com/4lMxDnl
rdcu.be/fbtak -
Nature Biotechnology
@NatureBiotech
Recent moves of note in and around the biotech and pharma industries go.nature.com/4ve7xOK
rdcu.be/fbs8E -
Nature Biotechnology
@NatureBiotech
Mapping cis-regulatory mutations at scale in sorghum enables modulation of gene expression go.nature.com/3O7mDEN
Nature Biotechnology
@NatureBiotech
Research Briefing: Massively parallel promoter mapping identifies edits to boost sorghum gene expression www.nature.com/articles/s41587-026-03060-0
rdcu.be/fbqNf -
Nature Biotechnology
@NatureBiotech
Adenosine deaminase acting on RNA-based RNA editing is improved when single guide RNAs imitate natural targets go.nature.com/4lx84GH
rdcu.be/fa3y6 -
Nature Biotechnology
@NatureBiotech
A mucosal vaccine exploiting the interplay between the adaptive and innate immune systems protects mice from diverse respiratory pathogens #nbthighlight www.science.org/doi/10.1126/science.aea1260
Nature Biotechnology
@NatureBiotech
Research Highlight: Broadly protective mucosal vaccine harnesses integrated immunity www.nature.com/articles/s41587-026-03072-w
-
Nature Biotechnology
@NatureBiotech
For 30 years, populist and commercial lobbies have sidetracked regulations ā in particular, those for GMOs and biosimilars. In a lesson germane in todayās political climate, re-establishing a rational path rapidly may reduce the damage go.nature.com/4bCDaZ6
-
Nature Biotechnology
@NatureBiotech
Scalable homology detection with ERAST go.nature.com/3PUcImw
-
Nature Biotechnology
@NatureBiotech
Circular RNA aptamers dampen Alzheimer disease phenotypes in mouse models go.nature.com/4jgtKVA
rdcu.be/fa3yp -
Nature Biotechnology
@NatureBiotech
Biotech news from around the world: Israel, Australia, China, Saudi Arabia www.nature.com/articles/s41587-026-03063-x
rdcu.be/fa3u5 -
Nature Biotechnology
@NatureBiotech
Over the last 30 years, biotechnology has been driven by the genome sequencing revolution. For the next decade, it will be artificial intelligence that leads the charge in translating the biological complexity that results from these data go.nature.com/4sLrzhi
-
Nature Biotechnology
@NatureBiotech
Philanthropies can serve scientistsā careers with more than money go.nature.com/4lXKHq5
-
Nature Biotechnology
@NatureBiotech
Scalable single-cell total RNA sequencing unifies coding and noncoding transcriptomics go.nature.com/4tjA7MI
-
Nature Biotechnology
@NatureBiotech
Mirror-enhanced 4Pi-SMLM with one objective enables isotropic nanoscale imaging go.nature.com/3Ocpn3N
-
Nature Biotechnology
@NatureBiotech
In Brief: Denali Therapeuticsā enzyme therapy for Hunter syndrome approved by @US_FDA www.nature.com/articles/s41587-026-03066-8
rdcu.be/faNhp -
Nature Biotechnology
@NatureBiotech
A logic-gated trispecific engager enhances macrophage killing of cancer cells in solid tumors go.nature.com/4uC0qiM
Nature Biotechnology
@NatureBiotech
Research Briefing: Engineering macrophage-targeted trispecific immune cell engagers for tumor immunotherapy www.nature.com/articles/s41587-026-03104-5
rdcu.be/faNah -
Nature Biotechnology reposted
Mikaela Koutrouli @MKoutrouli
Single-cell and spatial proteomics are moving fast. We can now measure thousands of proteins across cells and tissues. But the main limitation is no longer measurement. It is integration.
In this piece, we focus on a reality that is often overlooked:
Nature Biotechnology
@NatureBiotech
Unpaired data as a first-order challenge in single-cell and spatial proteomics go.nature.com/3NHDkGP
-
Nature Biotechnology reposted
Jim Shaw
@jim_elevator
Myloasm, our long-read metagenome assembler, is now published! w/ Max Marin & @lh3lh3
Very rewarding after > a year of development and countless hours thinking about assembly. Thanks to beta testers, Li lab, and reviewers for helpful feedback.
Link: rdcu.be/famFj
Nature Biotechnology
@NatureBiotech
High-resolution metagenome assembly for modern long reads with myloasm - @lh3lh3 go.nature.com/3PBEwvR
-
Nature Biotechnology reposted
David R. Liu
@davidrliu
From @NatureBiotech: New rules spur cell and gene therapy trials in China
āOnce proven safe and effective in investigator-initiated trials, therapies [in China] can then be given to patients as treatments, again without requiring national regulatory approval. And the hospital that made the therapy and conducted the trial can charge for the treatment, creating a financial incentive for hospitals to deploy high-quality cell and gene therapies.
This situation contrasts with that in individual European Union countries, for example, where regulations enable hospitals to deliver investigational cell therapies when few or no approved alternatives remain. But, unlike in China, national regulatory approval is usually needed to go ahead with testingā¦
In the United States, the process is more onerous. Hospital-developed cell therapies destined for patients require an Investigational New Drug application approved by the US Food and Drug Administration, with some exceptions for compassionate use.ā
@US_FDA @HHSGov
www.nature.com/articles/s41587-026-03065-9 -
Nature Biotechnology reposted
Sanjay Tyagi @SanjayT11908708
30th anniversary of @NatureBiotech. Any one remember the cover of the first issue? With this issue the older journal Biotechnology became Nature Biotechnology.
-
Nature Biotechnology reposted
Grace E. Colón, Ph.D. (she/her/they) @ColonGraceE
Honored to have been included in @NatureBiotechās 30th anniversary issue in the Voices of Biotech Leaders feature, and especially humbled to be included such accomplished company. Thanks to the @NatureBiotech team for your continued leadership in this incredible field!
Nature Biotechnology
@NatureBiotech
Voices of biotech leaders
Nature Biotechnology asks a selection of leaders from across biotech to look at the future of the sector and make some predictions for the coming years go.nature.com/4uR7pVa -
Nature Biotechnology reposted
Petrie-Flom Center
@PetrieFlom
A new article in @Nature Biotechnology,Ā by Andreas Panagopoulos, @KatSideri, @CohenProf, @TiMinCeBIL, and @WNicholsonPrice,Ā looks at the next frontier of medical technology, AI-drug hybrids: www.nature.com/articles/s41587-026-03041-3
@CeBIL_Center @novonordiskfond -
Nature Biotechnology reposted
Bruce Booth
@LifeSciVC
It was a fun privilege to share a few thoughts on building biotechs with Nature Biotechnology for their 30th Anniversary issue - covering a broad range of topics including translating science into medicines, technology cycles, and financing biotech companies...
-
Nature Biotechnology
@NatureBiotech
Unpaired data as a first-order challenge in single-cell and spatial proteomics go.nature.com/3NHDkGP
-
Nature Biotechnology
@NatureBiotech
High-resolution metagenome assembly for modern long reads with myloasm - @lh3lh3 go.nature.com/3PBEwvR
-
Nature Biotechnology
@NatureBiotech
An RNA-binding protein on leukemia cells provides an effective target in mouse models go.nature.com/3YbT1In
rdcu.be/e9Csu -
Nature Biotechnology
@NatureBiotech
The March issue is live nature.com/nbt/volumes/44/issues/3
On the cover, Chen et al. engineered TadA-derived mitochondrial DNA adenine base editors for efficient mtDNA A-to-G editing with expanded targeting scopes and minimal off-target effects. This robust editing approach led to the successful generation of mitochondrial disease models go.nature.com/3TaxaOg go.nature.com/4dHqZea
Nature Biotechnology
@NatureBiotech
Optimized TALE base editors are used to generate a rat model of mitochondrial disease and then revert the disease mutation in the next generation #nbtnv go.nature.com/45O9PJM
rdcu.be/eyosE -
Nature Biotechnology
@NatureBiotech
Innovation and policy challenges of AIādrug hybrids go.nature.com/41u0p2R
-
Nature Biotechnology
@NatureBiotech
Rally around the therapeutic hub go.nature.com/4d8aDx3
-
Nature Biotechnology
@NatureBiotech
The newest gene editors are shifting away from tackling mutations one by one and toward universal therapies that will hopefully create cheaper and more broadly applicable medicines www.nature.com/articles/s41587-026-03058-8
rdcu.be/e90t1 -
Nature Biotechnology
@NatureBiotech
Voices of biotech research
Nature Biotechnology asks a selection of faculty about the most exciting frontier in their field and the most needed technologies for advancing knowledge and applications go.nature.com/4rSBl0g -
Nature Biotechnology
@NatureBiotech
In Brief: China revamps its clinical trial rules, aiming to position itself as a go-to country for early cell and gene therapies www.nature.com/articles/s41587-026-03065-9
rdcu.be/e9YeG -
Nature Biotechnology
@NatureBiotech
Human pluripotent cells are differentiated into lung progenitors and alveolar type 1 cells go.nature.com/4hQa5eI
rdcu.be/e9CqB -
Nature Biotechnology
@NatureBiotech
Precise, minimally evolved adenine base editors generated through mutation reversion analysis go.nature.com/4rHWkmu
Nature Biotechnology
@NatureBiotech
Curing the bystander effect: a new base editing tool minimizes unwanted edits to DNA #nbtinthenews via @UCSanDiego today.ucsd.edu/story/curing-the-bystander-effect
Nature Biotechnology
@NatureBiotech
New base editing tool reduces unintended DNA changes, overcoming the bystander effect #nbtinthenews bioengineer.org/new-base-editing-tool-reduces-unintended-ā¦
-
Nature Biotechnology
@NatureBiotech
Research Highlight: A bridge recombinase for human genome editing www.nature.com/articles/s41587-026-03071-x
Oana Pelea @OanaPelea
Happy to share that my postdoctoral work is now out in @ScienceMagazine. We show that the RNA-programmable bridge recombinase ISCro4 can insert, delete, or invert multi-kilobase DNA fragments at defined genomic sites in human cells.
Study link: www.science.org/doi/10.1126/science.adz1884
CRISPR-Cas has transformed genome editing, but many diseases involve diverse patient-specific mutations within the same gene. A mutation-agnostic alternative is to insert a healthy gene copy at a defined genomic locus, but gene-sized, site-specific insertions remain a major challenge.
Main findings of our work:
(1) ISCro4 is highly active in human cells and can be delivered by plasmid or all-RNA formats
(2) Proof-of-concept programmable multi-kb insertions, deletions, and inversions
(3) Structural insights into the basis of enhanced ISCro4 activity
(4) Specificity and off-target characterisation
(5) A framework to support future development and adoption of bridge recombinases
The work was made possible through a close collaboration between the Jinek Lab, @schwanklab, and @jcornlab. I am deeply grateful to all of my co-authors for the team spirit, hard work, and dedication that went into this publication: @talasandris, Javier FernƔndez Carrera, @nicopmat, Lilly van de Venn, Charles Yeh, @p_kulcsar, @marquark, @YanikWeber, @SaskiaGerecke, Isabelle Harvey-Seutcheu, Dominic MailƤnder, @MorPfl, and @ChrisChanez89. Special thanks to my supervisor, Prof. Martin Jinek, for his outstanding mentorship, and to Prof. Gerald Schwank and Prof. Jacob Corn for their generous support throughout. Finally, I would like to thank everyone in the Jinek lab for creating a supportive work environment, and @EMBO for funding my postdoctoral work.
In parallel, independent work led by @ntperry13, @SKonermann and @pdhsu also reported ISCro4 activity in human cells, reinforcing the robustness and momentum of this direction.
Please reach out if you would like to test the system or discuss potential applications. Relevant plasmids are now available via @Addgene. -
Nature Biotechnology
@NatureBiotech
Patents on AI-derived drugs: empirical evidence and legal challenges go.nature.com/3Pw0osu
-
Nature Biotechnology
@NatureBiotech
Balenciaga debuts eight-legged yarns www.nature.com/articles/s41587-026-03062-y
-
Nature Biotechnology
@NatureBiotech
Lessons from biotechās unscientific evolution go.nature.com/4bCDaZ6
-
Nature Biotechnology
@NatureBiotech
A base editor designed using circular permutation reduces off-target effects while enhancing purity go.nature.com/433euF5
rdcu.be/e9Cpn -
Nature Biotechnology
@NatureBiotech
Manufacturing-aware generative models enable petascale synthesis of designed DNA go.nature.com/3NxXt1I
Nature Biotechnology
@NatureBiotech
Generative models power petascale designed DNA synthesis #nbtinthenews bioengineer.org/generative-models-power-petascale-designeā¦
-
Nature Biotechnology
@NatureBiotech
Establishing a commercial solution for extremely rare genetic diseases - @DrStanleyCrooke @AndrewWLo go.nature.com/4aHSIvu
Nature Biotechnology
@NatureBiotech
.@n_lorem publishes commentary offering insight into potential commercialization strategies for nano-rare medicines #nbtinthenews www.nlorem.org/n-lorem-publishes-commentary-offering-insiā¦
-
Nature Biotechnology
@NatureBiotech
Biotech building from a venture capitalist perspective
For Nature Biotechnologyās 30th anniversary, we talked with Bruce Booth about the successes and failures that have shaped the biotech industry. He shares insights for those who wish to translate scientific discoveries into impactful therapeutics go.nature.com/4lMxDnl -
Nature Biotechnology
@NatureBiotech
Startups are providing tantalizing glimpses of AI-assisted antibody discovery and claiming game-changing potential, even as new models remain hidden and industry awaits full disclosure and benchmarking www.nature.com/articles/s41587-026-03048-w
[šread free with login] -
Nature Biotechnology
@NatureBiotech
Voices of biotech leaders
Nature Biotechnology asks a selection of leaders from across biotech to look at the future of the sector and make some predictions for the coming years go.nature.com/4uR7pVa -
Nature Biotechnology reposted
Rong
@_RongL
The brief digital edition of @NatureBiotechās 30th anniversary issue is live now! Check it out here: mp.weixin.qq.com/s/NklmWJ7y-HqtY9e01t2PYA
Nature Biotechnology
@NatureBiotech
The March issue is live nature.com/nbt/volumes/44/issues/3
On the cover, Chen et al. engineered TadA-derived mitochondrial DNA adenine base editors for efficient mtDNA A-to-G editing with expanded targeting scopes and minimal off-target effects. This robust editing approach led to the successful generation of mitochondrial disease models go.nature.com/3TaxaOg go.nature.com/4dHqZea -
Nature Biotechnology reposted
Paolo De Coppi
@paolodecoppi
We have shown that lab-grown oesophagus successfully replaces a full segment and restores swallowing without immunosuppression. www.nature.com/articles/s41587-026-03043-1
A major step forward for children with long-gap oesophageal atresia. @GOSHCharity @UCLPopHealthSci @ucl @NEWSFORTOFS -
Nature Biotechnology reposted
Nanjing University
@NJU1902
NJU scientists contribute to this development.
Nature Biotechnology
@NatureBiotech
A logic-gated trispecific engager enhances macrophage killing of cancer cells in solid tumors go.nature.com/4uC0qiM
-
Nature Biotechnology reposted
Eric Topol
@EricTopol
AI to understand the language of life.
Our review @NatureBiotech just published
www.nature.com/articles/s41587-026-03064-w
Free access rdcu.be/e89lQ
@VishRao5 @serena2z @BrianPlosky @pdhsu @BoWang87 @james_y_zou @marinkazitnik @pranavrajpurkar -
Nature Biotechnology reposted
UCSD Sanford Stem Cell Institute
@ucsdstemcell
SSCIās Alexis Komor, PhD, and colleagues created an improved version of a gene base editor with higher efficiency minimizing unwanted bystander edits - enhancing 𧬠gene editing & disease modeling for treating genetic disorders. Learn more @ today.ucsd.edu/story/curing-the-bystander-effect @NatureBiotech
-
Nature Biotechnology reposted
Elizabeth Wood š§¬š„ļøš„¼ @lizbwood
Our paper on variational synthesis is out now in Nature Biotechnology. Manufacturing-aware generative models ā AI architectures that know how to physically build their own designs ā enabling synthesis of DNA encoding ~10^16 AI-designed proteins at a cost that would be roughly a quadrillion dollars using conventional methods.
-
Nature Biotechnology
@NatureBiotech
Generalist biological artificial intelligence in modeling the language of life go.nature.com/3NdkqaE
-
Nature Biotechnology reposted
Fusion Conferences
@Fusion_Conf
šØSAVE THE DATE!
5th Synthetic Biology of Natural Products Conference
š Date: 01 - 04 November 2026
šLocation: Playa del Carmen, Mexico
š¢Early Bird & Talk Submission: 04 May 2026
Don't miss out, Register now ā”ļøfusion-conferences.com/conference/209
#sbnp #fusiongenomics #fusionmolbio #fusionbiochem -
Nature Biotechnology
@NatureBiotech
In Brief: @US_FDA changes its stance and agrees to review @moderna_txās mRNA flu vaccine after the biotech amends its Biologics License Application www.nature.com/articles/s41587-026-03067-7
rdcu.be/e83HZ -
Nature Biotechnology
@NatureBiotech
Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy - @PKU1898 go.nature.com/4sk7MpB
Nature Biotechnology
@NatureBiotech
Research Briefing: An engineered E. coli strain sustains intratumoral nitric oxide production to boost effectiveness of tumor immunotherapy www.nature.com/articles/s41587-026-03055-x
rdcu.be/e80pQ -
Nature Biotechnology
@NatureBiotech
A decade of research in review
For Nature Biotechnologyās 30th anniversary, our editors look back at a few of their favorite papers published in the past decade go.nature.com/4sWhZs1 -
Nature Biotechnology
@NatureBiotech
Genome editingās third act www.nature.com/articles/s41587-026-03058-8
[šread free with login] -
Nature Biotechnology
@NatureBiotech
In vivo base editing restores a neurodevelopmental disorder in mice #nbthighlight www.nature.com/articles/s41586-026-10113-6
Nature Biotechnology
@NatureBiotech
Research Highlight: In vivo base editing reverses a neurodevelopmental disorder www.nature.com/articles/s41587-026-03070-y
-
Nature Biotechnology
@NatureBiotech
Mitigating the negative environmental effects imposed by agri-food systems demands a much better understanding and management of the ecosystems and value chains on which our food production depends. Such a development in farming and food production requires extensive use and understanding of agri-food big data go.nature.com/4raUN86
rdcu.be/e8Ef7 -
Nature Biotechnology
@NatureBiotech
Transposable elements, such as retrotransposons and endogenous retroviruses, are increasingly recognized for their important roles in genome function and impact on disease development go.nature.com/4tQ1zTn
rdcu.be/e8Eci -
Nature Biotechnology
@NatureBiotech
30 years of Nature Biotechnology go.nature.com/4sLrzhi
-
Nature Biotechnology
@NatureBiotech
AI turbocharges antibody hunt for binders with drug-like qualities www.nature.com/articles/s41587-026-03048-w
[šread free with login] -
Nature Biotechnology
@NatureBiotech
Next-generation psychedelics: should new agents skip the trip? www.nature.com/articles/s41587-024-02285-1
Nature Biotechnology
@NatureBiotech
The New Yorker
@NewYorker
Scientists want to redesign psychedelics so that they donāt induce a tripābut they still improve mental health. newyorkermag.visitlink.me/ojr5fq
-
Nature Biotechnology
@NatureBiotech
We're seeking an Interim Associate or Senior Reviews Editor to join our editorial team, working across all aspects of the journal, commissioning Reviews, Perspectives and opinion pieces, and providing detailed developmental and line-by-line editing. This is a 12-month, full-time contract and can be based in our Berlin or Heidelberg offices springernature.wd3.myworkdayjobs.com/en-US/SpringerNatureā¦
-
Nature Biotechnology
@NatureBiotech
In vivo endosomal escape assay identifies mechanisms for efficient hepatic LNP delivery go.nature.com/4usXJ2U
Nature Biotechnology
@NatureBiotech
Gene-based therapies poised for major upgrade thanks to Oregon State University research #nbtinthenews news.oregonstate.edu/news/gene-based-therapies-poised-majā¦
-
Nature Biotechnology
@NatureBiotech
AI tool predicts over 1,000 diseases years before they happen ā and more are on the way www.nature.com/articles/s41587-026-03019-1
[šread free with login]
Nature Biotechnology
@NatureBiotech
The rise of AI-powered health prediction, featuring Epicās Curiosity #nbtinthenews www.epic.com/epic/post/the-rise-of-ai-powered-health-predā¦
-
Nature Biotechnology
@NatureBiotech
Trimodal single-cell profiling of transcriptome, epigenome and 3D genome in complex tissues with scHiCAR go.nature.com/4rZqimf
Nature Biotechnology
@NatureBiotech
Simultaneous decoding of genetic maps inside cells... A game changer for understanding complex human diseasesā #nbtinthenews via @kaistpr news.kaist.ac.kr/newsen/html/news/?mode=V&mng_no=58970&skā¦
-
Nature Biotechnology reposted
Wei Gao
@WeiGaoLab
New in @NatureBiotech, we discuss the convergence of mass spectrometry and wearable biosensing for noninvasive health monitoring. @Caltech
Read the paper:Ā www.nature.com/articles/s41587-026-03050-2 -
Nature Biotechnology reposted
Bruce Levine, Ph.D. šŗš¦š„¼š¬š§¬š§Ŗš
@BLLPHD
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers? in @NatureBiotech
I am optimistic based on what I've seen that In vivo CAR will get to where it needs to be, in terms of effectiveness and CRS safety, for autoimmune www.nature.com/articles/s41587-026-03069-5 -
Nature Biotechnology reposted
Gaurav Sahay
@sahayg1
Measuring the elusive process of endosomal escape in vivo and introducing branched ionizable phospholipids ā the most potent lipids weāve tested for RNA delivery. Led by exceptional graduate students Antony Jozic @OregonState and Chloe Le Roux (Univ-Brest)!
Nature Biotechnology
@NatureBiotech
In vivo endosomal escape assay identifies mechanisms for efficient hepatic LNP delivery go.nature.com/4usXJ2U
-
Nature Biotechnology
@NatureBiotech
Sensitive detection of cancer antigens enabled by user-defined peptide libraries go.nature.com/4kvvwUC
-
Nature Biotechnology
@NatureBiotech
The January issue is live www.nature.com/nbt/volumes/44/issues/1
On the cover, Luebbert et al. present a method to detect viral sequences in bulk and single-cell transcriptomic data using conserved amino acid domains instead of annotated reference genomes go.nature.com/4lGrSY3 -
Nature Biotechnology
@NatureBiotech
Targeted delivery of genome editors in vivo go.nature.com/4qKp6Tb
-
Nature Biotechnology
@NatureBiotech
Now with oligos: antibodyāoligonucleotide conjugates are the new drug modality to watch www.nature.com/articles/s41587-025-02987-0
-
Nature Biotechnology
@NatureBiotech
Integrated experimental and AI innovations for RNA structure determination go.nature.com/3NcBzk8
-
Nature Biotechnology
@NatureBiotech
Mapping isoforms and regulatory mechanisms from spatial transcriptomics data with SPLISOSM go.nature.com/3NaXw31
-
Nature Biotechnology
@NatureBiotech
Engineering bispecific exosome activators of T cells to target immune checkpoint inhibitor-resistant metastatic melanoma go.nature.com/496Ins7
-
Nature Biotechnology
@NatureBiotech
Multiplexed profiling of transcriptional regulators in plant cells go.nature.com/4pw5cL1
Nature Biotechnology
@NatureBiotech
Scientists build 'speed scanner' to test thousands of plant gene switches at once #nbtinthenews via @BerkeleyLab newscenter.lbl.gov/2025/12/18/scientists-build-speed-scanā¦
-
Nature Biotechnology
@NatureBiotech
The December issue is live www.nature.com/nbt/volumes/43/issues/12
The cover shows a representation of hybrid quantum computing for drug design. Ghazi Vakili et al. present a hybrid quantumāclassical generative model to design molecules to inhibit KRAS activity. Two candidates are synthesized and further characterized go.nature.com/3EitbLm -
Nature Biotechnology
@NatureBiotech
2025: research in review go.nature.com/4oCK84L
-
Nature Biotechnology
@NatureBiotech
In vivo gene editing of human hematopoietic stem and progenitor cells using envelope-engineered virus-like particles go.nature.com/4a39S6X
-
Nature Biotechnology
@NatureBiotech
Growth-coupled microbial biosynthesis of the animal pigment xanthommatin go.nature.com/3Ll0VeT
Nature Biotechnology
@NatureBiotech
Scientists produce powerhouse pigment behind octopus camouflage #nbtinthenews via @UCSanDiego today.ucsd.edu/story/scientists-produce-powerhouse-pigmenā¦
Nature Biotechnology
@NatureBiotech
Bioengineering āhackā allows scientists to recreate octopus camouflage pigment using bacteria #nbtinthenews via @Debriefmedia thedebrief.org/bioengineering-hack-allows-scientists-to-rā¦
-
Nature Biotechnology
@NatureBiotech
Deep-learning-based virtual screening of antibacterial compounds - @genentech go.nature.com/47oIdKy
-
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
VickoviÄ Lab publishes a new study on colon aging #nbtinthenews via @Cancer_dynamics cancerdynamics.columbia.edu/news/vickovic-lab-publishes-nā¦
-
Nature Biotechnology
@NatureBiotech
Integrated epigenetic and genetic programming of primary human T cells go.nature.com/3WOJJAJ
-
Nature Biotechnology
@NatureBiotech
Predicting functions of uncharacterized gene products from microbial communities go.nature.com/435C4lp
-
Nature Biotechnology
@NatureBiotech
The October issue is live nature.com/nbt/volumes/43/issues/10
The cover shows perturbations that convert stem-like, atypical teratoid rhabdoid tumor (AT/RT) cells into a more differentiated, neuron-like state go.nature.com/4hXER5O -
Nature Biotechnology
@NatureBiotech
Chronic silencing is a critical barrier to breaking the cycle of bullying in academia and industry - @MoriMahmoudi go.nature.com/482BUOY
-
Nature Biotechnology
@NatureBiotech
Efficient sequence alignment against millions of prokaryotic genomes with LexicMap go.nature.com/3K09TgJ
-
Nature Biotechnology
@NatureBiotech
Targeted delivery of diverse biomolecules with engineered bacterial nanosyringes go.nature.com/46OFcoj
-
Nature Biotechnology
@NatureBiotech
Severus detects somatic structural variation and complex rearrangements in cancer genomes using long-read sequencing go.nature.com/3R334eH
Nature Biotechnology
@NatureBiotech
NIH researchers create algorithm to detect somatic structural variation in cancer genomes using long-read sequencing #nbtinthenews via @oncodaily oncodaily.com/insight/somatic-structural-variation-341636
-
Nature Biotechnology
@NatureBiotech
The July issue is live www.nature.com/nbt/volumes/43/issues/7
On the cover, Chen et al. have developed a precise chemo-enzymatic method to synthesize and modify protein-coding mRNA to optimize functionality and pharmacokinetics go.nature.com/47EXbfq -
Nature Biotechnology
@NatureBiotech
Evolution-guided protein design of IscB for persistent epigenome editing in vivo go.nature.com/44XVBph
-
Nature Biotechnology
@NatureBiotech
Discovery requires an openness to new ideas and unexpected insights go.nature.com/4i1wQf5
rdcu.be/ej7H7 -
Nature Biotechnology
@NatureBiotech
Detection of viral sequences at single-cell resolution identifies novel viruses associated with host gene expression changes go.nature.com/4lGrSY3
-
Nature Biotechnology
@NatureBiotech
Virtual cells for predictive immunotherapy go.nature.com/4jfqM3Y
-
Nature Biotechnology
@NatureBiotech
Scalable spatial transcriptomics through computational array reconstruction go.nature.com/3QYfSDd
Nature Biotechnology
@NatureBiotech
Scientists have developed a way to scale up spatial genomics and lower costs #nbtinthenews via @broadinstitute www.broadinstitute.org/news/scaling-up-spatial-genomics
-
Nature Biotechnology
@NatureBiotech
In Brief: Real-life Jurassic Park startup @colossal BioSciences has raised $200 million to bring back three extinct animals: the woolly mammoth, the Tasmanian tiger and the dodo bird www.nature.com/articles/s41587-025-02578-z
rdcu.be/eaosC -
Nature Biotechnology
@NatureBiotech
Single-molecule live-cell RNA imaging with CRISPRāCsm go.nature.com/3EJPKsM
-
Nature Biotechnology
@NatureBiotech
Precise RNA targeting with CRISPRāCas13d go.nature.com/4gEn95x
-
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
How hungry fat cells could someday starve cancer to death #nbtinthenews via @UCSF www.ucsf.edu/news/2025/01/429411/how-hungry-fat-cells-couā¦
-
Nature Biotechnology
@NatureBiotech
Quantum-computing-enhanced algorithm unveils potential KRAS inhibitors go.nature.com/3EitbLm
Nature Biotechnology
@NatureBiotech
.@uoftmedicine researchers develop new approach using quantum computers to accelerate drug discovery #nbtinthenews temertymedicine.utoronto.ca/news/u-t-researchers-develop-ā¦
-
Nature Biotechnology
@NatureBiotech
Uniform volumetric single-cell processing for organ-scale molecular phenotyping go.nature.com/40wig8l
-
Nature Biotechnology
@NatureBiotech
Bacterial-MERFISH combines 1000-fold volumetric expansion with multiplexed fluorescence in situ hybridization, enabling high-throughput, spatially resolved profiling of thousands of operons within individual bacteria. www.science.org/doi/10.1126/science.adr0932 #nbthighlight
-
Nature Biotechnology
@NatureBiotech
Five questions with Anastassia Vorobieva go.nature.com/40FEHsZ
-
Nature Biotechnology
@NatureBiotech
The January issue is live www.nature.com/nbt/volumes/43/issues/1
On our cover, a minigame integrated within a popular video game let more than 4 million players contribute to improving a multiple sequence alignment for microbial phylogeny estimations and association go.nature.com/4aSfOg6 -
Nature Biotechnology
@NatureBiotech
A cure for HIV? TCR agents seek to wipe out viral reservoirs www.nature.com/articles/s41587-024-02529-0
-
Nature Biotechnology
@NatureBiotech
Intestinal mucosal barrier repair and immune regulation with an AI-developed gut-restricted PHD inhibitor go.nature.com/4iteK6Z
Nature Biotechnology
@NatureBiotech
Insilico details AI-designed IBD candidateās path to nomination #nbtnthenews via @GENbio www.genengnews.com/topics/artificial-intelligence/insilicā¦
Nature Biotechnology
@NatureBiotech
Generative chemistry enables Insilico to develop gut-restricted PhD inhibitors promising for intestinal mucosal barrier repair and immunomodulation #nbtnthenews www.eurekalert.org/news-releases/1067877
Nature Biotechnology
@NatureBiotech
Generative AI helps Hong Kongās @InSilicoMeds design potential new IBD drug #nbtnthenews via @scmpnews sc.mp/hakta
-
Nature Biotechnology
@NatureBiotech
Pooled CRISPR screens with joint single-nucleus chromatin accessibility and transcriptome profiling go.nature.com/4hXER5O
-
Nature Biotechnology
@NatureBiotech
Many human pluripotent stem cell lines have acquired cancer-related mutations go.nature.com/427VVPb
rdcu.be/d0DBv -
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
New research reveals what underlies the mental health crisis among science graduate students and calls for action to address key stressors #nbtinthenews via @asunews news.asu.edu/b/20241112-new-research-reveals-what-underliā¦
-
Nature Biotechnology
@NatureBiotech
Directed evolution of engineered virus-like particles with improved production and transduction efficiencies go.nature.com/3YMR3h5
-
Nature Biotechnology
@NatureBiotech
Mapping multimodal phenotypes to perturbations in cells and tissue with CRISPRmap go.nature.com/481iCHt
Nature Biotechnology
@NatureBiotech
A new optical pooled screening approach enables the coupling of optical properties of single cells to targeted genetic perturbations #nbtinthenews via @Cancer_dynamics cancerdynamics.columbia.edu/news/mapping-multimodal-phenoā¦
-
Nature Biotechnology
@NatureBiotech
Model-directed generation of artificial CRISPRāCas13a guide RNA sequences improves nucleic acid detection - @PardisSabeti @haydenmetsky go.nature.com/4dLvhQf
-
Nature Biotechnology
@NatureBiotech
One-step nanoscale expansion microscopy reveals individual protein shapes go.nature.com/3Y1FD8M
-
Nature Biotechnology
@NatureBiotech
Scalable, compressed phenotypic screening using pooled perturbations go.nature.com/3ZV58uX
-
Nature Biotechnology
@NatureBiotech
Multistate and functional protein design using RoseTTAFold sequence space diffusion go.nature.com/4gGcus0
-
Nature Biotechnology
@NatureBiotech
Plastic-eating bacteria boost growing business of bioremediation go.nature.com/4gzeSAW
-
Nature Biotechnology
@NatureBiotech
Chemical and topological design of multicapped mRNA and capped circular RNA to augment translation go.nature.com/47EXbfq
Nature Biotechnology
@NatureBiotech
New approach may yield modified messenger RNAs for treating a wide range of conditions #nbtinthenews via @broadinstitute www.broadinstitute.org/news/multi-capped-messenger-rna-coā¦
-
Nature Biotechnology
@NatureBiotech
The Wild West of spike-in normalization go.nature.com/3XLUMw3
-
Nature Biotechnology
@NatureBiotech
Organoid culture promotes dedifferentiation of mouse myoblasts into stem cells capable of complete muscle regeneration go.nature.com/47lBikW
-
Nature Biotechnology
@NatureBiotech
The resurrection of strings of extinct molecules raises intriguing questions of patentability and bioethical considerations in an emerging area of patent law go.nature.com/4cz9f2k
rdcu.be/dR3Sb -
Nature Biotechnology
@NatureBiotech
Companies are moving therapeutic testing from plastic wells into pooled in vivo screening, generating physiologically relevant data by screening many drug candidates at once in a single animal www.nature.com/articles/s41587-024-02361-6
-
Nature Biotechnology
@NatureBiotech
Fast, sensitive detection of protein homologs using deep dense retrieval go.nature.com/3YWwP6j
-
Nature Biotechnology
@NatureBiotech
Slaughter-free meat hits the grocery shelf
As cultivated meat begins to enter grocery stores, governments should promote the fieldās development in line with broad public goals of sustainability and accessibility go.nature.com/3ApQr8j -
Post not available here, view on XPost not available here, view on X
Nature Biotechnology
@NatureBiotech
Cancer treatment approach targets resistance, gene drive style #nbtinthenews via @GENbio www.genengnews.com/topics/cancer/cancer-treatment-approacā¦
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
Genetic circuits reprogram cancer cells to reduce drug resistance #nbtinthenews via @Inside_PM www.insideprecisionmedicine.com/topics/oncology/genetic-cā¦
-
Nature Biotechnology
@NatureBiotech
Complete substitution with modified nucleotides in self-amplifying RNA suppresses the interferon response and increases potency go.nature.com/3RYbPHK
-
Nature Biotechnology
@NatureBiotech
Effects of the first successful lawsuit against a consumer neurotechnology company for violating brain data privacy go.nature.com/3xunS8U
-
Nature Biotechnology
@NatureBiotech
Barriers and enablers to the effective implementation of omics research in low- and middle-income countries go.nature.com/3za26rp
-
Nature Biotechnology
@NatureBiotech
šļøEpisode 3 of 'From Bench to Podcast' is live! Listen as @claudiasjv7 talks to first author @rsarrazing of @McGillScience about #borderlandsscience, a citizen science approach to microbiome dataš®š¦ shows.acast.com/forum/episodes/from-bench-to-podcast-romaā¦
-
Nature Biotechnology
@NatureBiotech
Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens go.nature.com/3yxjW7q
-
Nature Biotechnology
@NatureBiotech
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method go.nature.com/4akbFkj
-
Nature Biotechnology
@NatureBiotech
Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms go.nature.com/4b8aN3p
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
AI-powered model identifies most potent cancer-killing immune cells #nbtinthenews via @AZoRobotics www.azorobotics.com/News.aspx?newsID=14848
-
Nature Biotechnology
@NatureBiotech
Improving microbial phylogeny with citizen science within a mass-market video game go.nature.com/4aSfOg6
Nature Biotechnology
@NatureBiotech
#behindthepaper: The making of Borderlands Science, from its inception to its launch communities.springernature.com/posts/the-making-of-borderā¦
-
Nature Biotechnology
@NatureBiotech
We continue to celebrate outstanding leaders in biotech for #womenshistorymonth. Claire Mazumdar is the founding CEO of Bicara Therapeutics, which develops first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators
-
Nature Biotechnology
@NatureBiotech
Quality assessment of gene repertoire annotations with OMArk go.nature.com/4bH5OaF
Nature Biotechnology
@NatureBiotech
Research Briefing: OMArk, a tool for gene annotation quality control, reveals erroneous gene inference go.nature.com/4bIazAS
-
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
Femmes & Sciences : construire un mentorat opĆ©rationnel avec les outils de lāintelligence collective #nbtinthenews www.insb.cnrs.fr/fr/cnrsinfo/femmes-sciences-construire-uā¦
-
Nature Biotechnology
@NatureBiotech
Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo go.nature.com/48sHk38
-
Nature Biotechnology
@NatureBiotech
Encapsulated stem cellāderived β cells exert glucose control in patients with type 1 diabetes go.nature.com/49XuevC
-
Nature Biotechnology
@NatureBiotech
Spatial hostāmicrobiome sequencing reveals niches in the mouse gut go.nature.com/3sGmJbU
-
Nature Biotechnology
@NatureBiotech
The UK medicines regulator approves the first therapy using CRISPR gene editing. @VertexPharma and @CRISPRTX's Casgevy will treat the blood conditions sickle-cell disease and β-thalassemia #nbtnewsbeat www.nature.com/articles/d41586-023-03590-6
-
Nature Biotechnology
@NatureBiotech
Single-cell lineage capture across genomic modalities with CellTag-multi reveals fate-specific gene regulatory changes go.nature.com/3rkazov
-
Nature Biotechnology
@NatureBiotech
Precision RNA base editing with engineered and endogenous effectors go.nature.com/3LxRiXu
-
Nature Biotechnology
@NatureBiotech
Integration of spatial and single-cell data across modalities with weakly linked features go.nature.com/44KZcTU
-
Nature Biotechnology
@NatureBiotech
Imaging brain tissue architecture across millimeter to nanometer scales go.nature.com/3P0nSC1
-
Nature Biotechnology
@NatureBiotech
SComatic identifies somatic mutations from scRNA-seq and scATAC data without a matched reference sample go.nature.com/44brDLt
-
Nature Biotechnology
@NatureBiotech
Compact genome editors were discovered by mining a transposon library go.nature.com/3CTqoEH
-
Nature Biotechnology
@NatureBiotech
Recent advances in plant molecular farming and the advantages of using plant molecular farming methods to reduce production costs, thereby enhancing affordability and global access
go.nature.com/47zU3RB
rdcu.be/diK6T -
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
New gene editing tool helps zero in on small cancer-linked mutations #nbtinthenews via @WeillCornell news.weill.cornell.edu/news/2023/08/new-gene-editing-toolā¦
-
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
Methodological concerns and lack of evidence for single-synapse RNA-seq go.nature.com/3Oy2uFh
-
Nature Biotechnology
@NatureBiotech
The Human BioMolecular Atlas Program collection is out! @_hubmap endeavors to construct comprehensive spatial maps that feature a range of biomolecules such as RNA, proteins and metabolites in human organs at single-cell resolution www.nature.com/collections/aihihijabe
-
Nature Biotechnology
@NatureBiotech
Five questions with Sanja VickoviÄ go.nature.com/3OmrPlK
rdcu.be/dg9s4 -
Nature Biotechnology
@NatureBiotech
The disease biology of amyotrophic lateral sclerosis is complex and varied, but the field's understanding is growing ā and a biomarker of neuronal damage is a useful trial endpoint to aim at www.nature.com/articles/s41587-023-01862-0
-
Nature Biotechnology
@NatureBiotech
De novo detection of somatic mutations in high-throughput single-cell profiling data sets go.nature.com/44brDLt
-
Nature Biotechnology
@NatureBiotech
Prediction of on-target and off-target activity of CRISPRāCas13d guide RNAs using deep learning go.nature.com/3JFjQNy
-
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
Foldseek gives AlphaFold protein database a rapid search tool, via @Nature www.nature.com/articles/d41586-023-02205-4
-
Nature Biotechnology
@NatureBiotech
Genetic engineering and accelerated evolution of microbes can help climate change by, for example, decreasing methane production in livestock, offering better fertilizers, improving bioremediation and producing chemicals sustainably go.nature.com/43tQRUC
-
Nature Biotechnology
@NatureBiotech
Dictionary learning for integrative, multimodal and scalable single-cell analysis go.nature.com/437cxGb
-
Nature Biotechnology
@NatureBiotech
A fully integrated wearable ultrasound system to monitor deep tissues in moving subjects go.nature.com/43iV4dK
-
Nature Biotechnology
@NatureBiotech
The promise of phages
Phage therapy is an exciting alternative to antibiotics. Why now? go.nature.com/3poKjb1 -
Nature Biotechnology
@NatureBiotech
Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing go.nature.com/3KlMaFA
-
Nature Biotechnology
@NatureBiotech
We're highlighting outstanding scientists for #womenshistorymonth. Today we recognize Cathie Martin, whose research focuses on the relationship between food and health and how crops can be fortified to improve diets and address the global challenge of escalating chronic disease
-
Nature Biotechnology
@NatureBiotech
For #womenshistorymonth, we're celebrating outstanding scientists in the biotech industry. We salute Sarah Diermeier, founder and chief scientific officer of Amaroq Therapeutics, which is focused on developing a new class of therapeutics that target long non-coding RNAs in cancer
-
Nature Biotechnology
@NatureBiotech
A base editor is engineered for A-to-T and A-to-C transversion editing go.nature.com/3Cwgjh6
-
Nature Biotechnology
@NatureBiotech
Trans-segmental imaging in the spinal cord of behaving mice go.nature.com/3Zwdlms
Nature Biotechnology
@NatureBiotech
Wearable microscopes advance spinal cord imaging in mice #nbtinthenews via @salkinstitute www.salk.edu/news-release/wearable-microscopes-advance-spā¦
-
Nature Biotechnology
@NatureBiotech
Women build strength in numbers
Womenās networks are strong, and making a difference #iwd2023 #embraceequity #womeninbiotech go.nature.com/3F3pffh -
Nature Biotechnology
@NatureBiotech
Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis go.nature.com/3EzGWmt
-
Nature Biotechnology
@NatureBiotech
Natural killer cells are attractive as cancer immunotherapy agents because ā unlike T cells ā they evade immune rejection and do not induce cytokine storms. But capturing their activity in effective therapies remains a work in progress www.nature.com/articles/s41587-023-01671-5
-
Nature Biotechnology
@NatureBiotech
Three-dimensional structured illumination microscopy with enhanced axial resolution - @NIBIBgov go.nature.com/3kLNoQc
-
Nature Biotechnology
@NatureBiotech
Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123 go.nature.com/3iBQx4j
-
Nature Biotechnology
@NatureBiotech
RNA recording in single bacterial cells using reprogrammed tracrRNAs go.nature.com/3Zdjvbf
-
Nature Biotechnology
@NatureBiotech
High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform go.nature.com/3GzQsaD
-
Nature Biotechnology
@NatureBiotech
Integration of whole transcriptome spatial profiling with protein markers idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.natā¦
-
Nature Biotechnology
@NatureBiotech
Recording of cellular physiological histories along optically readable self-assembling protein chains go.nature.com/3Ch1sXA
-
Nature Biotechnology
@NatureBiotech
Nanobody-tethered transposition enables multifactorial chromatin profiling at single-cell resolution go.nature.com/3jgzdBH
-
Nature Biotechnology
@NatureBiotech
How to grow (almost) anything: a hybrid distance learning model for global laboratory-based synthetic biology education idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.natā¦
-
Nature Biotechnology
@NatureBiotech
Structural variants that modify chromatin structure are widespread in cancer genomes and contribute to oncogene activation #nbthighlight idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.natā¦
-
Nature Biotechnology
@NatureBiotech
Filling the gap - AlphaFill adds ligands and cofactors to AlphaFold2 predicted protein structures. #nbthighlight www.nature.com/articles/s41592-022-01685-y
-
Nature Biotechnology
@NatureBiotech
Multifactorial profiling of epigenetic landscapes at single-cell resolution using MulTI-Tag go.nature.com/3NjDrnn
-
Nature Biotechnology
@NatureBiotech
A comprehensive SARS-CoV-2āhuman proteināprotein interactome reveals COVID-19 pathobiology and potential host therapeutic targets go.nature.com/3MlUogb
-
Nature Biotechnology
@NatureBiotech
Scalable in situ single-cell profiling by electrophoretic capture of mRNA using EEL FISH go.nature.com/3r4svzm
-
Nature Biotechnology
@NatureBiotech
Biodefense stockpiles are helping to curb the monkeypox outbreak, but the vaccines are based on old technology with significant side effects. Are other vaccines on the horizon? www.nature.com/articles/s41587-022-01463-3
-
Nature Biotechnology
@NatureBiotech
Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics go.nature.com/3LdOEF3
-
Nature Biotechnology
@NatureBiotech
DeepConsensus improves the accuracy of sequences with a gap-aware sequence transformer go.nature.com/3q8kiK0
-
Nature Biotechnology
@NatureBiotech
Human ureteric bud organoids recapitulate branching morphogenesis and differentiate into functional collecting duct cell types go.nature.com/3PY6xbz
-
Nature Biotechnology
@NatureBiotech
Can hackathons unlock a new talent pool from the developing world? go.nature.com/3bJPcFf
-
Nature Biotechnology
@NatureBiotech
Synthetic embryos generated from naive mouse embryonic stem cells proceed through gastrulation and attain a developmental stage resembling 8.5-day mouse embryos. #nbthighlight www.cell.com/cell/fulltext/S0092-8674(22)00981-3
-
Nature Biotechnology
@NatureBiotech
Shallow whole genome sequencing of cell free DNA with Oxford Nanopore Technology shows promise for the detection of cell type and cancer-specific methylation changes. #nbthighlight
genomebiology.biomedcentral.com/articles/10.1186/s13059-0⦠-
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
CRISPR therapeutics can damage the genome #nbtinthenews via @medical_xpress medicalxpress.com/news/2022-07-crispr-therapeutics-genomeā¦
-
Nature Biotechnology
@NatureBiotech
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants go.nature.com/3B3oYaZ
-
Nature Biotechnology
@NatureBiotech
Smartphone apps in the COVID-19 pandemic go.nature.com/39BuvKr
-
Nature Biotechnology
@NatureBiotech
The GA4GH Phenopacket schema defines a computable representation of clinical data go.nature.com/3NZ1bwx
-
Nature Biotechnology
@NatureBiotech
On a new #nbtforum podcast, senior editor Barbara Cheifet talks with Ana Pombo and Jennifer Phillips-Cremins about how 3D genome methods are providing insights into genome structure and function shows.acast.com/forum/episodes/3d-genome-roundtable-phillā¦
-
Nature Biotechnology
@NatureBiotech
We are seeking a talented immunologist to join us as an Associate or Senior Editor. The deadline for applications is June 10, 2022 careers.springernature.com/job/New-York-Associate-or-Seniā¦
-
Nature Biotechnology
@NatureBiotech
Spatially informed cell-type deconvolution for spatial transcriptomics go.nature.com/3FbtDry
-
Nature Biotechnology
@NatureBiotech
The largest hackathon in Africa (@ZindiAfrica) just concluded, with @azer_ksouri winning the snake antivenom challenge posed by @TimothyPJenkins & @instadeepai. A great showcase of how talent can be empowered to aid in global challenges, such as snakebite www.youtube.com/watch?v=u-ELJK9KMwc&ab_channel=ZindiAfrica
-
Nature Biotechnology
@NatureBiotech
Accelerated identification of disease-causing variants with ultra-rapid nanopore genome sequencing go.nature.com/3JZNKdu
-
Nature Biotechnology
@NatureBiotech
Characterizing cellular heterogeneity in chromatin state with scCUT&Tag-pro go.nature.com/3izgLAN
-
Nature Biotechnology
@NatureBiotech
In Brief: @BioNTech_Group develops a new type of vaccine factory for Africa. The ābioNTainerā miniaturizes all the processes needed to manufacture mRNA vaccines into a modular unit made up of two groups of six 40-foot containers www.nature.com/articles/s41587-022-01268-4 rdcu.be/cJAKc
-
Nature Biotechnology
@NatureBiotech
Designing sensitive viral diagnostics with machine learning go.nature.com/3IHDdDp
Nature Biotechnology
@NatureBiotech
Creating a good viral diagnostic requires time and labor. Co-authors @PillaiPriyaP and @haydenmetsky go #behindthepaper on how they created ADAPT to design highly accurate viral diagnostics in a fully automated system go.nature.com/3hHZchE
-
Nature Biotechnology
@NatureBiotech
Rare variants, detected by WGS, explain a substantial fraction of missing heritability. #nbthighlight
www.nature.com/articles/s41588-021-00997-7 -
Nature Biotechnology
@NatureBiotech
To celebrate outstanding leaders in the biotech industry for #womenshistorymonth, today we recognize Isemar and Jacqueline Cruz, co-founders of @leqarabio, which uses no-waste bioengineering processes to produce biomaterials such as leather from microorganisms
-
Nature Biotechnology
@NatureBiotech
We continue to celebrate outstanding leaders in the biotech industry for #womenshistorymonth. Today we recognize Gerit Tolborg, co-founder and CEO of @Chromologics, whose novel production platform is able to produce new, natural colors by microbial fermentation
-
Nature Biotechnology
@NatureBiotech
We continue to highlight outstanding researchers to celebrate #blackhistorymonth. We salute Guillermo Ameer of Northwestern University, a pioneer in developing biomaterials and nanotech for regenerative & tissue engineering, medical devices, and drug & cell delivery applications
-
Nature Biotechnology
@NatureBiotech
Using deep learning to annotate the protein universe go.nature.com/3v4tKlv
-
Nature Biotechnology
@NatureBiotech
To celebrate #blackhistorymonth we highlight outstanding Black researchers around the US. We salute Angela Brooks, associate professor of biomolecular engineering at UC Santa Cruz, whose lab is committed to developing novel sequencing analysis tools to study and fight cancer
-
Nature Biotechnology
@NatureBiotech
Weāre highlighting outstanding Black researchers around the US to celebrate #blackhistorymonth. Today we recognize Bryan Bryson, assistant professor of biological engineering at MIT, whose lab is developing new tools to dissect the complex dynamics of bacterial infection
-
Nature Biotechnology
@NatureBiotech
In Brief: Japan approves the sale of two CRISPR-edited fish: a tiger puffer and a red sea bream, both developed by the Kyoto-based startup Regional Fish Institute with Kyoto University and Kindai University www.nature.com/articles/s41587-021-01197-8 rdcu.be/cD9it
-
Nature Biotechnology
@NatureBiotech
A humanized mouse model of chronic COVID-19 go.nature.com/3p3bBRM
-
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
New prime editing system inserts entire genes in human cells #nbtinthenews via @broadinstitute www.broadinstitute.org/news/new-prime-editing-system-inseā¦
-
Nature Biotechnology
@NatureBiotech
Biocomposite building blocks of lignocellulosic feedstocks infused with bacteria and fungi can be used to engineer living human-scale structures with sensing and responsive capabilities. Work from @harriswangnyc and co @ecovative #nbthighlight
www.nature.com/articles/s41563-021-01123-y -
Nature Biotechnology
@NatureBiotech
Weāre highlighting outstanding researchers for #hispanicheritagemonth. We recognize Penn assistant professor Kellie Ann Jurado, whose lab defines biologically honed antiviral immune regulatory networks in order to identify novel tactics for immunomodulation of disease at large
-
Nature Biotechnology
@NatureBiotech
High-confidence structural annotation of metabolites absent from spectral libraries go.nature.com/3aDfJju
-
Nature Biotechnology
@NatureBiotech
To celebrate #hispanicheritagemonth, we recognize UCLA assistant professor in computational medicine and human genetics Harold Pimentel @hjpimentel, who is developing software that enables the analysis of complex genomic datasets that sample the transcriptional landscape
-
Nature Biotechnology
@NatureBiotech
Wireless closed-loop optogenetics across the entire dorsoventral spinal cord in mice go.nature.com/2XUW9vF
-
Nature Biotechnology
@NatureBiotech
After the vaccine triumphs of Pfizer/BioNTech and Moderna, a raft of startups is developing mRNA, circular RNA and self-amplifying RNA therapeutics www.nature.com/articles/s41587-021-01056-6
-
Nature Biotechnology
@NatureBiotech
Performance assessment of DNA sequencing platforms in the ABRF Next-Generation Sequencing Study go.nature.com/3BWsWzd
-
Nature Biotechnology
@NatureBiotech
In Brief: Two newly published machine learning algorithms that predict protein three-dimensional structure from amino acid sequence will have far-reaching implications for biological research and medicine @DeepMind @UWproteindesign www.nature.com/articles/s41587-021-01029-9 rdcu.be/ctTX1
-
Nature Biotechnology
@NatureBiotech
Remote smartphone monitoring of Parkinsonās disease and individual response to therapy go.nature.com/3fIv9FS
-
Nature Biotechnology
@NatureBiotech
Bioorthogonal information storage in L-DNA with a high-fidelity mirror-image Pfu DNA polymerase go.nature.com/3j1IbPF
-
Nature Biotechnology
@NatureBiotech
Learning to love GMOs. Overblown fears have turned the public against genetically modified food. But the potential benefits have never been greater #nbtinthenews via @NYTmag www.nytimes.com/2021/07/20/magazine/gmos.html
-
Nature Biotechnology
@NatureBiotech
Leveraging the expertise of co-founders Matthew Porteus and Maria Grazia Roncarolo, @GraphiteBio is pursuing a strategy of repairing the mutations behind sickle cell and other genetic diseases at the source #nbtacademicstartups www.nature.com/articles/d41587-021-00010-w
-
Nature Biotechnology
@NatureBiotech
LAMP-Seq enables sensitive, multiplexed COVID-19 diagnostics using molecular barcoding go.nature.com/3y85GfE
-
Nature Biotechnology
@NatureBiotech
Karl Deisseroth of Stanford and Caltech's Viviana Gradinaru speak with senior editor Markus Elsner about the current state of #optogenetics and how it can be used to better understand and treat human disease, on our latest #nbtforum podcast play.acast.com/s/forum/optogeneticsroundtable-deisserothaā¦
-
Nature Biotechnology
@NatureBiotech
An artificial virus-like particle that packages the mRNA encoding its capsid protein #nbthighlight
science.sciencemag.org/content/372/6547/1220 -
Nature Biotechnology
@NatureBiotech
Ultra-precision medicine. New initiatives in N-of-1 drug development and clinical trial design offer the possibility of therapies for ultra-rare disease patients who have been long neglected by the drug industry go.nature.com/3fTN38Y
-
Nature Biotechnology
@NatureBiotech
Scalable, multimodal profiling of chromatin accessibility, gene expression and protein levels in single cells go.nature.com/3pjUuJH
-
Nature Biotechnology
@NatureBiotech
Seurat v4 allows integration of multimodal single-cell data.
#nbthighlight
www.cell.com/cell/fulltext/S0092-8674(21)00583-3 -
Nature Biotechnology
@NatureBiotech
Tracking cell lineages to improve research reproducibility go.nature.com/3oDxZ2k
-
Nature Biotechnology
@NatureBiotech
Profiling the genetic determinants of chromatin accessibility with scalable single-cell CRISPR screens go.nature.com/32XTnoG
-
Nature Biotechnology
@NatureBiotech
The missing sex. For most of its history, biomedical research and clinical testing has neglected over half of the worldās population. Finally, researchers and funders are starting to recognize the importance of sex differences - @CarolineSeydel go.nature.com/2O4lC0I
-
Nature Biotechnology
@NatureBiotech
Weāre highlighting outstanding Black researchers around the US to celebrate #blackhistorymonth. Today we recognize Theanne Griffith, University of California Davis neuroscientist and author of the science-adventure chapter book series, "The Magnificent Makers" #bhm
-
Nature Biotechnology
@NatureBiotech
The @US_FDA approved nearly as many drugs and biologics in 2020 as it had in 2019 (itself the second highest year since 1996) go.nature.com/3ct79FU
-
Nature Biotechnology
@NatureBiotech
Rapid progress is being made in our understanding of RNAāprotein interactions, their role in disease and their influence on the action of oligonucleotide drugs go.nature.com/36mC9nI
-
Nature Biotechnology
@NatureBiotech
FDALabel for drug repurposing studies and beyond - @US_FDA go.nature.com/39gRlES
-
Nature Biotechnology
@NatureBiotech
A nanogel loaded with IL-2 activates regulatory T cells locally for allograft protection while avoiding adverse effects associated with systemic IL-2 delivery. Work by Jamil Azzi @jazziup and colleagues. stm.sciencemag.org/content/12/569/eaaw4744 #nbthighlight
-
Nature Biotechnology
@NatureBiotech
As approval of the first #covid19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make enough vaccine not for a few million people, but for hundreds of millions go.nature.com/2TrpXuw
-
Nature Biotechnology
@NatureBiotech
A near-infrared genetically encoded calcium indicator for in vivo imaging go.nature.com/34vXpXd
-
Nature Biotechnology
@NatureBiotech
Recent patents related to methods for the mass production of exosomes and engineering of exosomes for therapeutic use go.nature.com/2TpdFD4 rdcu.be/b86mn
-
Nature Biotechnology
@NatureBiotech
Deep brain optogenetics without intracranial surgery go.nature.com/3jzvv1o
-
Nature Biotechnology
@NatureBiotech
Epineural optogenetic activation of nociceptors initiates and amplifies inflammation go.nature.com/2ZXn08H
-
Nature Biotechnology
@NatureBiotech
Antibody engineers seek optimal drug targeting TIGIT checkpoint
Nature Biotechnology
@NatureBiotech
Four antibodies are already in trials to test efficacy against the emerging checkpoint molecule TIGIT, but debate swirls around the importance of Fc binding for drug action - @ElieDolgin www.nature.com/articles/s41587-020-0666-1
-
Nature Biotechnology
@NatureBiotech
Four antibodies are already in trials to test efficacy against the emerging checkpoint molecule TIGIT, but debate swirls around the importance of Fc binding for drug action - @ElieDolgin www.nature.com/articles/s41587-020-0666-1
-
Nature Biotechnology
@NatureBiotech
Inducible de novo expression of neoantigens in tumor cells and mice go.nature.com/2Dfjdef
-
Nature Biotechnology
@NatureBiotech
Metabolic engineering generates a transgene-free safety switch for cell therapy go.nature.com/3iVaTkm
-
Nature Biotechnology
@NatureBiotech
Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking go.nature.com/3eILDvj
-
Nature Biotechnology
@NatureBiotech
3D and 4D bioprinted human model patenting and the future of drug development go.nature.com/37Lyxuh
-
Nature Biotechnology
@NatureBiotech
CRISPR āTAPE : A new proteinācentric sgRNA design algorithm. Brought to you by the @laboratorychild idp.springer.com/transit?redirect_uri=https%3A%2F%2Flink.⦠#nbthighlight
-
Nature Biotechnology
@NatureBiotech
Recent patents for pharmaceutical compounds comprising and treatments using histone deacetylase and DNA methyltransferase inhibitors go.nature.com/3esjQ1p rdcu.be/b4tea
-
Nature Biotechnology
@NatureBiotech
Viral contamination in biologic manufacture and implications for emerging therapies go.nature.com/3eXzraf
-
Nature Biotechnology
@NatureBiotech
Our annual survey of academic spinouts highlights startups tackling intractable viruses with new vaccine design, engineering a reliable source of platelets, universalizing cell therapies, improving cancer screening, and more go.nature.com/2S0NqCD
-
Nature Biotechnology
@NatureBiotech
Dissecting cellular crosstalk by sequencing physically interacting cells go.nature.com/3cLl344
-
Nature Biotechnology
@NatureBiotech
A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy go.nature.com/2u6baMX
-
Nature Biotechnology
@NatureBiotech
Leveraging crowdsourcing to accelerate global health solutions go.nature.com/2GkiBCP
Nature Biotechnology
@NatureBiotech
Strength in numbers: Crowdsourcing challenge seeks new methods to combat drug-resistant #malaria #nbtinthenews via @nd_news news.nd.edu/news/strength-in-numbers-crowdsourcing-challeā¦
-
Nature Biotechnology
@NatureBiotech
Flexible, thin-film electrode for soft auditory brainstem implants from @splacour40 stm.sciencemag.org/content/11/514/eaax9487.full #nbthighlight
-
Nature Biotechnology
@NatureBiotech
Data storage in DNA with fewer synthesis cycles using composite DNA letters go.nature.com/2k7gx9p
-
Post not available here, view on X
Nature Biotechnology
@NatureBiotech
The United States and China should collaborate, not compete, to bring artificial intelligence to healthcare #nbtinthenews via @scrippsresearch www.scripps.edu/news-and-events/blog/read/index.php?id=553
-
Nature Biotechnology
@NatureBiotech
A new Collection, "The 3D genome," showcases the latest methodologies used to study genome organization & our recent understanding of how genome organization & nuclear architecture regulate gene expression, cell fate & cell function in physiology & disease www.nature.com/collections/rsxlmsyslk
-
Nature Biotechnology
@NatureBiotech
The April issue is live www.nature.com/nbt/volumes/37/issues/4
-
Nature Biotechnology
@NatureBiotech
In our January issue: How companies pick a virus to win at #genetherapy - @Cormac_Sheridan rdcu.be/bfJKn
-
Nature Biotechnology
@NatureBiotech
#firstrounders podcast: Christoph Lengauer of @ThirdRockV, @celsiustx & @BlueprintMeds on growing up in Austria, why he nearly gave up research to help settle refugees & and his role in the #henriettalacks story. Sponsored by the MBEE program @jhuaap www.acast.com/en/naturebiotechnologypodcast/first-rounderā¦
-
Nature Biotechnology
@NatureBiotech
Be a part of the conversation on #bigdata and Cancer #precisionmedicine with @ThomasFuchsAI @corrie_painter and @suchisaria. Check out the meeting program go.nature.com/2KRWrYa #bigdatacpm18
-
Nature Biotechnology
@NatureBiotech
Repair of double-strand breaks induced by #crisprāCas9 leads to large deletions and complex rearrangements go.nature.com/2NlkMXM #genomeediting
-
Nature Biotechnology
@NatureBiotech
De novo DNA synthesis using polymerase-nucleotide conjugates go.nature.com/2JMiZOh
-
Nature Biotechnology
@NatureBiotech
Immune-centric network of cytokines and cells in disease context identified by computational mining of PubMed go.nature.com/2JOBmST
-
Nature Biotechnology
@NatureBiotech
Cell-type-specific metabolic labeling of nascent proteomes in vivo go.nature.com/2hgBhuf #proteomics
-
Nature Biotechnology
@NatureBiotech
The July issue is live www.nature.com/nbt/journal/v35/n7/index.html
-
Nature Biotechnology
@NatureBiotech
Digital-to-biological converter for on-demand production of #biologics go.nature.com/2shvPGY #expressionsystems
-
Nature Biotechnology
@NatureBiotech
#reproducibility of computational workflows is automated using continuous analysis go.nature.com/2n1H0ow
-
Nature Biotechnology
@NatureBiotech
At #genedrivestudy? Brush up with our current News Feature: Gene drive overdrive www.nature.com/articles/nbt.3361








































































































































































































































































































































































































































































































































































